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Gene regulation in eukaryotes is tightly controlled at multiple levels to ensure 
proper expression and cellular homeostasis.  Misregulation of gene expression is a 
common source of genetic disease.  One mechanism by which cells are able to control 
gene expression is through the synthesis and degradation of the mRNA molecules 
encoding the genes.  The transcription and degradation of mRNA molecules controls the 
pool mRNAs that are available to the translational machinery.  One of the well-studied 
mRNA decay pathways is the Nonsense-Mediated mRNA Decay pathway (NMD).  
Originally, NMD was discovered as a posttranscriptional mRNA surveillance mechanism 
responsible for the deadenylation-independent decapping and rapid 5’3’ degradation of 
mRNAs that harbor premature termination codons (PTCs).  Approximately one-third of 
all inherited genetic disease and cancers are related to NMD.  It is now known that NMD 
plays a much larger role in the stability and expression of wild-type mRNAs as well.  
Wild-type mRNAs with NMD-targeting signals, which include 1) a translated uORF, 2) a 
long 3’ UTR, 3) leaky scanning leading to out-of-frame initiation of translation, 3) 
programmed ribosome frameshift sites, and 5) regulated alternative splicing variants, are 
rapidly destabilized by NMD.  It has also been observed that some wild-type mRNAs 
contain NMD targeting signals but are not degraded by NMD due to protecting 
mechanism.  Here we show that the SSY5 mRNA in Saccharomyces cerevisiae is a wild-
type mRNA with multiple NMD targeting signals but is not degraded by NMD.  None of 
the current models for NMD protection explain the SSY5 mRNA stability so the 
mechanism of protection is likely to be novel.  Additionally, we show the SSY5 mRNA is 
primarily degraded 5’3’.  We also explore two additional mRNAs, YAP1 and GCN4, in 
S. cerevisiae that also contain at least one NMD-targeting signal but are not degraded by 
NMD.  Elucidating the mechanism of protection from NMD of these three mRNAs will 
provide valuable insight to the underlying molecular mechanisms of NMD, which despite 
thorough investigation remain unclear.  Understanding the molecular intricacies of the 
NMD pathway will allow for the efficient development of NMD-related disease therapies 
with minimal risks and side-effects.   
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CHAPTER 1: 
Introduction 
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1.0 Overview 
 Eukaryotic gene expression is an incredibly intricate process and is controlled 
with high fidelity at many different levels.  When something goes awry at any level in the 
tight control of gene expression the result can be detrimental not only to the cell but to 
the organism as a whole manifesting in cell death and disease.  The most obvious level of 
control is at the level of protein synthesis from the mRNA transcript (translation).  
However, a level of control even before that of translation occurs with the biogenesis of 
the mRNA transcripts (transcription) and also turnover of the mRNA transcripts 
(degradation).  The processes of mRNA transcription and degradation are also tightly 
controlled.  Eukaryotes have evolved several quality control (QC) mechanisms to help 
maintain the fidelity of gene expression by quickly riding the cell of aberrant mRNAs 
(Lykke-Andersen and Bennett, 2014).  It is now known that these pathways can also be 
exploited to regulate gene expression of wild-type mRNAs.  One of the most extensively 
studied QC mechanisms is the nonsense-mediated mRNA decay (NMD) pathway.  
However, despite extensive study and characterization over the past several years the 
exact molecular mechanisms of NMD are not entirely known. 
 The NMD pathway was originally characterized for its role in the rapid 
degradation of mRNAs that contain a premature termination codon (PTC).  If these PTC-
containing mRNAs were not rapidly removed from the translatable pool they would lead 
to the build-up of C-terminally truncated proteins, which could result in deleterious 
consequences (Akimitsu, 2008; Baker and Parker, 2004; Behm-Ansmant et al., 2007; 
Chang et al., 2007; Frischmeyer and Dietz, 1999; Hentze and Kulozik, 1999; Hilleren and 
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Parker, 1999; Muhlemann et al., 2008; Schweingruber et al., 2013; Shyu et al., 2008).  
The NMD pathway plays a vital role in the regulation of gene expression and exists in all 
eukaryotes that have been examined including yeast, Drosophila, Caenorhabditis 
elegans, Arabidopsis, and humans (Bedwell et al., 1997; Grimson et al., 2004; Hall and 
Thein, 1994; He et al., 2003; Hentze and Kulozik, 1999; Kalyna et al., 2012; Kurihara et 
al., 2009; Maquat and Carmichael, 2001; Maquat and Serin, 2001; Mendell et al., 2004; 
Pulak and Anderson, 1993; Rayson et al., 2012; Rehwinkel et al., 2005; Sun and Maquat, 
2000).  Importantly, it is now recognized that the NMD pathway is also responsible for 
the degradation of a significant portion of wild-type mRNAs (non-PTC-containing) as 
well.  Studies in Saccharomyces cerevisiae, Drosophila, C. elegans, Arabidopsis, and 
humans have revealed that a significant portion of the transcriptome is affected when the 
NMD pathway is inactivated (Guan et al., 2006; He et al., 2003; Johansson et al., 2007; 
Kalyna et al., 2012; Lelivelt and Culbertson, 1999; Mendell et al., 2004; Mitrovich and 
Anderson, 2005; Peccarelli and Kebaara, 2014; Rayson et al., 2012; Rehwinkel et al., 
2005). 
 The NMD pathway requires to coordinated action of the three core trans-acting 
factors, up-frameshift proteins Upf1, Upf2 and Upf3, which have orthologs in all 
eukaryotes examined (Applequist et al., 1997; Cali et al., 1999; Cui et al., 1995; Denning 
et al., 2001; Gatfield et al., 2003; He and Jacobson, 1995; Hodgkin et al., 1989; Isken and 
Maquat, 2008; Jeong et al., 2011; Leeds et al., 1991; Leeds et al., 1992; Lykke-Andersen 
et al., 2000; Pulak and Anderson, 1993).  It has been shown that mutation or deletion in 
any of the genes coding for these three factors results in the stabilization of NMD-
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substrates (Cui et al., 1995; He and Jacobson, 1995; Leeds et al., 1991; He et al., 1997; 
Lee and Culbertson, 1995; Lelivelt and Culbertson, 1999; Maderazo et al., 2000).  Upf1 
is the most highly conserved of the three NMD factors and is enriched in binding to 
NMD substrates (Johansson et al., 2007).  This ~109 kDa protein exhibits both RNA-
dependent ATPase activity and 5’3’ ATP-dependent RNA helicase activity in addition 
to RNA binding (Altamura et al., 1992; Bhattacharya et al., 2000; Czaplinski et al., 1995; 
Weng et al., 1996a, b).  Upf1 interacts with the eukaryotic translation release factors 
eRF1 and eRF3, and upon recognition of an NMD substrate interacts with Upf2 (directly) 
and Upf3 (indirectly) to form a surveillance complex (Czaplinski et al., 1999; Czaplinski 
et al., 1998; Ivanov et al., 2008; Kadlec et al., 2006).  There is evidence to support the 
idea that the formation of the surveillance complex occurs through the staged assembly of 
two subcomplexes—1) Upf1/eRF1/eRF3 and 2) Upf2/Upf3—which come together to 
form a complete NMD mRNP (Atkin et al., 1997).  Additionally, Upf1 has also been 
shown to interact with mRNA decay factors Dcp1 and Dcp2 as well as Ski7, an exosome-
associated protein (Lykke-Andersen, 2002; Takahashi et al., 2003).  Upf1 localizes 
predominantly to the cytoplasm, but can shuttle between the nucleus and the cytoplasm 
(Lykke-Andersen et al., 2000; Mendell et al., 2002).  Upf2 interacts with both Upf1 and 
Upf3 likely serving as a bridge between the two proteins (He et al., 1997; Lykke-
Andersen et al., 2000).  The N-terminal domain of Upf2 contains multiple nuclear 
localization signals but the protein localizes predominantly to the perinuclear region of 
the cytoplasm (Lykke-Andersen et al., 2000; Mendell et al., 2002; Muhlemann et al., 
2008).  Upf3 is the smallest and least conserved of the three core NMD factors and 
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contains multiple nuclear localization and nuclear export signals (Lee and Culbertson, 
1995; Lykke-Andersen et al., 2000; Serin et al., 2001; Shirley et al., 1998). 
 The exact mechanism by which the cellular machinery identifies an NMD-
substrate, whether the mRNA contains a PTC or is a wild-type mRNA with an NMD-
targeting signal (discussed below), among all mRNAs remains unclear despite thorough 
investigation.  However, it is known that targeting of an mRNA for degradation by NMD 
begins with the recruitment and assembly of the NMD mRNP, which consists of the three 
core factors discussed above (Nicholson et al., 2010; Rebbapragada and Lykke-Andersen, 
2009).  Upf1is the first to interact with the terminating ribosome and release factors eRF1 
and eRF3.  Upf1 then binds to the Upf2/Upf3 subcomplex, mRNA decay factors are 
recruited, and mRNA decay is initiated through deadenylation-independent decapping by 
the Dcp1/Dcp2 decapping complex and 5’3’ mRNA decay by the exonuclease Xrn1 
(Coller and Parker, 2004; Decker and Parker, 1993; Hsu and Stevens, 1993; Maderazo et 
al., 2000; Muhlrad et al., 1994, 1995; Nicholson et al., 2010; Rebbapragada and Lykke-
Andersen, 2009).  It has been shown that presence of poly(A)-binding protein (Pab1), 
which is bound to the 3’ poly(A) tail of the mRNA, is able to inhibit assembly of the 
NMD mRNP when in close proximity to the terminating ribosome (Amrani et al., 2004; 
Behm-Ansmant et al., 2007; Beilharz and Preiss, 2007; Gallie, 1991; Silva et al., 2008; 
Wilusz et al., 2001).  However, the presence of Pab1 is not absolutely required for the 
recognition of NMD substrates by the cellular machinery (Meaux et al., 2008; Roque et 
al., 2015).  Additionally, some mRNAs with long 3’ UTRs—which distances the 
interaction between the terminating ribosome and Pab1—are not affected by NMD-
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mediated mRNA degradation (Kebaara and Atkin, 2009; Nicholson et al., 2010; 
Obenoskey et al., 2014; Rebbapragada and Lykke-Andersen, 2009, Chapter 2).  These 
observations suggests that other mechanisms exist that are able to antagonize activation 
of the NMD pathway.  Because of the critical role of NMD in the regulation of gene 
expression and in the development of many human diseases it is critical in moving 
forward to identify the exact mechanism(s) by which the cellular machinery distinguishes 
an NMD substrate from the rest of the mRNA pool. 
 
2.0 NMD in Human Health 
Due to the vital role of NMD in the fidelity of gene expression it is not surprising 
that as many as 33% of all genetic disorders and inherited cancers are directly linked to 
NMD (Culbertson, 1999; Frischmeyer and Dietz, 1999).  The majority of these result as a 
consequence of the cell not being able to produce sufficient levels of full-length protein.  
A few of these prominent disorders include β-thalassemia, Duchene’s and Becker’s 
Muscular Dystrophy, Marfan Syndrome, and Cystic Fibrosis (Bhuvanagiri et al., 2010; 
Frischmeyer and Dietz, 1999; Khajavi et al., 2006).   
β-thalassemia, a disorder of hemoglobin production, is an example that portrays 
the protective effects of NMD.  This disease has multiple genetic and phenotypic variants 
all related to NMD and PTCs in the HBB mRNA which codes for the β-globin protein.  A 
homozygous PTC mutation able to trigger NMD in both β-globin alleles results in a 
deficiency of tetrameric hemoglobin, which requires both α-globin and β-globin, and 
leads to severe anemia.  However, individuals that are heterozygous for the NMD-
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competent PTC in the β-globin gene are usually able to produce sufficient β-globin and 
remain physically healthy.  Both of these cases, in which the PTC elicits NMD, result in a 
recessive mode of inheritance.  In contrast, a dominant negative form of β-thalassemia 
arises when an individual is heterozygous for an NMD-incompetent PTC (Hall and 
Thein, 1994; Thein et al., 1990a; Thein et al., 1990b).  In this case the PTC does not elicit 
NMD due to a positional effect of its location in the last exon (exon 3) of the β-globin 
gene (Nagy and Maquat, 1998; Thermann et al., 1998).  One model of NMD in 
mammalian cells posits that in order to trigger NMD in mammalian cells a PTC must be 
at least 50-55 nt upstream of the final exon junction that is marked by an exon-junction 
complex (EJC; Neu-Yilik et al., 2011; Thermann et al., 1998).  Because this mutant β-
globin gene does not trigger NMD it results in the production of toxic levels C-terminally 
truncated β-globin which accumulates in precipitation bodies (Neu-Yilik et al., 2011; 
Peixeiro et al., 2011).  These individuals are severely anemic and sometimes require 
transfusions to survive among other developmental complications (Cao and Galanello, 
2010). 
Marfan Syndrome is a connective tissue disorder that results from mutations in 
fibrillin 1 mRNA, and is another example of the protective effects of NMD.  Nonsense 
mutations in the fibrillin 1 mRNA that trigger NMD leading to significantly reduced 
accumulation of functional protein are associated with a milder disease phenotype.  
However, when mutant mRNA escapes degradation by NMD and truncated protein is 
allowed to build up the disease phenotype becomes much more severe (Dietz, 1993; 
Dietz et al., 1993). 
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 The other side of NMD in human disease is the aggravation of disease severity 
due to haploinsufficiency because of the degradation of mRNAs that could potentially 
produce proteins with partial function.  Duchenne’s muscular dystrophy (DMD) is a 
severe form of muscular dystrophy that is caused by lack of functional dystrophin protein 
in skeletal and cardiac muscles.  As many as 98% of the mutations in the dystrophin open 
reading frame result in the introduction of a PTC and subsequent elimination of the 
mRNA by NMD.  However, a less severe form of muscular dystrophy, Becker’s 
muscular dystrophy (BMD), results when mRNAs with PTCs are able to escape NMD 
and produce partially functionally C-terminally truncated dystrophin protein (Kerr et al., 
2001). 
 NMD also plays a role in a portion of Cystic Fibrosis patients as well.  Cystic 
fibrosis results from mutations in the mRNA that codes for Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR) protein.  Several different mutations in 
the mRNA can result in the clinical manifestation of Cystic Fibrosis.  Different mutations 
in the mRNA are categorized into classes and affect the CFTR protein at different stages 
of development.  Class I mutations are those that result in a PTC and cause the 
degradation of the mRNA through the NMD pathway.  Thus, the CFTR protein is never 
able to reach the cell membrane where it is needed.  These mutations represent 
approximately 10% of the mutations that cause Cystic Fibrosis (Bhuvanagiri et al., 2010; 
Rogan et al., 2011). 
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2.1 Nonsense Codon Readthrough Therapies 
 Given the role of NMD in the clinical outcome of a significant portion of 
detrimental diseases it is of no surprise the NMD pathway is a targeted area of clinical 
research.  As discussed above, NMD-associated disease occurs when 1) mRNAs with 
PTCs are rapidly removed from the translatable pool of mRNAs so necessary levels of 
functional protein are never translated, 2) mRNAs with PTCs are able to avoid 
degradation by NMD but still harbor the PTC resulting in the production of only partially 
functional protein, or 3) mRNAs containing PTCs escape NMD which leads to the build-
up of toxic levels of truncated protein. 
 Different therapies are being investigated based on two classes of nonsense 
mutations: 1) those that introduce a PTC as the result of point mutations so the rest of the 
mRNA can still be translated in the native reading frame, and 2) those that introduce a 
PTC as the result of a frameshift mutation leaving the remainder of the mRNA to be 
translated in an alternate reading frame.  The end goal, which is subject to overcoming 
many hurdles, is the synthesis of full-length functional protein from the mutant mRNA 
without perturbing the translation of any other mRNAs. 
 Some of the therapies currently being investigated are the use of aminoglycosides, 
small molecule drugs that promote ribosome readthrough at nonsense codons (e.g. 
Ataluren), suppressor tRNAs, targeted gene repair, antisense oligonucleotides (AOs), and 
the upregulation of proteins that could compensate for loss of the functional protein 
(Kuzmiak and Maquat, 2006; Peltz et al., 2013).  The latter two of these approaches are 
being investigated specifically for the nonsense codons that introduce a PTC as a result of 
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a frameshift mutation, as these provide the more challenging case for therapy 
development.  
 These therapies are promising—some have even made it through late-stage 
clinical trials—and provide hope for individuals living with NMD-associated debilitating 
diseases.  However, there are still many questions related to the basic underlying 
mechanism of the NMD pathway that remain unanswered, which makes therapy 
development both risky and challenging.  Elucidating the basic molecular mechanism of 
NMD and how the cell is able to distinguish NMD substrates from non-NMD substrates 
will be provide crucial information for the development of nonsense therapies as well as 
help to understand the potential risks and side effects of new and current therapies. 
 
3.0 Wild-Type mRNA Degradation by NMD 
 One way by which we can continue to untangle the underlying mechanism of the 
NMD pathway is by studying the category of wild-type mRNAs that are regulated by 
NMD.  Several wild-type mRNA NMD-targeting signals have already been described.  
These include: 1) a long 3’ UTR (Amrani et al., 2004; Kebaara and Atkin, 2009; Muhlrad 
and Parker, 1999), 2) translation of an upstream open reading frame (uORF; Amrani et 
al., 2006; Barbosa et al., 2013; Gaba et al., 2005; Nyiko et al., 2009), 3) a start codon in a 
suboptimal context which can lead to leaky scanning and out of frame initiation of 
translation (Welch and Jacobson, 1999), 4) the presence of programmed ribosome 
frameshift (PRF) sites (Plant et al., 2004) and 5) the presence of pre-mRNA introns and 
11 
 
regulated alternative splicing resulting in PTCs (He et al., 1993; Lewis et al., 2003; 
McGlincy and Smith, 2008; Ni et al., 2007).    
 
3.1 NMD-targeting through the presence of a translated uORF 
 Many mRNAs contain one or more short open reading frames in the 5’ leader 
region of the mRNA known as a uORFs (Nagalakshmi et al., 2008).  These uORFs can 
have many functions but they are best known for their role in regulating mRNA 
translation and mRNA turnover (Arribere and Gilbert, 2013).  A genome-wide study 
conducted in S. cerevisiae projected that out of 220 predicted direct NMD substrates 135 
(~61%) contain putative uORFs (Guan et al., 2006).  The presence of a uORF, when 
translated, leads to the introduction of a stop codon that is far upstream of the native ORF 
stop codon and, thus, may be recognized as a PTC targeting the mRNA for degradation 
by NMD.  It has been shown that active translation of the uORF is required to elicit NMD 
while those mRNAs that contain untranslated uORFs are immune to NMD (Hurt et al., 
2013). 
 At least three mRNAs in S. cerevisiae have been verified as wild-type mRNAs 
that are targeted to NMD by a uORF: the CPA1, FZF1, and ALR1 mRNAs (Gaba et al., 
2005; Guan et al., 2006; Johansson and Jacobson, 2010).  The FZF1 mRNA, which 
encodes a transcription factor involved in sulfite metabolism, provides an interesting case 
in which the uORF begins in the 5’ leader and ends in the coding ORF (Breitwieser et al., 
1993; Guan et al., 2006).  The uORF has two potential start codons at -64 and -58 and the 
stop codon appears in the ORF at position +29.  Interestingly, when each of the two 
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uORF start codons was mutated (ATGAGG) individually the FZF1 mRNA remained a 
target for NMD.  However, when both uORF start codons were mutated simultaneously 
the FZF1 mRNA sensitivity to NMD was abolished.  This data indicates that the uORF, 
as long as both uORF start codons are able to be utilized, is an NMD-targeting feature for 
the FZF1 mRNA (Guan et al., 2006). 
 The CPA1 mRNA encodes the small subunit of carbamoyl phosphate synthetase, 
which plays a role in the synthesis of citrulline—an arginine precursor (Pierard et al., 
1979).  The CPA1 mRNA was originally identified as a wild-type mRNA that is sensitive 
to NMD (He et al., 2003; Ruiz-Echevarria and Peltz, 2000) and was later shown to be 
targeted to NMD by presence of the uORF (Gaba et al., 2005).  The study by Gaba et al., 
(2005) showed that mutation of the uORF start codon (AUGUUG) in a luciferase 
reporter resulted in a 2-fold increase in steady-state accumulation compared to the 
reporter with the wild-type uORF AUG codon in NMD+ cells.  Additionally, the reporter 
with the wild-type uORF AUG codon showed a ~7-fold increase in accumulation in an 
nmd- strain compared to the NMD+ strain (Gaba et al., 2005).  These results provide 
evidence that the CPA1 mRNA is targeted to NMD by presence of the uORF in the 5’ 
leader. 
 Another important example of the regulation of an mRNA by NMD in response to 
the presence of a uORF is the case of the ALR1 mRNA.  The ALR1 mRNA codes for a 
magnesium (Mg2+) transporter at the plasma membrane and is responsible for magnesium 
homeostasis in yeast (Graschopf et al., 2001; MacDiarmid and Gardner, 1998).  A study 
by Johansson and Jacobson in 2010 showed that yeast are able to control the fidelity of 
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translation, in part, by controlling magnesium uptake.  The control of magnesium uptake 
is regulated by the product of the ALR1 mRNA, which is in turn regulated by NMD.  The 
regulation of the ALR1 mRNA by NMD was shown to depend on the presence of a uORF 
in the 5’ leader of the mRNA.  The ALR1 mRNA actually contains three uORFs (and one 
of which has both an A and a B form), but mutational analysis revealed that NMD-
sensitivity could be incurred by the 3’-most uORF (uORF3) alone (Johansson and 
Jacobson, 2010). 
 The idea of regulation of mRNA susceptibility to NMD by the presence of a 
uORF is not exclusive to S. cerevisiae.  Studies in Saccharomyces pombe, C. elegans, 
mammals and plants all show evidence of uORF-containing mRNAs that are upregulated 
when NMD is inactivated (Calvo et al., 2009; Kochetov et al., 2002; Mendell et al., 2004; 
Nyiko et al., 2009; Ramani et al., 2009).   
 
3.2 NMD-targeting through the presence of PRF sites 
 Programmed ribosome frameshift (PRF) sites are cis-acting mRNA sequences 
that cause a ribosome to shift reading frames by one nucleotide either upstream (5’ 
direction) or downstream (3’ direction), -1 or +1 PRF site, respectively.  A -1 PRF site 
appears to be the most common phenomenon and is the best characterized of the two.  
The -1 PRF site consists of a “slippery site,” which is a heptameric mRNA sequence of 
the form X XXY YYZ (in the original reading frame where X is any three identical 
nucleotides, Y is either a triplet A or triplet U sequence, and Z is an A, U or C), followed 
downstream by an mRNA secondary structure of two or more stem-loops known as a 
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pseudoknot (Baranov et al., 2002; Jacks and Varmus, 1985; Namy et al., 2006).  The 
slippery site and the pseudoknot are separated by a region of 5-9 nucleotides known as 
the “spacer” region (Dinman et al., 1991).  The pseudoknot structure causes the ribosome 
to pause and shift its reading frame on the slippery site (Namy et al., 2006).  The binding 
strength of the nucleotides that compose the pseudoknot is directly correlated with the 
efficiency at which the structure is able to induce ribosomal frameshifting (Hansen et al., 
2007).  However, if the strength of the pseudoknot is too strong then it can actually 
decrease the efficiency of translation downstream (Tholstrup et al., 2012).  The +1 PRF 
site, which is less common, consists of a slippery site and at least one additional 
stimulatory element such as a pseudoknot (Ivanov et al., 2000).   
In recent years it has become increasingly evident that both +1 and -1 PRF sites 
are being used to control gene expression in a variety of organisms (Dinman, 2012; 
Namy et al., 2004).  It has been well-studied that viruses use -1 PRF sites to synthesize 
polyproteins from polycistronic mRNAs as a method of genome consolidation (Baril et 
al., 2003; Brierley and Dos Ramos, 2006; Dulude et al., 2002; Jacks and Varmus, 1985; 
Leger et al., 2007).  Additionally, PRF sites are responsible for the generation of an 
Escherichia coli DNA polymerase III subunit (Blinkowa and Walker, 1990) and release 
factor 2 (RF2; Baranov et al., 2002), two yeast telomerase-associated proteins (Aigner et 
al., 2000; Morris and Lundblad, 1997), actin-binding protein Abp140 in yeast (Asakura et 
al., 1998), and all metazoan ornithine decarboxylase antizymes (Ivanov et al., 2000). 
A computational study identified the -1 PRF motif at 260 locations in the S. cerevisiae 
genome, which is ~5.2-fold greater frequency than random chance (Hammell et al., 
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1999).  Further analysis indicated that many of the S. cerevisiae -1 PRF sites would result 
in the ribosome encountering a PTC after resuming translation following the frameshift 
event (Plant et al., 2004).  In a study by Plant et al., in 2004 the yeast PGK1 mRNA, 
which is an extensively characterized and very stable wild-type mRNA, was destabilized 
by the addition of a -1 PRF site.  This destabilization was NMD-dependent as the 
construct regained stability in an nmd- strain.  Additional confirmation was done to 
confirm that the destabilization in NMD+ strains was the result of a -1 PRF event (Plant 
et al., 2004).  This same study also showed that there in an inverse correlation between 
mRNA stability (half-life) and the efficiency of ribosome frameshifting.  Further, steady-
state mRNA accumulation is drastically reduced when -1 PRF efficiency is high (Plant et 
al., 2004). 
Thus, the frequency of PRF events among all organisms is greater than originally 
perceived and PRF events could potentially be used as a gene regulatory mechanism 
(Hammell et al., 1999; Plant et al., 2004).  PRF events that cause the ribosome to 
encounter a PTC can subject the mRNA to rapid degradation by NMD which limits the 
translational pool of the mRNA.      
 
3.3 NMD-targeting through leaky scanning 
 The sequence context that surrounds an AUG start codon is largely responsible 
for the ability of a ribosome to properly initiate translation at a particular AUG.  The -6 to 
+6 sequence surrounding the AUG is important in determining translation initiation 
efficiency, with the strongest influence at -3 position (Cigan et al., 1988; Yun et al., 
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1996).  The optimal start codon initiation consensus sequence appears to be 
(A/U)A(A/C)AA(A/C)AUGUC(U/C) (Hamilton et al., 1987).  Should the surrounding 
sequence of the AUG codon be suboptimal the ribosome can bypass the AUG in search 
of an AUG in a better context.  This concept is referred to as “leaky scanning.”  If the 
ribosome initiates at a different downstream start codon the initiation may occur in an 
alternate reading frame, which is referred to as out-of-frame initiation of translation.  
Leaky scanning resulting in out-of-frame initiation of translation may lead to the 
introduction of a PTC in the alternate reading frame being translated, which would 
destabilize the mRNA as a consequence of NMD. 
 In 1987 Sharp and Li developed a mathematical model, called the codon 
adaptation index (CAI), which measured the bias of synonymous amino acid codon 
(different codons that code for the same amino acid) usage which had been shown to 
have a nonrandom distribution (Sharp and Li, 1987).  Later, the CAI equation was 
adapted to model start codon context resulting in the AUGCAI equation to show that there 
is a relationship between codon usage bias and translation initiation context (Miyasaka, 
1999).  Finally, the AUGCAI equation was revised into the AUGCAI(r) equation, which was 
used to test the leaky scanning model for NMD (Guan et al., 2006).  This equation takes 
into consideration the weighted contribution of each nucleotide at each position (from -6 
to +6) and how frequently each nucleotide is used at each position.  The result is a value 
from 0 to 1 that measures the likelihood of translation initiation, and consequently the 
likelihood of leaky scanning, to occur at a particular AUG with 0 being poor and 1 being 
efficient (Guan et al., 2006).  Further, limited experimental analysis led to the general 
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conclusion that AUG codons with an AUGCAI(r) score of ≤0.32 might be good candidates 
for leaky scanning while those with a score ≥0.44 would be poor candidates for leaky 
scanning (Guan et al., 2006).  No examples were shown that have scores in the 0.32-0.44 
range, so whether AUG codons with values in that range are subject to leaky scanning 
remains to be determined. 
The SPT10 mRNA is wild-type mRNA in yeast that exhibits sensitivity to NMD.  
The SPT10 mRNA does contain a uORF in the 5’ leader region, however, mutational 
analysis of the uORF start codon (AUGCCC) revealed that translation of this uORF 
has little to do with the susceptibility of the mRNA to NMD (Welch and Jacobson, 1999).  
To determine the cis-element responsible for the SPT10 mRNA susceptibility to NMD 
chimeric reporters were constructed which contained portions of the SPT10 mRNA and 
portions of the well-characterized and stable PGK1 mRNA.  These experiments indicated 
that the mRNA destabilizing element was located within the 5’ UTR and first 94 
nucleotides of the ORF of the SPT10 mRNA.  Further analysis revealed that the ORF 
AUG of the SPT10 mRNA is in a suboptimal context with an AUGCAI(r) value of 0.32 
(Guan et al., 2006).  Given this it was confirmed that the ribosome is able to bypass the 
first AUG and initiate at an AUG in a better context downstream in the +1 reading frame.  
When the ribosome initiates at the second AUG a PTC is encountered just 15 nucleotides 
downstream which targets the mRNA for degradation by NMD (Welch and Jacobson, 
1999). 
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3.4 NMD-targeting through the presence of a long 3’ UTR 
 It has also been shown that wild-type mRNAs with long 3’ UTRs are substrates 
for degradation by NMD in S. cerevisiae, C. elegans, Drosophila, plants and mammals.  
Studies report mRNAs that contain mutations resulting in a long 3’ UTR and synthetic 
mRNAs that terminate at a normal stop codon but contain a long 3’ UTR are both 
substrates for NMD (Amrani et al., 2004; Muhlrad and Parker, 1999).   
 This has been most extensively studied in S. cerevisiae in which the normal 3’ 
UTR length is 50-200 nucleotides with a median length of 121 nucleotides (Graber et al., 
1999).  A screen of wild-type mRNAs in S. cerevisiae revealed that 56 mRNAs were 
predicted to have a 3’ UTR of longer than 350 nucleotides (an arbitrary cut-off).  Of these 
56 mRNAs 11 were experimentally tested.  Of these 11 mRNAs 10 accumulated to 
significantly higher levels in a upf1Δ strain compared to wild-type.  Additionally, half-
lives were determined for 5 of the 11 mRNAs and all 5 tested had a significantly longer 
half-life in the upf1Δ strain compared to wild-type (Kebaara and Atkin, 2009).  The one 
anomaly was the SSY5 mRNA.   
 The presence of a long 3’ UTR has also been identified as a cis-acting NMD-
targeting element in Nicotiana benthamiana and Arabidopsis (Kalyna et al., 2012; 
Kertesz et al., 2006).  In plants, increasing the length of the 3’ UTR correlates with an 
increase in NMD efficiency (Kertesz et al., 2006).  The same correlation has been 
observed in murine embryonic stem cells as well (Hurt et al., 2013).  Additionally, human 
mRNAs with long 3’ UTRs are also subject to NMD and some of these mRNAs are those 
that code for crucial NMD factors, which predicts a feedback loop (Longman et al., 2013; 
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Yepiskoposyan et al., 2011).  Further studies show that this regulatory feedback loop is 
conserved across different organisms (Longman et al., 2013).  
The collective data from many of these studies supports a model developed by 
Amrani et al., in 2004 known as the faux 3’ UTR model.  This model is based on the idea 
that the cellular machinery recognizes a PTC because the terminating ribosome and 
associated factors are positioned too far upstream from the poly(A) tail (Amrani et al., 
2004; Muhlrad and Parker, 1999).  The distance between the termination complex and the 
poly(A) tail fails to initiate the normal interaction of the ribosome-bound eRF3 with 
poly(A) tail-bound protein Pab1 (Behm-Ansmant et al., 2007).  Because this interaction 
fails to occur the termination complex is subject to recruitment of the NMD factors and 
subsequent degradation (Amrani et al., 2004; Brogna and Wen, 2009).  Further, artificial 
tethering of Pab1 in close proximity to a prematurely terminating ribosome is able to 
abrogate NMD-sensitivity (Amrani et al., 2004).  The faux 3’ UTR model is able to 
explain the degradation of mRNAs by NMD that contain PTCs and also those mRNAs 
that are substrates for NMD because of a long 3’ UTR. 
This regulation of wild-type mRNAs by NMD due to the presence of a long 3’ 
UTR may also be physiologically relevant as revealed by the PGA1 mRNA.  The PGA1 
mRNA codes for an essential component of the GPI-mannosyl-transferase II, which is 
involved in the synthesis of GPI anchors that are added to proteins for membrane 
attachment (Sato et al., 2007).  The PGA1 mRNA also has a 3’ UTR of ~750nt and is a 
substrate for NMD (Kebaara and Atkin, 2009).  Interestingly, NMD has also been shown 
to regulate the expression of a set of mRNAs involved the assembly of GPI-anchored cell 
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wall proteins (Guan et al., 2006).  Consistent with this, cells of the upf1Δ strains are much 
more sensitive to Calcofluor White (a fluorescent stain that binds to cellulose and chitin 
in cells walls and can compromise cell wall integrity at high concentrations; Kebaara and 
Atkin, 2009). 
 
3.5 NMD-targeting through pre-mRNA introns and alternative splicing  
 Wild-type pre-mRNAs that escape to the cytoplasm still containing introns as 
well as regulated alternative splicing are related events that also provide wild-type 
mRNAs that become NMD substrates.  In yeast, the CYH2, RP51B, and MER2 pre-
mRNAs are inefficiently spliced and are substrates for the NMD pathway.  In wild-type 
cells a very small accumulation of all three pre-mRNAs is observed while in upf1Δ cells 
the pre-mRNAs accumulate to significantly higher levels and have longer half-lives (He 
et al., 1993).  It was also shown that the three mRNAs associate with ribosomes, which is 
consistent with 1) these inefficiently spliced mRNAs are escaping to the cytoplasm, and 
2) the notion that NMD is a translation-dependent mechanism (He et al., 1993; Peltz et 
al., 1993).  The inefficient splicing of these pre-mRNAs and their subsequent association 
with ribosomes results in the translating ribosome, which begins at the normal ORF 
translation initiation site, terminating at a PTC, which triggers NMD. 
 Similarly, many alternative splicing events result in mRNAs that introduce a PTC 
in the normal reading frame.  Because these alternative splicing events are regulated it is 
likely that alternative-splicing induced NMD serves an intentional role in gene regulation.  
Studies of regulated alternative splicing events showed that this is indeed the case in 
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mammalian cells where NMD is exploited to achieve post-transcriptional regulation by 
destabilizing certain mRNA isoforms (Cuccurese et al., 2005; Lejeune et al., 2001; 
Sureau et al., 2001; Weischenfeldt et al., 2012; Wollerton et al., 2004).  Notably, the 
polypyrimidine tract binding protein, PTBP1, and the SC35 protein are regulators of 
alternative splicing and the proteins themselves are encoded by mRNAs that are subject 
to alternative-splicing induced NMD in HeLa cells (Sureau et al., 2001; Wollerton et al., 
2004).  Alternative-splicing induced NMD is also responsible for the regulation 
ribosomal genes in mammalian cells and in C. elegans (Cuccurese et al., 2005; Mitrovich 
and Anderson, 2000). 
 Although a very small percentage of S. cerevisiae mRNAs contain introns, a 
recent study by Kawashima and colleagues in 2014 found that of those mRNAs that do 
contain introns many produce nonproductive alternatively spliced mRNAs that resulted in 
degradation by NMD (Kawashima et al., 2014).  Studies also confirm alternatively 
spliced mRNA isoforms that are subject to NMD in Drosophila, Arabidopsis and 
zebrafish (Hansen et al., 2009; Jaillon et al., 2008; Kertesz et al., 2006). 
 
4.0 Mechanisms of Protection of Wild-Type mRNAs from NMD 
 Although it has been widely shown that wild-type mRNAs containing certain 
NMD-targeting features (and there are likely additional features that remain to be 
discovered) are substrates for NMD, there are exceptions.  Some mRNAs have one or 
more NMD-targeting element discussed above but show no significant difference in 
steady-state accumulation or half-life in wild-type versus upf1Δ cells (Kebaara and Atkin, 
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2009; Obenoskey et al., 2014; Ruiz-Echevarria et al., 1998; Vilela et al., 1998) (Chapter 
2).  A few mechanisms that are able to protect mRNAs with NMD-targeting signals from 
degradation by NMD have been discovered.  Given that these mechanisms are not able to 
explain the stability of all mRNAs that are protected from NMD (e.g. SSY5 mRNA) 
future studies are likely to expand this list.  It is important that we identify all of the wild-
type mRNA NMD-targeting mechanisms as well as the features that are able to protect an 
mRNA from degradation by NMD so that we can gain a deeper more comprehensive 
understanding of the molecular mechanisms of gene regulation by NMD.  This 
information can then be exploited for safer and more efficient therapy development for 
individuals that are affected by NMD-related diseases. 
 
4.1 Inhibition of translation 
 Several observations have led to the idea that NMD is a translation-dependent 
process.  First, NMD is perturbed by translation elongation inhibitors such as 
cycloheximide (Herrick et al., 1990; Zhang et al., 1997; Zuk and Jacobson, 1998).  
Additionally, NMD is able to resume once the drug is removed (Zhang et al., 1997).  
Second, mutations that block translation elongation, such as the addition of strong stem-
loops (pseudoknots) or mutations in the tRNA nucleotidyltransferase, also inhibit NMD 
(Peltz et al., 1992; Tholstrup et al., 2012).  Third, PTC-containing mRNAs do co-
fractionate with polyribosomes in a pattern that reflects the position of the PTC (i.e. early 
PTCs result in mRNAs in lighter fractions whereas later PTCs result in mRNAs in the 
heavier fractions; He et al., 1993).  Fourth, PTC suppression or stop codon readthrough 
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promoted by suppressor tRNAs results in the stabilization of nonsense containing 
mRNAs (Gozalbo and Hohmann, 1990; Keeling et al., 2004).  Fifth, eukaryotic release 
factors eRF1 and eRF3 are essential for NMD and only interact with a terminating 
ribosome when a stop codon is recognized in the A site during translation (Bertram et al., 
2001; Czaplinski et al., 1998; Kisselev et al., 2003; Rospert et al., 2005).  Together these 
observations lead us to the conclusion that if an mRNA is not actively translated then the 
mRNA is not likely to be degraded by the NMD machinery.  
 
4.2 Stop Codon Readthrough 
 Translation termination begins when any of the three stop codons (UAA, UGA 
and UAG) move into the ribosomal A site.  When the stop codon appears in the A site a 
release factor binds since there is no tRNA that corresponds to any of the three stop 
codons.  Binding of the release factor mediates the cleavage of the polypeptide chain 
from the tRNA in the ribosomal P site.  In eukaryotes the two release factors are eRF1 
(encoded by the SUP45 mRNA) and eRF3 (encoded by the SUP35 mRNA).  eRF1, a 
class I release factor, recognizes all three stop codons and eRF3, a class II release factor, 
forms a complex with eRF1 to mediate termination through GTP-dependent hydrolysis 
(Bertram et al., 2001; Kisselev et al., 2003; Rospert et al., 2005). 
Just as the start codon of an mRNA has an optimal and suboptimal surrounding 
sequence context that varies translation initiation efficiency, the efficiency at which the 
stop codon is recognized is also influenced by the surrounding sequence context.  In S. 
cerevisiae the nucleotide with the most prominent influence is the one immediately 
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following (3’) the trinucleotide stop codon.  The nucleotide at this position can influence 
the ability of the ribosome efficiently terminate at the stop codon by at least 100-fold 
(Bonetti et al., 1995).  This has led to the idea that translation termination is actually 
directed by a tetranucleotide sequence rather than a trinucleotide sequence.  Additionally, 
the six nucleotides upstream and downstream of the stop codon can also influence 
termination efficiency, but to a smaller degree (Namy et al., 2001).  A ribosome can fail 
to terminate translation at a termination codon by incorporating a near-cognate 
aminoacyl-tRNA, which complements the sequence of the stop codon at two out of three 
nucleotide positions, into the ribosomal A site instead of the release factor (Fearon et al., 
1994).  This occurrence is known as stop codon suppression, also frequently referred to 
as translational readthrough or leaky termination.  The result is a continually growing C-
terminally extended polypeptide chain that can have significantly altered function, even if 
only a few amino acids are added (DePristo et al., 2005; Namy et al., 2002).  The ORF 
stop codon of many yeast mRNAs is followed immediately by more in-frame stop-
codons which can serve as a secondary protection if readthrough of the first stop codon 
were to occur (Williams et al., 2004). 
It is interesting, but not surprising, that the ability of the ribosome to readthrough 
a PTC is able to suppress degradation of the mRNA by NMD.  Reading through a PTC 
may cause the incorporation of one wrong amino acid, but the rest of the polypeptide 
remains unchanged since the reading frame was not altered (Keeling et al., 2004).  Once 
the ribosome bypasses the PTC by incorporating a near-cognate aminoacyl-tRNA instead 
of a release factor translation is able to proceed until the normal ORF stop codon is 
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recognized.  This is the basis for the nonsense suppression therapies that target 
readthrough of PTC so the cells can produce full-length functional protein (Finkel, 2010; 
Gunn et al., 2014; Peltz et al., 2013).  A potential challenge to this approach is the ability 
to cause readthrough of the PTC without perturbing translation termination at the natural 
stop codon, especially if the PTC and natural Stop codon are the same triplet codon. 
The idea of stop codon readthrough can also be applied to those mRNAs that are targeted 
for degradation by a long 3’ UTR.  If the faux 3’ UTR model is correct, which there is 
much evidence to support this, then translation termination at a normal stop codon 
followed by a long 3’ UTR would place the terminating ribosome in an improper special 
context for the termination complex to interact with Pab1 (Amrani et al., 2004; Behm-
Ansmant et al., 2007; Brogna and Wen, 2009; Muhlrad and Parker, 1999).  Thus, if 
readthrough of the stop codon were to occur—even though the stop codon is not a PTC—
and terminate at another in frame stop codon downstream (i.e. in closer proximity to the 
poly(A) tail), it would result in two important outcomes: 1) a C-terminally extended 
polypeptide which could have altered function, either harmful or beneficial, and 2) the 
mRNA, which originally had a long 3’ UTR, would no longer be a substrate for NMD. 
 
4.3 Translation Reinitiation 
 Another mechanism by which mRNAs can avoid degradation by NMD is by 
reinitiation of translation at a downstream AUG after termination at a PTC.  Evidence of 
reinitiation as an NMD-antagonist comes from a studies of the human β-globin mRNA.  
In humans, NMD appears to be positional dependent.  It has been shown that typically 
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mRNAs with PTCs at the 3’ end of the mRNA fail to trigger NMD which can result in 
the build-up of C-terminally truncated proteins.  This follows an exon-junction complex 
(EJC) model in which presence of an EJC triggers degradation of an mRNA if 
termination occurs more than 50-55nt upstream of the final EJC (Chamieh et al., 2008; 
Le Hir et al., 2001; Lykke-Andersen et al., 2001; Shibuya et al., 2004; Singh et al., 2007).  
EJC-independent NMD has also been observed, but most of these examples are based on 
the improper spatial context of the terminating ribosome and the poly(A) tail.  This 
follows the faux 3’ UTR model in that PTCs located near the 3’ end of the mRNA, thus 
in closer spatial context to the poly(A) tail, may fail to trigger NMD because the 
termination event would provide normal termination interactions between eRF3 and the 
poly(A) binding protein (PABP in humans, Pab1 in yeast; Amrani et al., 2004; Behm-
Ansmant et al., 2007; Eberle et al., 2008; Ivanov et al., 2008; Singh et al., 2008). 
 When a PTC is located near the 3’ end of the β-globin mRNA, allowing the 
mRNA to escape NMD, a C-terminally truncated polypeptide is produced that acts in a 
dominant-negative manner and results in a severe form of heterozygous symptomatic β-
thalassemia (Thein et al., 1990, Hall and Thein 1994).  In contrast, PTCs that are located 
more 5’ in the β-globin mRNA are able to trigger NMD which limits the build-up of 
toxic C-terminally truncated polypeptides.  The result is an asymptomatic form of 
heterozygous β-thalassemia (Nagy and Maquat, 1998; Thermann et al., 1998).  However, 
there is one particular set of mutations in the β-globin mRNA that do not fit this pattern.  
Nonsense mutations in the first exon of the β-globin mRNA, which should activate 
NMD, do not trigger degradation of the mRNA by NMD and do not result in 
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symptomatic β-thalassemia (Inacio et al., 2004; Romao et al., 2000).  In 2011 Neu-Yilik 
and colleagues solved this mystery by showing that PTCs in the first exon do not trigger 
NMD because the ribosome is able to reinitiate translation in exon 2 at Met55.  This 
Met55 is the only in-frame downstream start codon and is located within an optimal 
initiation context.  Importantly, they showed that mutation of the downstream Met55 start 
codon restores the NMD-sensitivity of the mRNA when a PTC is present upstream.  
Additionally, PTCs that are located downstream of this Met55 do trigger NMD (Neu-
Yilik et al., 2011).  Together, these results confirm translation reinitiation as a method of 
protecting mRNAs from degradation by NMD, but further examples have not yet been 
demonstrated. 
 
4.4 Trans-acting factor Pub1 
 Two examples of wild-type mRNAs with NMD targeting signals that are not 
destabilized by NMD are the YAP1 and GCN4 mRNAs in S. cerevisiae.  These two 
mRNAs contain translated uORFs but show no significant difference in mRNA 
accumulation or half-life (Michel et al., 2014; Ruiz-Echevarria et al., 1998; Vilela et al., 
1998; Chapter 4).  A study by Ruiz-Echevarria and Peltz in 2000 identified the trans-
acting factor poly(U)-binding protein, Pub1, as the mechanism responsible for the 
protection of these two mRNAs from NMD.  They determined that Pub1 bound to 
stabilizer elements (STEs) located in the 5’ leader region of the mRNA.  When Pub1 was 
removed from the cells (pub1Δ strains) the mRNAs were significantly destabilized and, 
importantly, this destabilization was dependent on NMD factor Upf1 (Ruiz-Echevarria 
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and Peltz, 2000).  However, this data was not reproducible in a follow-up study 
(unpublished data, Chapter 4). 
 
5.0 Perspective and Discussion 
 Although originally discovered as a surveillance mechanism, further studies of 
NMD provide evidence that this mechanism of mRNA turnover plays a significant role in 
regulating the fragile and intricate process of eukaryotic gene regulation.  When gene 
regulation is in check and expression is occurring normally then organisms achieve 
cellular homeostasis which leads to overall health.  However, when gene regulation goes 
awry it most often results in cellular malfunction and the development of disease.  The 
NMD pathway has been shown to play a role in the development of a significant number 
of diseases.  Interestingly, NMD has been shown to play both a protective and 
aggravating role in the development of disease.  If the C-terminally truncated proteins 
produced from an mRNA with a PTC would be toxic to the cell then NMD serves a 
protecting role.  However, if the truncated protein would still retain enough activity to be 
at least partially functional, then continually degrading the mRNA leads to a severe 
deficiency of the protein.  Because inherited PTCs play a role in the development of a 
significant number of genetically related diseases and cancers researchers are actively 
pursuing ways of modulating the cellular machinery in order to suppress or readthrough 
the nonsense codon.  Because PTCs can arise through a variety of mechanism (point 
mutations, insertions or deletions, errors in alternative splicing) the approach to nonsense 
suppression is not likely to be universal for all PTCs.  Accordingly, it is much easier to 
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approach nonsense suppression of PTCs that have arisen due to a point mutation than it is 
to approach the suppression of PTCs that have arisen in a way that would cause a shift in 
the downstream reading frame.  The latter of these also poses the complication 
introducing multiple downstream PTCs due to the shift in reading frame.   
 It is important to point out that we currently do not have a thorough understanding 
of the molecular mechanisms of NMD.  Notably, it remains elusive as to exactly how a 
cell is able to distinguish a normal termination event from a premature termination event.  
Several models have been proposed but so far none of them are able to fully explain all of 
the observed results of the summation of NMD studies.  Considering the diversity of 
results in studies aiming to elucidate the mechanism behind PTC versus normal 
termination codon (NTC) differentiation it is reasonable to hypothesize that this 
mechanism may be cell/tissue-specific.  Indeed the faux 3’ UTR model seems to provide 
the most comprehensive model and is supported by a significant number of studies and 
observations.  
 Additionally, only recently have we begun to appreciate the full breadth of wild-
type gene regulation by NMD.  Genome-wide studies in various organisms all provide 
evidence that NMD plays a significant role outside of mRNA surveillance.  As the 
studies of wild-type gene regulation by NMD continue to expand our knowledge we are 
likely to gain a better understanding of additionally NMD-targeting mechanisms as well 
as NMD-protection mechanisms.  These studies are important as they may provide 
valuable insight into understanding the underlying mechanisms of NMD. 
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 Understanding the intricate molecular mechanisms of NMD will provide a more 
solid foundation for the treatment of NMD-related diseases.  Therapies can be developed 
with greater efficiency and, with a better understanding of the overall role of NMD in the 
cell, we can minimize side-effects and risks associated with disease therapy.  
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CHAPTER 2 
Saccharomyces cerevisiae SSY5 mRNA is a wild-type mRNA with multiple NMD-
targeting signals but is not degraded by NMD   
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Abstract 
Nonsense-mediated mRNA decay is a translation-dependent surveillance 
mechanism responsible for rapidly degrading mRNAs with premature termination codons 
(PTCs).  However, there is a significant portion of mRNAs that do not contain a PTC but 
are substrates for the NMD pathway.  The underlying mechanisms of how the cellular 
machinery determines whether or not to degrade an mRNA via the NMD pathway are not 
well understood.  Here we present the case of the Saccharomyces cerevisiae SSY5 
mRNA, which is a wild-type mRNA containing multiple NMD-targeting signals, but is 
not degraded by the NMD pathway.  We demonstrate that known mechanisms for the 
protection of mRNAs from NMD do not apply to SSY5 mRNA as the mRNA is translated 
and we do not find evidence of stop codon readthrough or translation reinitiation.  Thus, 
the protection of the SSY5 mRNA from NMD is likely due to a novel mechanism that 
may provide further clues in unraveling the mystery of gene regulation and substrate 
recognition by NMD.  
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Introduction 
Nonsense-mediated mRNA decay (NMD) was historically identified as a post-
transcriptional surveillance mechanism responsible for the rapid degradation of mRNAs 
containing premature termination codons (PTCs; Gonzalez et al., 2001; Isken and 
Maquat, 2008; Muhlemann et al., 2008).  The identification of a termination event as 
premature and the subsequent activation of the NMD machinery is critical for cellular 
homeostasis as this process ensures that truncated proteins, which can otherwise have 
dominant-negative deleterious effects, are not allowed to build up in the cell (Hentze and 
Kulozik, 1999; Hilleren and Parker, 1999; Maquat and Serin, 2001).  Additionally, a role 
for NMD is implicated in as many as one third of inherited genetic diseases and cancers 
(Frischmeyer and Dietz, 1999).   
NMD requires the coordinated activity of three core factors: Upf1, Upf2 and 
Upf3.  Mutations or deletions in one or more of the genes encoding these factors 
stabilizes NMD substrates (Cui et al., 1995; He et al., 1997; He and Jacobson, 1995; Lee 
and Culbertson, 1995; Maderazo et al., 2000).  Importantly, NMD is conserved from 
yeast to humans and has been observed in all eukaryotes examined (Bedwell et al., 1997; 
Hall and Thein, 1994; He et al., 2003; Hentze and Kulozik, 1999; Maquat and 
Carmichael, 2001; Maquat and Serin, 2001; Mendell et al., 2004; Pulak and Anderson, 
1993; Rehwinkel et al., 2005).  However, the mechanism underlying the identification of 
a termination event as premature and the subsequent rapid activation of the NMD 
pathway remains largely obscure.  Moreover, it has also been observed that NMD has an 
impact on the accumulation of 3-10% of yeast mRNAs, many of which do not contain 
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PTCs (Culbertson, 1999; Guan et al., 2006; Lelivelt and Culbertson, 1999).  Thus, we are 
beginning to appreciate a broader role for NMD in the overall regulation of gene 
expression.  Given this, it has become increasingly important to understand the 
underlying mechanisms of the NMD pathway and how an mRNA is able to trigger 
degradation by NMD. 
Aside from the presence of a PTC in an aberrant mRNA, there are several known 
features that can target a wild-type mRNA for degradation by NMD: 1) a long 3’ UTR 
(Amrani et al., 2004; Kebaara and Atkin, 2009; Muhlrad and Parker, 1999), 2) translation 
of an upstream open reading frame (uORF; Amrani et al., 2006; Barbosa et al., 2013; 
Nyiko et al., 2009), 3) a start codon in a suboptimal context which can lead to leaky 
scanning and out of frame initiation of translation (Welch and Jacobson, 1999), 4) the 
presence of programmed ribosome frameshift (PRF) sites (Plant et al., 2004), and 5) the 
presence of pre-mRNA introns and regulated alternative splicing resulting in PTCs (He et 
al., 1993; Lewis et al., 2003; McGlincy and Smith, 2008; Ni et al., 2007).  All of these 
NMD-targeting signals can result in either the ribosome terminating in a context that is 
different from a normal termination event (i.e. proximity to the poly(A) tail; signals 1-2) 
or in the introduction of a PTC (signals 2-4).  Comparing wild-type mRNAs that have 
NMD-targeting signals and are degraded by NMD with those that have NMD-targeting 
signals and are not degraded by NMD may provide important insights as to the 
underlying mechanisms of NMD. 
Currently, there are four known mechanisms that can protect a wild-type mRNA 
that has an NMD-targeting signal from degradation by NMD, but there are likely more to 
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be discovered.  These NMD-protecting mechanisms include: 1) inhibition of translation, 
2) translational readthrough (also known as stop codon suppression), 3) reinitiation of 
translation, and 4) trans-acting factors (Carter et al., 1995; Dang et al., 2009; Keeling et 
al., 2004; Neu-Yilik et al., 2011; Noensie and Dietz, 2001; Ruiz-Echevarria and Peltz, 
2000; Wang et al., 2001).  In support of the idea that there are more NMD-protecting 
mechanisms yet to be discovered, we have identified an mRNA, SSY5, in Saccharomyces 
cerevisiae that has multiple NMD-targeting signals but is protected from decay by the 
NMD pathway through a novel mechanism. 
The SSY5 mRNA codes for an essential component of the SPS amino acid sensor 
in S. cerevisiae.  The SPS sensor consists of three subunits: integral membrane protein 
Ssy1, and peripheral membrane proteins Ssy5 and Ptr3.  When extracellular amino acids 
are present a signaling cascade is initiated by the binding of an amino acid to Ssy1, which 
then transduces a signal via Ptr3 to Ssy5.  Ssy5 is a serine protease that consists of two 
domains: an inhibitory N-terminal pro domain and a catalytic C-terminal cat domain.  
During the biogenesis of Ssy5 the two subunits are autolytically cleaved but remain 
noncovalently associated until an activation signal is received (Andreasson et al., 2006; 
Conrad et al., 2014; Ljungdahl, 2009).  Once activated the Ssy5 pro domain is degraded 
by the proteasome and the cat domain cleaves the N-terminal domain of transcription 
factors Stp1 and Stp2, which allows them to enter the nucleus and activate the expression 
of the amino acid permease (AAP) genes (Ljungdahl, 2009).  AAP gene products then 
facilitate the uptake of extracellular amino acids (Fig 1).  Given the importance of Ssy5 
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and the intricacies of the SPS amino-acid-sensing pathway, it is likely that the regulation 
of SSY5 mRNA levels is tightly controlled and has physiological significance.        
 Here we show the wild-type SSY5 mRNA, which has multiple NMD-targeting 
signals, is not degraded by NMD.  Based on previous studies, at least one of the targeting 
signals—the long 3’ UTR—is able to target a reporter mRNA for degradation by NMD 
(Obenoskey et al., 2014).  We demonstrate that many of the current mechanisms for 
protection of an mRNA from NMD do not apply to the SSY5 mRNA.  This provides 
evidence that the SSY5 mRNA is actually protected from degradation by NMD through 
an unknown mechanism.  Thus, the SSY5 mRNA provides a unique and intriguing case to 
help elucidate the underlying mechanisms of gene regulation by the NMD pathway. 
 
Materials and Methods 
Yeast strains 
The yeast strains used in this study are listed in Table 2-1.  All yeast 
transformations were done using Lithium Acetate-Mediated transformation as previously 
described (Gietz and Woods, 2002).  AAY590 was constructed by transforming AAY538 
with the upf1Δ2 fragment from pAA70 using primers oAA48 and oAA79.  
5’-tagged SSY5 mRNA constructs: AAY561 was constructed by transforming 
BY4743 with the fragment amplified from the pFA6a-His3MX6-PGAL1-GFP plasmid 
using primers F4 and R5 containing sequence to target the product to the SSY5 mRNA 5’ 
leader (Longtine et al., 1998).  AAY568 was constructed by sporulation and random 
spore analysis of AAY561.  AAY625 was constructed by transforming AAY568 with the 
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upf1Δ2 fragment from pAA70 using primers oAA48 and oAA79.  AAY630 was 
constructed by transforming BY4743 with the fragment amplified from the pFA6a-
His3MX6-PGAL1 plasmid using primers F4 and R2 containing sequence to target the 
product to the SSY5 mRNA 5’ leader to make AAY559 (Longtine et al., 1998).  AAY630 
was the result of the sporulation and random spore analysis of AAY559.  AAY632 was 
constructed by transforming AAY630 with the upf1Δ2 fragment from pAA70 using 
primers oAA48 and oAA79. 
3’-tagged SSY5 mRNA constructs: AAY572 was constructed by transforming 
BY4741 with the fragment amplified from pFA6a-GFP(S65T)-HIS3MX6 plasmid using 
primers F2 and R1 containing sequence to target the product in-frame just before the 
SSY5 mRNA stop codon (Longtine et al., 1998).  AAY623 was constructed by 
transforming AAY572 with the upf1Δ2 fragment from pAA70 using primers oAA48 and 
oAA79.  AAY581 was constructed by transforming BY4741 with the fragment amplified 
from pFA6a-GFP(S65T)-HIS3MX6 plasmid using primers F2 and R1 containing 
sequence to target the product in-frame just before the SSY5 mRNA stop codon that 
would be used if reinitiation were to occur in the 3’UTR (Longtine et al., 1998).  
AAY585 was constructed by transforming BY4741 with the fragment amplified from 
pFA6a-GFP(S65T)-HIS3MX6 plasmid using primers F2 and R1 containing sequence to 
target the product in-frame just before the SSY5 mRNA stop codon that would be used if 
readthrough were to occur (Longtine et al., 1998).  AAY572, AAY581 and AAY585 
were sequenced to verify that the GFP sequence was inserted into the correct reading 
frame. 
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SSY5 mRNA terminator constructs: AAY576 was constructed by transforming BY4741 
with the fragment amplified from pFA6a-GFP(S65T)-HIS3MX6 plasmid using primers 
F3 and R1 containing sequence to target the product to the SSY5 mRNA stop codon.  
AAY601 was constructed by transforming AAY576 with the upf1Δ2 fragment from 
pAA70 using primers oAA48 and oAA79. 
 
Growth conditions 
Unless otherwise noted yeast cells were grown using standard techniques with 
mild agitation equivalent to 225rpm at 30˚C.  When cells are stated as being grown in a 
certain type of media, the same media was used to grow plate cultures from frozen stock 
and all subsequent liquid cultures.  In this study, YAPD media consists of: 1% yeast 
extract, 2% Bacto-Peptone, 2% dextrose, and 100mg/L Adenine hemisulfate salt; YAPG 
media consists of: 1% yeast extract, 2% Bacto-Peptone, 2% galactose, and 100mg/L 
Adenine hemisulfate salt; and minimal media (SD+amino acids) consists of: 0.67% yeast 
nitrogen base without amino acids, 2% dextrose, 20 mg/L L-Histidine, 30 mg/L L-
Leucine, 20 mg/L L-Methionine, 20 mg/L Uracil, and 30 mg/L L-Lysine. 
 
Utilization of the GWIPS-viz Ribo-seq Genome Browser 
Ribosome profiles were obtained from the QWIPS-viz Ribo-seq Genome 
Browser: gwips.ucc.ie (Michel et al., 2014).  Search: Group [Yeast], Genome [S. 
cerevisiae], Assembly [Apr. 2011 (SacCer_Apr2011/SacCer3)], Position [chrX: 128,943-
128,987].  Select options: Reverse, then PS/PDF [Image configuration: text size-18, 
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image width-1346 pixels, label area width-14 characters, uncheck option to show light 
blue vertical lines], download current browser in PDF. 
 
RNA Extractions 
Yeast strains were grown in 10mL cultures to an OD600 of 0.4-0.6.  Cells were 
harvested by centrifugation, washing in DEPC-ddH20, and flash-freezing in dry 
ice/ethanol or liquid nitrogen.  Cell pellets were stored at -70˚C until used for RNA 
extractions.  RNA extractions were performed as previously described (Kebaara et al., 
2012).  RNA samples were diluted to 1µg/µl in DEPC-ddH20 and stored at -70˚C.  RNA 
quality check gels are performed for every RNA sample (1µl of 1µg/µl Total RNA is run 
through a 0.8% agarose gel to check for degradation). 
 
Quantitative Northern Analysis 
10µg of Total RNA mixed with 3µl Formaldehyde loading dye (Ambion, cat. no. 
8552) was separated through a 1.0% agarose gel containing 5.6% Formaldehyde and 1% 
MOPS (10X MOPS: 0.2 M sodium morpholinopropanesulfonic acid (MOPS), pH 7.0, 
0.05 M sodium acetate, 0.01 M EDTA; adjust pH to 7.0 with 10 M NaOH, do not 
autoclave, store at room temperature in the dark.)  RNA was transferred onto a 
GeneScreen Plus membrane (PerkinElmer) using NorthernMax transfer buffer (Ambion, 
cat. no. 8672) following the manufacturer’s protocol for downward transfer.  The lane 
with the RNA ladder was cut off of the gel before transfer and stained overnight in 
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0.5µg/ml ethidium bromide.  Transfer was allowed to proceed for 2 hours with a 9mm 
thick RNA gel.  Membranes were rinsed in 2X SSC and dried for 15 minutes at 80˚C.   
 Membranes were hybridized with NorthernMax prehybridization/hybridization 
buffer (Ambion # 8677).  32P-labelled probes were synthesized using ~25ng of PCR 
product corresponding to the gene of interest, the RadPrime DNA Labeling system 
(Invitrogen #18428-011), and ∼50 μCi [α-32P]dCTP (3000 Ci/mmol, 10 mCi/ml) (Perkin 
Elmer) following the manufacturer’s protocol.  Probes are purified through a Sephadex 
G-50 column equilibrated with TE pH 8.0.  Membranes were hybridized overnight (12-24 
hours) and then washed once at room temperature with 2X SSPE and once at 65˚C with 
2X SSPE/2% SDS.  Membranes were PhosphorImagedTM (GE Healthcare, Typhoon FLA 
9500) and quantified using the ImageQuantTM software.  All membranes were also 
autoradiographed using a phosphorescent ruler to determine the size of the bands by 
comparison to the RNA ladder.  Membranes are stripped and stored at -20˚C for re-
probing.  Detailed protocol for Northern analysis can be found in Kebaara et al. (2012). 
  
Westerns 
Total protein was extracted as described in Atkin et al., 1995 from 40mls of mid-
log culture (OD600 of 0.4-0.6).  Protein extracts were quantified in triplicate using BSA 
standards (Pierce #23225).  40µg of total protein was separated through a 7.5% SDS-
Polyacrylamide gel and transferred to a .45µM Nitrocellulose membrane.  Blocking was 
done using 5% w/v Carnation® Instant Dry Milk overnight at 4˚C.  Primary GFP 
antibody used was a rabbit polyclonal ChIP-grade antibody (Abcam #ab290) and was 
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incubated at a concentration of 1:2000 diluted in 5% w/v Carnation® Instant Dry Milk 
for 1hr at room temperature (per Abcam protocol).  Secondary antibody was anti-rabbit 
IgG, HRP-linked (Cell Signaling #7074) and was used at a concentration 1:6000 diluted 
in 5% w/v Carnation® Instant Dry Milk for 1hr at room temperature (per Cell Signaling 
protocol).  Pierce ECL Western Blotting Substrate kit (Pierce #32109) was used for 
detection.  Signal was detected using film. 
 
Polyribosome Analysis 
Yeast polyribosome analysis was performed as previously described (Atkin et al., 
1995).  Lysis buffer was composed of 20mM Tris-HCl pH 8.0, 140mM KCl, 1.5 mM 
MgCl2, 1% Triton X, 0.1 mg/ml Cycloheximide, and 1.0 mg/ml Heparin; Cycloheximide 
and Heparin were made fresh and added just before use.  Gradient buffer (50% and 15% 
sucrose) was composed of 20mM Tris-HCl pH 8.0, 140mM KCl, 5.0 mM MgCl2, 0.1 
mg/ml Cycloheximide, 0.5 mg/ml Heparin, and 0.5mM DTT; Cycloheximide, Heparin, 
and DTT were made fresh and added just before use.  15%-50% sucrose gradients were 
made by hand, frozen at -70˚C and thawed at 4˚C overnight just before use.  After 
fractionation RNA was extracted from each fraction using acid phenol/chloroform 
extraction.  Total RNA from each fraction collected was loaded onto an RNA Northern 
gel and transferred to a GeneScreen Plus membrane as described above.  Membranes 
were hybridized with a 32P-labelled probe as described above. 
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Results: 
SSY5 mRNA has multiple NMD-targeting signals 
The wild-type S. cerevisiae SSY5 mRNA was previously identified as an mRNA 
with a long 3’ UTR that is not degraded by the NMD pathway (Kebaara and Atkin, 
2009).  Upon further inspection, we identified three additional potential NMD-targeting 
signals present in the SSY5 mRNA: a translated uORF, a start codon in a poor context, 
and five predicted ribosome frameshift sites (Fig. 2A-B; Belew et al., 2008; Guan et al., 
2006; Michel et al., 2014).   
A map of ribosome footprints in the SSY5 uORF was compiled using the 
GWIPS-viz Ribo-seq Genome Browser (Michel et al., 2014).  The compiled ribosome 
profile (summary profile from all studies) for the SSY5 mRNA uORF is displayed in 
Figure 2B.  The reading frame for the uORF is identified in the middle row (): the ATG 
start codon begins at position 128, 986 (-34) and the UAA stop codon ends at position 
128, 966.  The reading frame for the SSY5 mRNA open reading frame (ORF) is identified 
in the bottom row () with the ATG start codon beginning at position 128, 952 (+1).  
The ribosome density peaks (in red) in the SSY5 mRNA 5’ leader region shows 
ribosomes are present in a periodic pattern that represents translation (Ingolia et al., 
2009).  When the ribosome terminates translation at the end of the uORF this termination 
event can be recognized by the cellular machinery as a premature termination event, 
which would target the mRNA for degradation by NMD (Guan et al., 2006; Hurt et al., 
2013).  
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Targeting to NMD by leaky scanning due to poor translation initiation at the start 
codon is also a likely possibility for the SSY5 mRNA.  Previously, H. Miyasaka 
developed a method for quantifying the surrounding context of an AUG codon 
(Miyasaka, 1999).  This value, the AUGCAI (which stands for start Codon Adaptation 
Index), is built on the concept of the CAI devised by Sharp and Li in 1987 and is used to 
describe the optimal context of an AUG start codon (Miyasaka, 1999; Sharp and Li, 
1987).  The AUGCAI takes into account the nucleotide frequency at each position 
surrounding the AUG from -6 to +6.  Guan et al., (2006) revised the AUGCAI to test the 
leaky scanning model for NMD.  They created the AUGCAI(r) (start Codon Adaptation 
Index revised), which is a score from 0 to 1.0 that takes into account both the frequency 
at which each nucleotide appears at each position from -6 to +6 and how much each 
nucleotide contributes to the overall start codon context, in order to determine the 
efficiency of translation initiation at a particular AUG (Guan et al., 2006).  Scores closer 
to 0 indicate a start codon in a poor context that is more likely to be subject to leaky 
scanning.  Optimal start codon context, defined as (A/U)A(A/C)AA(A/C)AUGUC(U/C), 
is assigned a value of 1.0; however, the frequency of mRNAs with an AUGCAI(r)=1.0 is 
very low (data not shown; Hamilton et al., 1987).  The SSY5 mRNA has an 
AUGCAI(r)=0.375.  In comparison, the AUGCAI(r) of the SPT10 mRNA, which is 
targeted to NMD by leaking scanning, is 0.320 (Guan et al., 2006; Welch and Jacobson, 
1999).  Based on this observation, Guan et al. came to the conclusion that the best 
candidates for leaky scanning are those with an AUGCAI(r) value ≤0.320.  While the 
AUGCAI(r) of the SSY5 mRNA is slightly above this cutoff, a value of 0.375 is still 
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relatively low and suggests that the start codon of the SSY5 mRNA could be subject to 
leaky scanning.  
Programmed ribosome frameshifting (PRF) can also cause an mRNA to become a 
substrate for NMD.  PRF sites are cis-elements within an mRNA that cause a ribosome to 
shift reading frames either in the +1 direction or the -1 direction, although the -1 PRF is 
much more frequent (Jacobs et al., 2007; Plant et al., 2004).  A -1 PRF site is identified 
by the presence of a heptameric “slippery site” sequence (X XXY YYZ, where X is any 
three identical nucleotides, Y is either three A nucleotides or three U nucleotides, and Z 
is either an A, U, or C) followed within eight nucleotides by a sequence that creates an 
RNA pseudoknot (Dinman et al., 1991; Somogyi et al., 1993; Tu et al., 1992).  A 
previous study found that at least 2.54% of S. cerevisiae genes contain a consensus 
sequence for a -1 PRF site.  In contrast to viruses—where the PRF phenomenon was 
originally discovered—the analysis in this study revealed that most of the -1 PRF signals 
in yeast would result in the introduction of a PTC into the reading frame (Hammell et al., 
1999).  We used the Programmed Ribosome Frameshift Database (PRFdb), a database 
that contains computationally predicted -1 PRF sites in eukaryotic genomes, to analyze 
the SSY5 mRNA for the presence of -1 PRF sites (Belew et al., 2008).  The PRFdb 
predicts five potential -1 PRF sites in the SSY5 mRNA at +18, +132, +324, +333, and 
+1728.  Using the GWIPS-viz Genome Browser, which shows all three reading frames of 
an mRNA, we noted that any shift in the reading frame of the SSY5 mRNA results in the 
introduction of multiple stop codons throughout the ORF (Michel et al., 2014).  However, 
the predicted -1 PRF sites in the SSY5 mRNA have not yet been experimentally validated. 
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Finally, long 3’ UTRs have been identified in both S.cerevisiae and humans as 
NMD-targeting signals (Amrani et al., 2004; Eberle et al., 2008; Hogg and Goff, 2010; 
Kebaara and Atkin, 2009; Muhlrad and Parker, 1999; Rebbapragada and Lykke-
Andersen, 2009; Yepiskoposyan et al., 2011).  One explanation for how PTCs trigger 
NMD was proposed in the faux 3’ UTR model which suggests that early translation 
termination (e.g. at a PTC) is distinct from normal termination because the terminating 
ribosome is not in the proper context (e.g. proximity) to interact with 3’ UTR-bound 
poly(A) binding protein, Pab1.  The failed interaction between the terminating ribosome 
and Pab1 leaves the ribosome open for binding of the NMD factors (Upf1, Upf2, and 
Upf3), which triggers NMD.  A long 3’ UTR would place the stop codon, even though it 
is not a PTC, in the same context (i.e. too far from the poly(A) tail for the terminating 
ribosome to bind Pab1) as if it were a PTC.  In S. cerevisiae, most 3’ UTRs are short 
ranging in length from 50-200 nt with a median length of 121nt (Graber et al., 1999).   
The SSY5 mRNA has a 3’ UTR of ~475 nt determined by 3’ RACE (Obenoskey et al., 
2014).  The use of alternative Poly(A) sites is predicted to produce SSY5 mRNA 3’UTRs 
that range from 420-500nt (Kebaara and Atkin, 2009).  
The long 3’ UTR of the SSY5 mRNA has been validated as an NMD-targeting 
signal by replacing the native 3’ UTR of the CYC1 mRNA, which is normally NMD-
insensitive, with the long 3’ UTR of the SSY5 mRNA.  The CYC1-SSY5 3’UTR construct 
is a substrate for NMD indicating that the long 3’ UTR of the SSY5 mRNA is sufficient to 
target an mRNA for degradation by NMD (Obenoskey et al., 2014).  However, the 
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remaining three potential NMD-targeting signals (Fig. 2A 1-3) have yet to be validated as 
positive NMD-targeting signals for the SSY5 mRNA. 
Codon optimality of an mRNA was recently identified as a significant 
determinant of mRNA stability (Presnyak et al., 2015).  A higher composition of codons 
designated as “optimal” results in stable mRNAs whereas a lower composition results in 
unstable mRNAs and higher turn-over.  The optimal codon content of an mRNA also 
influences the elongation rate of the translating ribosome where a lower content of 
optimal codons results in a slower elongation rate (Presnyak et al., 2015).  The optimal 
codon content of SSY5 mRNA is 285 optimal codons out of 698 codons total (subtracting 
out the AUG start codon and UGA stop codon) yielding a 40.83% optimal codon content.  
The original study showed that mRNAs with less than 40% optimal codon content are 
significantly more unstable (median half-life of 5.3 min) than mRNAs with 70% optimal 
codon content (median half-life of 20.1 min; Presnyak et al., 2015).  Thus, SSY5 mRNA 
percent optimal codon content falls much unstable mRNA category than to the stable 
mRNAs.  However, it should be noted that codon optimality is subject to exceptions and 
the contribution of codon optimality specifically to the stability of the SSY5 mRNA 
remains to be experimentally determined. 
The SSY5 mRNA has four of the known NMD-targeting features: 1) a translated 
uORF, 2) a start codon in a poor context based on the AUGCAI(r) value of 0.375, 3) five 
predicted -1 PRF sites that would all introduce multiple downstream stop codons, and 4) 
a long 3’ UTR that would result in the ribosome terminating a long distance from the 
poly(A) tail.  Additionally, the percent of optimal codons that compose the SSY5 mRNA 
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is low, and that alone should destabilize the mRNA.  All of this leads to the rational 
assumption that the SSY5 mRNA should be a substrate for degradation by NMD.  
However, below we show this is not the case. 
 
SSY5 mRNA is not degraded by NMD 
An initial screen of mRNA half-lives (T1/2) in wild-type and upf1Δ strains 
identified the SSY5 mRNA as being unaffected by the NMD pathway (Kebaara and 
Atkin, 2009).  In order to validate these results we grew S.cerevisiae cells in rich growth 
medium (YAPD) and confirmed by quantitative Northern analysis that steady-state SSY5 
mRNA levels show no significant fold change (FC) between wild-type and upf1Δ strains 
(fold change ratio (FCR) of upf1Δ/ wild-type =1.2±0.1) in the BY4741 genetic 
background (Fig. 3A).  Further, the T1/2 of the SSY5 mRNA was not significantly 
different between wild-type (T1/2=33.3min) and upf1Δ strains (T1/2=38.3min; Fig. 3B).  
ENT4 is an mRNA with a long 3’ UTR (~600 nt) that was previously identified in S. 
cerevisiae as a substrate for NMD (Kebaara and Atkin, 2009).  Here we use the ENT4 
mRNA as well as the CYH2 pre-mRNA as positive controls for NMD, and SCR1 serves 
as the loading control. 
It was previously shown that different genetic backgrounds in yeast can influence 
the relative accumulation of nonsense mRNAs in wild-type versus upf1Δ strains to 
varying degrees (Kebaara et al., 2003).  Thus, steady-state SSY5 mRNA levels were also 
determined in wild-type and upf1Δ strains in the W303 genetic background.  Consistent 
with results in the BY4741 background, there was no significant fold change in steady-
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state SSY5 mRNA levels between wild-type and upf1Δ strains (FCR of upf1Δ/wild-type 
=1.1±0.1) in the W303 background (Fig. 3A).  Half-lives were not determined for the 
W303 background in the present study as these were shown in a previous study (Kebaara 
and Atkin, 2009).  The BY4741 and W303 genetic backgrounds are two of the most 
commonly used genetic backgrounds in NMD work with S. cerevisiae.  BY4741 strains 
are derived from S288C and differences between the two are very minor (Brachmann et 
al., 1998).  W303 is a lab strain developed as a model organism and differs from S288C 
at >8,000 nucleotide positions, but still shares >85% of its genome with S288C (Ralser et 
al., 2012).  Based on these results all subsequent experiments were done using strains 
with the BY4741 background. 
 The SSY5 mRNA does not appear to be a substrate for NMD when cells are 
grown in rich media (Fig. 3A-B).  However, since the SSY5 mRNA codes for the catalytic 
subunit of an amino-acid-sensing complex (Fig. 1), we hypothesized that the stability of 
the SSY5 mRNA might vary in different growth conditions.  To test this hypothesis we 
grew the cells in minimal media which contained only the amino acids necessary to 
support the auxotrophies of the strains (Materials and Methods).  The steady-state 
accumulation of the SSY5 mRNA was not significantly different between wild-type and 
upf1Δ strains (FCR=1.1±0.2; Fig. 3C).  Additionally, the T1/2 of the SSY5 mRNA was not 
significantly different between wild-type (T1/2=12.4min) and upf1Δ strains (T1/2=13.3min; 
Fig. 3D). Although the T1/2 of the SSY5 mRNA is not significantly different between 
wild-type and upf1Δ strains in both types of media (rich vs. minimal) we did note that the 
overall T1/2 of the SSY5 mRNA in both strains (wild-type and upf1Δ) is much longer in 
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rich media than in minimal media (Fig. 3B vs. Fig. 3C).  This is likely due to the SPS-
sensor being in an active state during growth in rich media leading to higher turnover of 
the Ssy5 component.  An increase in demand for Ssy5 could lead to increased mRNA 
T1/2. 
Typically, NMD substrates are rapidly degraded in wild-type cells and 
accumulate to significantly higher levels in upf1Δ strains.  Additionally, the T1/2 of NMD 
substrates is significantly longer in upf1Δ strains compared to wild-type strains (Cao and 
Parker, 2003; He and Jacobson, 2001; Muhlrad and Parker, 1999).  Based on our results 
for steady-state mRNA accumulation and T1/2 analysis of the SSY5 mRNA in both rich 
and minimal media we conclude that the SSY5 mRNA is not degraded by the NMD 
pathway and this stability is not attributed to differences in environmental amino acid 
content.  However, it should be noted that the minimal media used still contains five 
amino acids, so true amino acid starvation was not obtained due to auxotrophic 
requirements of the strains (Materials and Methods).   
 
Replacing the long 3’UTR of SSY5 mRNA with a short 3’UTR does not influence 
SSY5 mRNA susceptibility to NMD 
 Given that the SSY5 mRNA has multiple NMD-targeting signals (Fig. 2), and that 
at least one of these targeting signals (the long 3’ UTR) is sufficient to target an mRNA 
for degradation by NMD (Obenoskey et al., 2014), yet we do not find an increase in 
steady-state accumulation of SSY5 mRNA or a difference in T1/2 between wild-type and 
upf1Δ strains (Fig. 3A-D) we hypothesize that the SSY5 mRNA is somehow protected 
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from degradation by the NMD pathway.  As a start to identifying the feature(s) and/or 
region(s) of the SSY5 mRNA responsible for protection from NMD we began with the 3’ 
UTR.  Since it has already been determined that the long 3’ UTR of the SSY5 mRNA, 
when placed on a different ORF, is sufficient to target an mRNA to NMD, we began with 
the reciprocal experiment of replacing the long 3’ UTR of the SSY5 mRNA with a short 
3’ UTR (Obenoskey et al., 2014).  To do this we selected the 180nt 3’ UTR of the ADH1 
mRNA (Fig. 4A).  The ADH1 mRNA 3’ UTR was selected for two reasons: 1) it has a 
length that falls within the range of typical S. cerevisiae 3’ UTRs (50-200nt), and 2) the 
tools for replacing the 3’ UTR of an mRNA with the ADH1 3’ UTR are readily available 
and have been validated (Graber et al., 1999; Longtine et al., 1998). 
 Using quantitative Northern analysis, we found no significant difference in 
steady-state mRNA accumulation of the SSY5+ADH1 3’ UTR mRNA between wild-type 
and upf1Δ strains (FCR=1.1±0.2; Fig. 4B, lanes 2 and 3).  Likewise, there was no 
significant increase in T1/2 of the SSY5+ADH1 3’ UTR mRNA in the upf1Δ strain 
(T1/2=16.3min) compared to the wild-type strain (T1/2=12.3min; Fig. 4C).  However, we 
did observe a higher accumulation of SSY5+ADH1 3’ UTR mRNA in both wild-type and 
upf1Δ strains compared to the normal SSY5 mRNA (FCR=1.6±0.2 and FCR=1.7±0.0, 
respectively; Fig. 4B, compare lanes 2 and 3 with lane 1).   
 Additionally, because SSY5 mRNA codes for an essential component of the SPS 
amino-acid-sensing complex we wanted to see if altering the 3’ UTR of the SSY5 mRNA 
had any influence on the function of Ssy5.  We considered this because sequence 
elements lead to speculation that readthrough of the annotated SSY5 mRNA stop codon is 
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a possibility (discussed below, Fig. 7).  If readthrough is occurring, then it is possible that 
replacing the native 3’ UTR of the SSY5 mRNA could influence Ssy5 structure and 
function.  To determine if Ssy5 enzymatic function is compromised in this strain we 
chose to look at mRNA accumulation of a downstream target of Ssy5.  Ssy5 is 
responsible for the proteolytic processing of the transcription factors Stp1 and Stp2, 
which, after being cleaved by Ssy5, enter the nucleus and upregulate the expression of 
amino acid permease (AAP) genes.  The AGP1 mRNA codes for an amino acid 
transporter with broad substrate range and is one of the AAP genes upregulated in 
response to Stp1/2 cleavage by Ssy5 (Fig.1; Ljungdahl, 2009).  There is no significant 
difference in the accumulation of the AGP1 mRNA between the strain with the native 
SSY5 3’ UTR (Fig. 4B, lane 1) and the strains with the SSY5+ADH1 3’ UTR construct 
(Fig. 4B, lanes 2 & 3).  Thus, using AGP1 mRNA accumulation as an indicator of Ssy5 
activity, there is no evidence of altered Ssy5 function as a result of replacing the SSY5 
mRNA 3’ UTR with the shorter ADH1 mRNA 3’ UTR. 
 Taken together, these results show that replacing the long 3’ UTR of the SSY5 
mRNA with a shorter 3’ UTR has no impact on SSY5 mRNA stability.  Hence, we 
conclude that the 3’ UTR of the SSY5 mRNA is not responsible for the protection of SSY5 
mRNA from NMD.  This is also significant because a previous study identified a 
stabilizer element (STE) that is able to protect mRNAs from NMD (Ruiz-Echevarria and 
Peltz, 2000).  This study showed that the STE must be downstream of a stop codon to 
confer protection from NMD.  Here we removed all the SSY5 3’ UTR sequence 
downstream of the stop codon, so even if there was an STE in the 3’ UTR that is not the 
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mechanism of protection of the SSY5 mRNA from NMD.  However, the long 3’ UTR is 
not the only NMD-targeting signal present in the SSY5 mRNA.  Investigation of the 
additional targeting signals may provide insight as to the mechanism of protection of the 
SSY5 mRNA from NMD. 
 
Perturbation of the SSY5 mRNA 5’ UTR does not affect SSY5 mRNA stability 
 Another potential NMD-targeting feature present in the SSY5 mRNA is the 
presence of a translated uORF (Fig. 2B).  Since replacing the long 3’ UTR of the SSY5 
mRNA with a shorter 3’ UTR did not provide evidence of a stabilizing element in the 3’ 
UTR we decided to refocus our attention to the uORF.  For this, we hypothesize that if 
disruption of the 5’ UTR influences SSY5 mRNA stability then there are two likely 
possibilities: 1) there is another cis-acting element present within the 5’ UTR responsible 
for SSY5 mRNA stability, or 2) there are trans-acting factors that bind to specific 
sequences within the 5’ UTR to confer stability.  It is also possible that SSY5 mRNA 
stability could be the result of a combination of any of these three ideas.  
 To determine if the SSY5 mRNA stabilizing element is located in the 5’ UTR we 
utilized a construct that had already been generated in our lab.  This construct uses a 
previously validated method for replacing the 5’ UTR of an mRNA with the S. cerevisiae 
galactose (GAL1-10) promoter sequence (pGAL; Longtine et al., 1998).  Using this 
method, 50nt of the SSY5 5’ UTR are replaced with the pGAL sequence, thus abolishing 
the SSY5 uORF and the majority of the SSY5 5’ UTR sequence.   
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 Using quantitative Northern analysis we measured the steady-state accumulation 
of the pGAL-SSY5 mRNA in wild-type and upf1Δ strains.  No significant difference in 
accumulation between the two strains (FCR=1.1±0.1) was observed.  We also measured 
the pGAL-SSY5 mRNA T1/2 in wild-type and upf1Δ strains. Although there is a slight 
increase in pGAL-SSY5 mRNA T1/2 in the upf1Δ strain (T1/2=57.6min) compared to wild-
type strain (T1/2=41.6min) this difference is too small to be considered significant (Fig 
5B).  If the pGAL-SSY5 mRNA does become a substrate for NMD then we would expect 
to see ≥2-fold increase in T1/2 in the upf1Δ strain.  These results indicate that abolishing 
the native SSY5 5’ UTR sequence does not influence SSY5 mRNA stability, thus the 5’ 
UTR does not contain the stabilizing element. 
 An important consequence of disruption of the SSY5 5’ UTR using the above 
method is that SSY5 mRNA is now under the control of an inducible promoter.  Using 
this we can also determine the effects of overexpression of the SSY5 mRNA.  When SSY5 
mRNA is placed under the control of the galactose promoter and the cells are grown in 
rich media containing 20% galactose (YAPG) we can achieve ~65-fold increase in SSY5 
mRNA expression (Fig. 5C).  Significantly, this substantial increase in SSY5 mRNA 
expression has no influence on SSY5 mRNA stability (Fig. 5A and B) and also has no 
consequence on Ssy5 downstream function (Figure 5C, AGP1 mRNA levels).  This 
indicates that significant overexpression of the SSY5 mRNA in the cell does not saturate 
the stabilizing mechanism (e.g. trans-acting factors).  It also indicates that there is a rate-
limiting step before Ssy5 protease activity in the SPS sensor signaling cascade.  Also 
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noted, the cells grow at average rates in liquid media and on plates, so overexpression of 
the SSY5 mRNA is not toxic to the cells (data not shown).  
 
SSY5 mRNA is not protected from NMD by inhibition of translation 
 NMD is a translation-dependent mechanism since targeting of an mRNA to NMD 
typically involves the interaction of the core NMD factors with the terminating ribosome 
(Bertram et al., 2001; Czaplinski et al., 1998; Kisselev et al., 2003; Rospert et al., 2005).  
In line with this, several studies have shown that the inhibition of translation, by blocking 
translation initiation or elongation, is able to suppress NMD (Carter et al., 1995; Dang et 
al., 2009; Noensie and Dietz, 2001).  We hypothesize that inhibition of translation is not 
the stabilizing mechanism of the SSY5 mRNA because ssy5Δ mutants are not viable and 
the Ssy5 protein is an essential component of the SPS sensor, which is required for proper 
cell homeostasis (Conrad et al., 2014; Ljungdahl, 2009).  Nevertheless, it is important to 
confirm that the SSY5 mRNA is actively translated in order to rule out this possibility. 
 Polyribosome analysis was performed using cell extracts from wild-type and 
upf1Δ strains. Density gradient centrifugation of total cell extracts through 15%-50% 
sucrose gradients was performed followed by gradient fractionation.  Total RNA was 
extracted from each fraction and quantitative Northern analysis was used to determine the 
mRNA distribution among fractions (Materials and Methods).  SSY5 mRNA is found 
primarily in the polyribosome fractions (9-15) of both wild-type and upf1Δ strains 
indicating that the mRNA does co-migrate with polyribosomes in both strains, which 
provides strong evidence in support of SSY5 mRNA association with polyribosomes (Fig. 
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6A).  The polyribosome analysis of the CYH2 pre-mRNA and mRNA in wild-type and 
upf1Δ strains is provided for comparison to show how the distribution of an NMD-
substrate (CYH2 pre-mRNA) differs from a non-NMD substrate (CYH2 mRNA) between 
wild-type and upf1Δ strains (Fig. 6A).  In comparison, the SSY5 mRNA distribution 
appears to mirror that of the CYH2 mRNA, which is translated and not an NMD-
substrate.  However, we cannot ignore the presence of the slower migrating SSY5 band 
that is specific to the polyribosome fractions in the upf1Δ strain.  This band could be a 
longer or modified form of the SSY5 mRNA that is actually a substrate for NMD. 
 To confirm that SSY5 mRNA co-migration with polyribosomes is in fact 
indicative of active translation we constructed a strain in which GFP is fused to the 5’end 
of the SSY5 mRNA.  Because endogenous levels of SSY5 mRNA and Ssy5 protein are 
extremely low we again employed the pGAL promoter when constructing these strains.  
GFP fused to the SSY5 mRNA under the control of the native promotor was not 
detectable by fluorescence microscopy or flow cytometry (data not shown).  By placing 
the GFP-SSY5 mRNA under the control of the GAL promoter (pGAL-GFP-SSY5) we 
were able to visualize GFP-Ssy5 using confocal fluorescence microscopy (Fig 6B).  GFP 
can be seen in the strains with the pGAL-GFP-SSY5 mRNA but not in the strains without 
the GFP-tagged Ssy5 (Fig. 6B, compare top and bottom rows).  Importantly, yeast cells 
do exhibit green autofluorescence; however we were able to filter out this 
autofluorescence (Fig. 6B, bottom row) so the green fluorescence seen in the pGAL-GFP-
SSY5 mRNA panels is specific to GFP-Ssy5.  Hoechst was used as the nuclear stain.  
These results confirm SSY5 mRNA is actively translated. 
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 Furthermore, we confirmed that addition of the pGAL-GFP sequence does not 
alter stability of the SSY5 mRNA as the pGAL-GFP-SSY5 mRNA accumulates to similar 
levels in both wild-type and upf1Δ strains (FCR=1.1±0.1; Fig. 6C).  This result is 
consistent with the results observed in Figure 5 for the pGAL-SSY5 mRNA without the 
GFP sequence. 
 
The SSY5 mRNA 3’ UTR is a good candidate for both stop codon readthrough and 
reinitiation of translation 
Upon closer analysis of the SSY5 mRNA 3’ UTR we find two unique features that 
are of interest concerning potential mechanisms of escape or protection of the mRNA 
from NMD.  First, the SSY5 mRNA stop codon is a good candidate for stop codon 
readthrough.  Second, the SSY5 mRNA 3’ UTR has the potential for translation 
reinitiation.   Either of these mechanisms independently would provide an explanation for 
the stability of the SSY5 mRNA (Bonetti et al., 1995; Keeling et al., 2004; Neu-Yilik et 
al., 2011; Wang et al., 2001). 
Previously, it was shown that leaky termination at PTCs allows mRNAs to escape 
degradation by NMD (Keeling et al., 2004).  Following this idea, it would make sense 
that leaky termination at the SSY5 stop codon could protect the SSY5 mRNA from NMD 
as it would reduce the length of the SSY5 mRNA 3’ UTR bringing the terminating 
ribosome in closer proximity to Pab1.  There are three features of the SSY5 mRNA stop 
codon and 3’ UTR that lead us to hypothesize there is a high probability of stop codon 
readthrough.  First, the SSY5 mRNA terminates with a UGA stop codon.  In yeast, the 
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UGA stop codon is recognized less efficiently by the terminating ribosome than the UAA 
or UAG stop codons (Keeling et al., 2004).  Second, the SSY5 mRNA stop codon is in a 
suboptimal context.  Optimal stop codon context occurs when the stop codon is followed 
immediately by a purine residue (A/G) whereas the SSY5 mRNA stop codon is followed 
by a T (Fig. 7; Bonetti et al., 1995).  Additionally, it has been shown that very efficient 
termination occurs when the codon immediately upstream of the stop codon is a UCC 
(serine) codon and immediately downstream is a GCA (alanine) codon, and the SSY5 
mRNA contains neither of these (Bonetti et al., 1995; Namy et al., 2001).  Third, the 
SSY5 mRNA UGA stop codon is not immediately followed by another in-frame stop 
codon or codons—a common feature of efficient termination context (Williams et al., 
2004).  If the ribosome failed to terminate at the initial UGA stop codon translation 
would proceed a significant distance (102 codons) before encountering another in-frame 
stop codon.  Moreover, the next downstream in-frame stop codon is a more efficiently 
recognized stop codon (UAA) and is followed by a purine residue, A (Fig. 7; Keeling et 
al., 2004). 
Previous work on the human β-globin mRNA presented a puzzling group of 
mutations in the first exon of the mRNA.  Typically, nonsense mutations near the 5’ end 
of the mRNA elicit degradation by NMD (Chamieh et al., 2008; Le Hir et al., 2001; 
Lykke-Andersen et al., 2001; Shibuya et al., 2004; Singh et al., 2007).  Interestingly, 
there are a group of nonsense mutations in the first exon of the human β-globin mRNA 
that do not trigger degradation by NMD (Inacio et al., 2004; Romao et al., 2000).  Further 
studies showed there is a sharp boundary in the position at which nonsense codons in this 
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mRNA trigger NMD or do not (Neu-Yilik et al., 2011).  It was shown that the reason for 
this sharp boundary and inability of the first exon nonsense mutations to trigger NMD 
was due to reinitiation of translation at a downstream AUG (Neu-Yilik et al., 2011).  The 
SSY5 mRNA 3’ UTR has the likely potential for translation reinitiation as there is a start 
codon not far downstream from the original stop codon but in a different reading frame.  
This start codon is followed by an 82-codon ORF that terminates with a UAA termination 
codon in a good context (i.e. followed by a purine residue; Fig. 7).  The idea of 
reinitiation in the mRNA 3’ UTR is intriguing as it introduces the possibility of a 
regulatory downstream open reading frame (dsORF) that may serve similar functions as 
the uORF.    
 
The SSY5 mRNA is not protected from NMD by stop codon readthrough 
We have identified reasons to speculate there is a good chance for stop codon 
readthrough of the SSY5 mRNA UGA codon (discussed above).  Thus, we hypothesize 
that stop codon readthrough may be protecting the SSY5 mRNA from NMD.  To test this 
idea we designed a reporter system that is similar to the one used previously (Bonetti et 
al., 1995).  Briefly, we placed a GFP tag in-frame in the SSY5 mRNA 3’ UTR 
immediately preceding the downstream UAA stop codon that would likely be used if 
readthrough of the original UGA stop codon was to occur (Reporter #2; Fig. 8A, orange 
arrow).  As a positive control we also made a reporter construct where the GFP tag was 
inserted in-frame immediately preceding the original SSY5 mRNA UGA stop codon 
(Reporter #1; Fig. 8A, green arrow).   
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Total protein extracts were examined for the presence of GFP in strains 
containing either reporter using Western analysis.  Ssy5 has a molecular weight of 77.5 
kDa while GFP has a molecular weight of 26.9 kDa, so the control reporter should appear 
at 104.4 kDa.  Reporter #2 contains the additional sequence of the SSY5 3’ UTR that 
would be translated if readthrough were to occur which adds another 0.3 kDa to the total 
protein size.  We were able to detect a band in the positive control at ~104.4 kDa that was 
not present in the negative control—untagged Ssy5 (Fig. 8B, compare lane one with lane 
two top asterisk).  However, we were not able to detect a band at ~104.7 kDa in the 
readthrough reporter (Fig. 8B, compare lane two with lane three top asterisks).   
Additionally, we looked for GFP signal in strains containing each construct using 
fluorescence microscopy and flow cytometry.  However, in these constructs each reporter 
is under the control of the native SSY5 promoter so protein levels are extremely low and 
we were unable to detect GFP signal even in the positive control using either method 
(data not shown). 
Using total protein extracts from the strains and a ChIP-quality GFP antibody we 
still observed the presence of numerous non-specific cross-reacting bands that can be 
seen in Figure 8 B.  Conversely, there is one band that is specific to the protein extract 
from the positive control (Fig. 8B, lane 2 bottom asterisk).  In looking for bands at 104.4 
kDa and 104.7 kDa we only accounted for the full-length uncleaved Ssy5-GFP.  
However, during the biogenesis of Ssy5 the protein is autolytically cleaved into the 35.5 
kDa catalytic C-terminal cat-domain and the 42.2 kDa inhibitory N-terminal pro-domain 
(Andreasson et al., 2006).  For the GFP reporter constructs used here we inserted the GFP 
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sequence at the 3’ end of the mRNA, which places the GFP tag at the C-terminal end of 
the cat-domain.  So, the band we observe at ~62.2 kDa is specific to Ssy5 and accounts 
for the GFP-tagged cat-domain of Ssy5 that has been autolytically cleaved from the pro-
domain (Fig. 8B, lane 2 bottom asterisk and schematic on the right).  
We also analyzed the steady-state mRNA levels in each construct to confirm that 
addition of the 3’ GFP sequence in either location does not influence SSY5 mRNA 
accumulation.  As expected, the stead-state mRNA accumulation is similar between wild 
type SSY5 mRNA and both SSY5-GFP mRNA constructs (Fig. 8C).  Also, addition of the 
3’ GFP tag does not appear to influence Ssy5 activity as downstream AGP1 mRNA levels 
remain unchanged in the Ssy5-GFP constructs compared to the untagged Ssy5 (Fig. 8C). 
Here we show that are able to detect Ssy5-GFP by Western analysis through the 
presence of two specific bands: one at 104.4 kDa and one at 62.2 kDa.  However, we are 
unable to detect the presence of specific Ssy5-GFP bands using the reporter designed to 
test for readthrough (Fig 8B).  This leaves us with two possibilities: 1) readthrough of the 
SSY5 mRNA UGA is not occurring or, 2.) SSY5 mRNA UGA readthrough is not 
occurring at a high enough frequency for us to be able to detect a readthrough product.  
Using the positive control reporter we determined that we cannot detect a specific Ssy5-
GFP band when ≤10µg of total protein extract is loaded.  Based on these results, we can 
conclude the SSY5 mRNA is not likely protected from NMD by stop codon readthrough. 
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The SSY5 mRNA is not protected from NMD by translation reinitiation 
In addition to stop codon readthrough, we have also identified features of the 
SSY5 mRNA 3’ UTR that are favorable for translation reinitiation (discussed above).  
Therefore, we hypothesize that translation reinitiation in the SSY5 mRNA 3’ UTR may be 
protecting the SSY5 mRNA from NMD.  To test this idea we again used our GFP reporter 
system designed above for the read through analysis.  We used the same reporter for the 
positive control (reporter #1 with GFP inserted in frame immediately preceding the SSY5 
mRNA UGA stop codon; Fig. 9A, green arrow).  The reporter designed to test for 
translation reinitiation places GFP in-frame with the downstream open reading frame 
immediately preceding the UAG stop codon that would be used for termination of this 3’ 
UTR ORF (Reporter #3; Fig. 9A, blue arrow). 
Total protein extracts were examined for the presence of GFP in strains 
containing either reporter using Western analysis as results using fluorescence 
microscopy and flow cytometry proved unsuccessful because of the low level of protein 
expression under the control of the native SSY5 mRNA promoter (data not shown).  We 
expected the same bands as before for the positive control at 104.4 kDa and 62.2 kDa.  
The translation reinitiation product, however, is much smaller and should appear at ~ 
36.6 kDa.  Since we did not separate the protein extracts using a gradient gel and the 
reinitiation product is so small, we were only able to distinguish the protein product for 
the processed GFP-tagged cat-domain in the positive control at 62.2 kDa because the 
104.4 kDa was obscured by the group of cross-reacting bands (Fig. 9B).  Nevertheless, 
based on our results in Figure 8B this band still allows us to confirm specificity for an 
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Ssy5-GFP product.  However, we were unable to detect a reinitiation product at 36.6 kDa 
(Fig. 9B).  Again, this means that either reinitiation in the SSY5 3’ UTR is not occurring 
or that the reinitiation is occurring at a frequency too low to be detected by our methods.  
Additionally, it is possible that reinitiation may be occurring in a different reading frame 
with a different AUG, as there are five additional out-of-frame AUG codons.  We tested 
the most likely position for reinitiation to occur based on start codon context, size of the 
ORF, and context of the stop codon. 
We also analyzed steady-state SSY5 mRNA levels in all of the constructs to 
confirm that addition of the 3’ UTR GFP sequence to test for translation reinitiation did 
not alter mRNA accumulation (Fig 9C).  The small decrease in accumulation in the SSY5-
GFP reinitiation mRNA construct is not considered significant.  The more diffuse 
banding pattern for the SSY5 mRNA in all of the 3’ GFP-tagged constructs in noted, and 
is likely the result of a more diverse population of mRNAs, but with small variation (Fig, 
8C and Fig. 9C).  Furthermore, addition of the 3’ UTR GFP sequence in the reinitiation 
reading frame does not appear to influence Ssy5 activity as downstream AGP1 mRNA 
levels remain unchanged in the Ssy5-GFP constructs compared to the untagged Ssy5 
(Fig. 9C). 
Thus, we conclude that the SSY5 mRNA is most likely not being protected from 
NMD due to translation reinitiation in the SSY5 3’ UTR at the most favorable potential 
downstream open reading frame.   
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SSY5 mRNA is translated equally efficient in both wild-type and upf1Δ cells 
 The current literature provides evidence that if translation initiation is inhibited 
then an mRNA is stable and not a substrate for degradation by NMD (Dang et al., 2009; 
Low et al., 2005; Zuk and Jacobson, 1998).  Additionally, translation elongation 
inhibitors such as cycloheximide and puromycin also block degradation of substrates by 
NMD (Carter et al., 1995; Herrick et al., 1990; Noensie and Dietz, 2001; Zhang et al., 
1997).  Finally, if translation proceeds past the ORF stop codon (i.e. stop codon 
readthrough/nonsense suppression) then NMD is also inhibited and the mRNA is stable 
(Keeling et al., 2004).  Further, mutations in any of the three NMD trans-acting factors 
(Upf1, Upf2, or Upf3) effectively reduce the efficiency of translation termination 
(Maderazo et al., 2000; Wang et al., 2001).  Importantly, it was previously shown that 
recognition of a nonsense codon in an mRNA leads to an overall decrease in the 
translational efficiency of the mRNA as a reporter carrying a nonsense mutation yielded 
significantly higher levels of protein in upf1Δ strains compared to wild-type (Muhlrad 
and Parker, 1999). 
 Together this information led us to the hypothesis that if the SSY5 mRNA is being 
recognized as an NMD substrate, and the mRNA is protected at a point after recognition, 
then inactivation of the NMD pathway (upf1Δ strains) should show significantly higher 
Ssy5 levels compared to wild-type strains.  To test this hypothesis we utilized our SSY5-
GFP reporter strains that were constructed above (Fig. 8 and Fig 9).  The reporter 
construct containing the GFP tag in-frame just before the SSY5 mRNA stop codon 
(Reporter #1) was transformed into NMD+ (wild-type strains used previously) and nmd- 
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(upf1Δ) strains.  Total protein extract was analyzed for Ssy5-GFP, which should produce 
bands at 104.4 kDa and 62.2 kDa (Fig. 10, lanes 2 and 3 asterisks).  Nonspecific cross-
reacting bands in all samples are shown to verify loading.  We were able to detect the 
specific Ssy5-GFP product in the NMD+ and nmd- strains, however, there does not 
appear to be a significant difference in the amount of protein present between the two 
strains (Fig. 10, lanes 2 and 3 asterisks).  These results indicate that the NMD pathway is 
not likely playing a role in the translation of the SSY5 mRNA.  Thus, the SSY5 mRNA is 
probably not being recognized as an NMD substrate, which is consistent with the rest of 
our results. 
 
SSY5 mRNA is not protected from NMD by RNA binding protein Pub1 
Finally, we wanted to determine if SSY5 mRNA is protected from NMD due to 
the interaction of trans-acting factors.  The search for potential candidates is a 
cumbersome task as the pool RNA binding proteins (RBPs) is quite large and there is no 
collective database that identifies specific binding motifs for the different RBPs.  
Additionally, it may be an indirect interaction that could be responsible for SSY5 mRNA 
protection from NMD in which case identifying RBP binding motifs present in the SSY5 
mRNA would be uninformative.  However, a recent study showed that poly(U) binding 
protein (Pub1) is able to protect two wild-type mRNAs, GCN4 and YAP1, from 
degradation by NMD (Ruiz-Echevarria and Peltz, 2000).  These two mRNAs are targeted 
for degradation by NMD through the presence of translated uORFs.  It was shown that 
both GCN4 and YAP1 mRNAs contain stabilizer elements (STEs) in their 5’ UTR which 
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binds Pub1.  The binding of Pub1 protects the mRNA from degradation by NMD (Ruiz-
Echevarria and Peltz, 2000). 
 Using this information we hypothesized that Pub1 could play a role in SSY5 
protection from NMD.  To determine if Pub1 is protecting SSY5 mRNA from degradation 
by NMD, we analyzed steady-state SSY5 mRNA accumulation in wild-type, upf1Δ, 
pub1Δ, and upf1Δpub1Δ strains when cells are grown in rich media (YAPD).  
Quantitative Northern analysis reveals no significant differences in SSY5 mRNA 
accumulation in pub1Δ (FCR of pub1Δ/wild-type =1.0±0.2) or upf1Δ pub1Δ (FCR of 
upf1Δpub1Δ/wild-type =1.2±0.2) cells compared to wild-type cells (Fig. 11A).  We also 
tested the possibility that Pub1 could be protecting SSY5 mRNA only under nutrient-
limiting conditions by analyzing steady-state SSY5 mRNA accumulation in wild-type, 
upf1Δ, and pub1Δ strains when cells are grown in minimal media (amino-acid limiting).  
We observed the same trend in this condition with no significant difference in SSY5 
mRNA accumulation in pub1Δ (FCR of pub1Δ/wild-type =1.0±0.2) cells compared to the 
wild-type cells (Fig. 11B). 
 Further, we confirmed that there is no change in SSY5 mRNA stability in wild-
type vs pub1Δ cells by determining the T1/2 of SSY5 mRNA in each of the strains.  The 
SSY5 mRNA had a T1/2 of 10.2±1.2 min in wild-type strains compared to a T1/2 of 
14.6±1.7 min in pub1Δ (Fig. 11C). 
 From this we conclude that SSY5 mRNA is not protected from NMD by the trans-
acting factor Pub1.  However, a much more thorough analysis of RBPs needs to be 
conducted to sufficiently analyze the role of trans-acting factors in the protection of 
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SSY5 mRNA from NMD.  We are in the early stages of developing a screen using the S. 
cerevisiae RBP mutant collection and our pGAL-GFP-SSY5 constructs developed for the 
translation analysis of Ssy5 (Fig. 6B). 
 
Discussion 
 Here we show the novel case of the wild-type SSY5 mRNA, which has multiple 
NMD targeting signals but is not degraded by NMD.  Importantly, it was previously 
shown that the long 3’ UTR of the SSY5 mRNA is able to target a reporter mRNA for 
degradation by NMD (Obenoskey et al., 2014).  Because one of the NMD-targeting 
signals is able to target an mRNA from degradation by NMD we hypothesized that the 
SSY5 mRNA is being protected by some mechanism from degradation by NMD.  
Elucidating the mechanism that is protecting the SSY5 mRNA from NMD can add 
valuable clues to understanding the role of NMD in gene regulation of wild-type mRNAs 
and the potential physiologic consequences of perturbing the NMD pathway (i.e. 
nonsense suppression and readthrough therapies). 
 Here we show that replacing the long 3’ UTR of the SSY5 mRNA with the much 
shorter 3’ UTR of the ADH1 mRNA does not alter the stability of the mRNA from NMD 
(Fig. 4).  We see the same result upon removal of the translated SSY5 uORF (Fig. 5).  
These results confirm that the mechanism of protection of the SSY5 mRNA is not in the 
cis-elements of the 5’ or 3’ UTR of the SSY5 mRNA.  This also rules out the role of tans-
acting factors that would be interfering with NMD by binding to a location within the 5’ 
or 3’ UTR of the SSY5 mRNA.  
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 Previous studies have identified several ways in which an mRNA can be protected 
from degradation by NMD.  One of the ways in which an mRNA is protected from NMD 
is by inhibition of translation (Carter et al., 1995; Dang et al., 2009; Low et al., 2005; 
Noensie and Dietz, 2001).  The trans-acting NMD factors (Upf1, Upf2 and Upf3) are 
activated by a terminating ribosome, thus, the translation machinery must be active for 
NMD to occur (Amrani et al., 2004; Bertram et al., 2001; Czaplinski et al., 1998; 
Kisselev et al., 2003; Rospert et al., 2005).  If an mRNA is not actively translated the 
formation of the NMD mRNP will not be initiated.  We did expect the SSY5 mRNA to be 
translated due to the vital role for the Ssy5 protease in S. cerevisiae in maintaining 
cellular homeostasis by initiating extracellular amino acid uptake via the activation of 
AAP genes (Fig. 1).  We confirmed by polyribosome analysis and fluorescence 
microscopy that the SSY5 mRNA is actively translated (Fig. 6).  However, endogenous 
Ssy5 protein levels are quite low as we are unable to detect GFP signal when SSY5 
mRNA is under the control of its native promoter.  
 We also tested the ideas that the SSY5 mRNA could be protected from NMD by 
translational readthrough or by translation reinitiation in the 3’ UTR.  The stop codon 
context of the SSY5 mRNA and the unique features of the SSY5 mRNA 3’ UTR are all 
conducive to either possibility (Fig. 7).  However, we did not find evidence of 
translational readthrough or translation reinitiation for the SSY5 mRNA within our 
detection limits (Fig. 8 and Fig. 9).  Further, it was previously shown that yeast mRNAs 
are destabilized when there is a very low frequency of translational readthrough events on 
an mRNA (≤0.5%; Keeling et al., 2004).  So, if an mRNA is stabilized by translational 
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readthrough the readthrough must occur at a frequency ≥0.5%, which should yield a 
detectable product in our Western analysis.  In support of this, the majority of studies 
providing ribosome footprint data do not indicate detectable ribosome footprints within 
the SSY5 mRNA 3’ UTR (Michel et al., 2014).   
 We began our search for the involvement of trans-acting factors in the protection 
of the SSY5 mRNA from NMD by looking at RBP Pub1.  Pub1 was previously shown to 
protect both GCN4 and YAP1 mRNAs from degradation by NMD (Ruiz-Echevarria and 
Peltz, 2000).  We show that Pub1 is not involved in the protection of the SSY5 mRNA 
from NMD by looking at both steady-state accumulation and mRNA half-lives in wild-
type and pub1Δ cells (Fig. 11).  However, during these experiments we attempted to use 
the GCN4 and YAP1 mRNAs as positive controls.  In doing this we were unable to 
reproduce the result that Pub1 is solely responsible for the protection of GCN4 and YAP1 
mRNAs from NMD (Chapter 4).  One explanation could be that we were not able to 
obtain the exact strains used in the original study (Ruiz-Echevarria and Peltz, 2000).  We 
did, however, obtain the parent strains for the ones used in the original study and 
reconstructed the strains, but were still unable to show that Pub1 definitively protects 
GCN4 and YAP1 mRNAs from NMD (data not shown). 
 For all of our studies, we were careful to take into consideration the physiologic 
role of Ssy5 when growing the cells (Fig. 1).  Because Ssy5 is a critical component of the 
SPS amino-acid sensing complex, we are aware that changes in the amino acid 
composition of the media may cause variations in SSY5 mRNA levels and possibly in 
susceptibility to NMD.  However, we do not find that growing cells in rich media 
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(YAPD/YEPD) vs minimal media (amino-acid limiting) has any effect on SSY5 mRNA 
levels or susceptibility to NMD (Fig. 3 and Fig. 11).  Although it is important to note that 
true amino-acid starvation, which would result in an inactive SPS-sensor and reduce the 
need for SSY5 mRNA translation, was not able to be evaluated as the strains used in this 
study require supplementation with amino acids to support the auxotrophic requirements 
(Materials and Methods).  
 Further, in this study, we characterize a new mRNA that can be used as a control 
in future NMD experiments.  The ENT4 mRNA was previously identified in a screen as 
an mRNA with a long 3’ UTR that is an NMD substrate.  Here we show in repeated 
experiments that the ENT4 mRNA is an NMD substrate, as steady-state mRNA 
accumulation is increased by ≥2.0-fold in upf1Δ cells compared to wild-type cells and the 
T1/2 is also ≥2.0 fold longer in upf1Δ cells compared to wild-type cells (Figs. 3A-C, Fig. 
5A, Fig. 6C, Fig. 8C, and Fig. 9C).  Thus, the ENT4 mRNA can serve as a positive NMD 
control for wild-type gene regulation by NMD. 
 Here we have presented a novel case for an mRNA that should be targeted for 
degradation by NMD, but is not, and the protection of the mRNA cannot be explained by 
current models.  Moving forward, it will be valuable to the NMD field to identify how 
this mRNA is protected from NMD.  We have provided the framework for narrowing 
down the mechanism and now the studies can proceed in a more focused manner.  We 
have also developed valuable tools that can be used as we move forward.  Designing a 
screen for trans-acting factors that stabilize/destabilize the SSY5 mRNA will be very 
informative, and we now have the GFP constructs to be able to do so.  Once stabilizing 
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trans-acting factors are identified we can then determine whether they protect the SSY5 
mRNA by direct or indirect binding and if the factors provide interference of the NMD 
mRNP or remodeling of the NMD mRNP.  This information will also help identify at 
which step in the NMD pathway that protection is incurred - before substrate recognition, 
or after substrate recognition but before mRNA degradation.  Determining if the NMD 
mRNP ever forms on the SSY5 mRNA would also provide valuable information.  In 
addition to looking further into trans-acting factors, it will be crucial to identify if certain 
cis-elements are playing a role.  Specifically, changing the start codon context, 
manipulating the predicted -1 PRF sites, and changing the termination codon context 
could all provide valuable results. 
 It is interesting to note that the human fungal pathogen Candida albicans also 
possesses all of the components of the SPS sensor (Martinez and Ljungdahl, 2004).  
Studies have shown that when C. albicans is unable to uptake extracellular amino acids 
the fungus is not able to establish infection in a mouse model (Martinez and Ljungdahl, 
2004).  Further, the ability of C. albicans to establish infection requires Stp1, Ssy5 and 
Ssy1 {Davis, 2011 #130.  This raises the possibility that the regulation of SSY5 mRNA is 
involved in pathogenicity of C. albicans.  Going forward, it would be interesting to 
analyze the SSY5 mRNA and its susceptibility to NMD in C. albicans. 
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Figure legends 
Fig. 2-1.  Ssy5p, encoded by the SSY5 mRNA is a major component of the yeast amino 
acid SPS sensor.  The SPS sensor is the primary complex of the yeast SPS-sensing 
pathway, which is responsible for the sensing and indirect uptake of extracellular amino 
acids. The SPS sensor consists of the integral membrane protein Ssy1 and two peripheral 
membrane proteins Ptr3 and Ssy5.  Free extracellular amino acids bind to Ssy1 inducing 
a conformational change, which activates this sensing protein.  When Ssy1 becomes 
activated a signal is transduced via Ptr3 to the serine protease Ssy5.  Ssy5 has a large N-
terminal Pro-domain and catalytic C-terminal Cat-domain.  These two domains are 
autolytically cleaved but remain noncovalently associated as an inactive complex.  When 
activated, Ssy5 cleaves the N-terminal domain of the cytosolic transcription factors Stp1 
and Stp2, which then enter the nucleus and activate the expression of amino acid 
permease genes required to generate amino acid transporters {Ljungdahl, 2009 
#109}(Conrad et al., 2014).   
 
Fig. 2-2.  SSY5 mRNA has multiple NMD-targeting signals.  A) Schematic representing 
the SSY5 mRNA and the approximate location of the NMD-targeting signals.  B) 
Ribosome profile of a region of the SSY5 mRNA 5’ leader region showing the compiled 
data from all ribosome profiling studies.  All three reading frames are shown.  Start 
codon methionines are denoted with “M” (green).  () Indicates the reading frame of the 
SSY5 mRNA uORF and () indicates the reading frame of the SSY5 ORF.  Image was 
downloaded from the GWIPS-viz browser (Michel et al., 2014). 
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Fig. 2-3.  SSY5 mRNA is not degraded by NMD.  A) Northern blot analysis of the steady-
state accumulation of the SSY5 and ENT4 (a wild-type NMD substrate) mRNAs in wild-
type (AAY277) and upf1Δ (AAY363) strains in the BY4741 background and in wild-type 
(AAY187) and upf1Δ (AAY320) strains in the W303 background.  Strains were grown in 
rich media (YAPD).  CYH2 pre-mRNA is an NMD control (CYH2 pre-mRNA is an 
NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown for loading.  
Fold change values are normalized and determined as a fold change ratio from wild-type; 
values are an average of three independent trials.  B) Northern blot analysis of the SSY5 
and ENT4 mRNA half-lives in wild-type (AAY277) and upf1Δ (AAY363) strains from 
the BY4741 background.  Strains were grown in rich media (YAPD).  10µg/ml Thiolutin 
was added to mid-log cultures at time=0 min.  Half-life calculations were determined 
using a graph of percent mRNA remaining at each time point during the exponential 
decay.  C) Northern blot analysis of the steady-state accumulation of the SSY5 and ENT4 
mRNAs in wild-type (AAY277) and upf1Δ (AAY363) strains in the BY4741 
background.  Strains were grown in minimal media (SD + his, leu, met, ura, lys).  D) 
Northern blot analysis of the SSY5 and ENT4 mRNA half-lives in wild-type (AAY277) 
and upf1Δ (AAY363) strains from the BY4741 background.  Strains were grown in 
minimal media (SD + his, leu, met, ura, lys).  10µg/ml Thiolutin was added to mid-log 
cultures at time=0 min.  Half-life calculations were determined using a graph of percent 
mRNA remaining at each time point during the exponential decay and are the average of 
three independent trials. 
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Fig. 2-4.  Replacing the long 3’ UTR of SSY5 mRNA with the short 3’ UTR of the ADH1 
mRNA does not destabilize the mRNA.  A) Schematic of constructs.  The native 475nt- 
long 3’ UTR of the SSY5 mRNA was replaced with the 180nt 3’ UTR of the ADH1 
mRNA.  B) Northern blot analysis of the steady-state accumulation of the native SSY5 
mRNA in the wild-type strain (AAY277), and the SSY5+ADH1 3’ UTR mRNA in wild-
type [NMD+] (AAY576) and upf1Δ (AAY601) strains in the BY4741 background.  The 
AGP1 mRNA is a downstream target (AAP gene) of Ssy5 activity and is shown to 
confirm that manipulation of the SSY5 mRNA 3’ UTR did not influence the enzymatic 
activity of the protein product.  Strains were grown in rich media (YAPD).  CYH2 pre-
mRNA is an NMD control (CYH2 pre-mRNA is an NMD substrate, CYH2 mRNA is not 
an NMD substrate) and SCR1 is shown for loading.  Fold change values are normalized 
and determined as a fold change ratio from wild-type (lane 1); values are an average of 
three independent trials.  C) Northern blot analysis of the SSY5+ADH1 3’ UTR mRNA 
half-life in wild-type [NMD+] (AAY576) and upf1Δ (AAY601) strains.  Strains were 
grown in rich media (YAPD).  10µg/ml Thiolutin was added to mid-log cultures at 
time=0 min.  Half-life calculations were determined using a graph of percent mRNA 
remaining at each time point during the exponential decay. 
 
Fig. 2-5.  Disrupting the 5’ UTR of the SSY5 mRNA does not destabilize the mRNA.  A) 
Northern blot analysis of the steady-state accumulation of the pGAL-SSY5 mRNA in 
wild-type [NMD+] (AAY630) and upf1Δ (AAY632) strains in the BY4741 background.  
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The ENT4 mRNA is a wild-type mRNA that is an NMD substrate.  Strains were grown in 
rich media with galactose (YAPG).  CYH2 pre-mRNA is an NMD control (CYH2 pre-
mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown 
for loading.  Fold change values are normalized and determined as a fold change ratio 
from wild-type and are an average of three independent trials.  B) Northern blot analysis 
of the pGAL-SSY5 mRNA in wild-type [NMD+] (AAY630) and upf1Δ (AAY632) strains 
in the BY4741 background.  Strains were grown in rich media with galactose (YAPG).  
10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-life calculations 
were determined using a graph of percent mRNA remaining at each time point during the 
exponential decay.  C) Northern blot analysis of steady-state mRNA accumulation of the 
native SSY5 mRNA in the wild-type strain (AAY277) and the pGAL-SSY5 mRNA in the 
wild-type [NMD+] background (AAY630) to show the increase in accumulation as a 
result of placing the SSY5 mRNA under the control of the galactose promoter.  Strains 
were grown in rich media with galactose (YAPG).  Fold change values are normalized 
and determined as a fold change ratio from wild-type.  The native SSY5 mRNA appears 
as a band at ~2.6 kb while the pGAL-SSY5 mRNA is slightly larger and appears as a band 
at ~3.0 kb. 
 
Fig. 2-6.  SSY5 mRNA is translated.  A) Polyribosome analysis of SSY5 mRNA (top) and 
CYH2 pre-mRNA and mRNA (bottom) in wild-type (AAY187) and upf1Δ (AAY320) 
strains.  Strains were grown in YAPD.  Whole cell lysate was centrifuged through a 15-
50% sucrose gradient.  Total RNA was extracted from each fraction collected and total 
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RNA from fractions 2-19 was transferred to a membrane for Northern analysis.  Fractions 
corresponding to the 40S ribosomal peak are in lanes 4-5, fractions corresponding to the 
60S ribosomal peak are in lanes 6-7, the fraction corresponding to the 80S ribosomal 
peak is in lane 8 and polyribosome fractions are in lanes 9-15.  The graph represents the 
distribution of the mRNA in each fraction based on the relative corrected volume of the 
mRNA present in each lane.  In lanes where two bands were present only the band 
corresponding to the size of the expected band for the mRNA was quantified (~2.6 kb for 
SSY5 mRNA).  Polysome analysis was repeated twice with similar results.  B) Confocal 
microscopy of haploid cells containing pGAL-GFP-SSY5 mRNA (AAY561; top) or 
untagged SSY5 mRNA (AAY527; bottom).  Strains are of the BY4743 background.  
Cells were grown to saturation in YAPG, washed, fixed in 3.7% formaldehyde and 
stained with 1.0 µg/ml Hoechst (33258) in the dark.  Cells were immediately imaged.  
Scale bar=5µM.  C) Northern analysis of steady-state mRNA accumulation of the pGAL-
GFP-SSY5 mRNA to confirm that there were no significant differences in accumulation 
of the mRNA between wild-type background [NMD+] (AAY568; haploid of AAY561) 
and upf1Δ (AAY625) strains.  Strains were grown in YAPG.  Fold change values are 
normalized and determined as a fold change ratio from wild-type and are an average of 
three independent trials. 
 
Fig. 2-7. The SSY5 mRNA 3’ UTR is a good candidate for both stop codon readthrough 
and reinitiation of translation.  The 475nt sequence of the SSY5 mRNA 3’ UTR.  The 
ORF stop codon (TGA) is in red with a single underline.  Triplet nucleotide codons are 
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highlighted in alternating gray and black corresponding to the main ORF reading frame.  
The sequence underlined with a dotted blue line and terminating at the TAA stop codon 
with a double red underline is the sequence that would be translated if stop codon 
readthrough of the ORF TGA codon were to occur.  The ATG in green is a downstream 
start codon that could be used for the ribosome to reinitiate translation.  Sequence in pink 
that terminates with the TAG codon in red is the sequence that would be translated if 
reinitiation were to occur in the SSY5 mRNA 3’ UTR.    
 
Fig. 2-8.  There is no evidence of SSY5 mRNA stop codon readthrough.  A) Schematic of 
the reporter constructs that were made along with a sequence snapshot to show exactly 
which reading frame the GFP sequence was added in (arrows).  Reporter #1 was made by 
placing the GFP sequence in-frame just before the SSY5 mRNA TGA stop codon.  
Reporter #2 was made by placing the GFP sequence in-frame just before the stop codon 
that would be used if translational readthrough were to occur.  The dark grey box 
represents the SSY5 mRNA ORF while the light gray box represents the additional 
sequence that would be translated should readthrough occur.  B) Western blot analysis of 
the Ssy5-GFP product from each strain; untagged Ssy5, lane 1 (AAY277), Ssy5-GFP 
before the stop codon (reporter 1), lane 2 (AAY572), Ssy5-GFP to test for readthrough 
(reporter 2), lane 3 (AAY585).  Asterisks indicate where expected bands should be.  
Schematics show why we see the presence of two bands (at ~104.4 kD and ~62.2 kD) for 
Ssy5-GFP.  The top band is unprocessed Ssy5-GFP while the bottom band is the C-
terminal domain of the autolytically cleaved Ssy5-GFP.  40µg of total protein was added 
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per lane.  Non-specific bands serve as an informal loading control; membranes were also 
stained with Ponceau S (not shown).  Western blots were done with three independent 
trials and results were reproducible.  C) Northern analysis of steady-state mRNA 
accumulation of the SSY5, AGP1 and ENT4 mRNAs in the strains used in part (B) to 
confirm that there were no significant differences in accumulation of the mRNAs 
between the strains and also to confirm that addition of the GFP tag did not influence the 
enzymatic activity of Ssy5.  ENT4 mRNA is a wild-type mRNA that is a substrate for 
NMD and AGP1 mRNA is a downstream target (AAP gene) of Ssy5.  Untagged SSY5 
mRNA appears as a band at ~2.6 kb while the SSY5-GFP mRNA is larger and appears as 
a band at ~2.8 kb.  Strains were grown in rich media (YAPD).  Fold change values are 
normalized and determined as a fold change ratio from wild-type (lane 1) and are an 
average of three independent trials.     
 
Fig. 2-9.  There is no evidence of translation reinitiation in the SSY5 3’ UTR.  A) 
Schematic of the reporter constructs that were made along with a sequence snapshot to 
show exactly which reading frame the GFP sequence was added in (arrows).  Reporter #1 
is the same as in figure 8 and was made by placing the GFP sequence in-frame just before 
the SSY5 mRNA TGA stop codon.  Reporter #3 was made by placing the GFP sequence 
in-frame just before the stop codon that would be used if the ribosome were to reinitiate 
translation in the small ORF present in the SSY5 mRNA 3’ UTR.  The dark grey box 
represents the SSY5 mRNA ORF while the light gray box represents the small ORF that 
would be translated should the ribosome reinitiate translation.  B) Western blot analysis 
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of the Ssy5-GFP product from each strain; untagged Ssy5, lane 1 (AAY277), Ssy5-GFP 
to test for reinitiation (reporter 3), lane 2 (AAY581), Ssy5-GFP before the stop codon 
(reporter 1), lane 3 (AAY572).  Asterisks indicate where expected bands should be.  Here 
we only show the bottom band of the Ssy5-GFP (~62.2 kD), which is the C-terminal 
domain of the autolytically cleaved Ssy5-GFP, and the bottom portion of the membrane 
because the reinitiation product is very small with an expected size of ~36.6 kD.  40µg of 
total protein was added per lane.  Non-specific bands serve as an informal loading 
control; membrane was also stained with Ponceau S (not shown).  Western blots were 
done with three independent trials and results were reproducible.  C) Northern analysis of 
steady-state mRNA accumulation of the SSY5, AGP1 and ENT4 mRNAs in the strains 
used in part (B) to confirm that there were no significant differences in accumulation of 
the mRNAs between the strains and also to confirm that addition of the GFP tag did not 
influence the enzymatic activity of Ssy5.  ENT4 mRNA is a wild-type mRNA that is a 
substrate for NMD and AGP1 mRNA is a downstream target (AAP gene) of Ssy5.  
Untagged SSY5 mRNA appears as a band at ~2.6 kb while the SSY5-GFP mRNA is 
larger and appears as a band at ~2.8 kb.  Strains were grown in rich media (YAPD).  Fold 
change values are normalized and determined as a fold change ratio from wild-type (lane 
1) and are an average of three independent trials. 
 
Fig. 2-10.  SSY5 mRNA is translated equally efficient in wild-type and upf1Δ strains.  
Western analysis of untagged Ssy5 (AAY277), and Ssy5-GFP in wild-type (AAY572) 
and upf1Δ (AAY623) strains to determine if NMD has an influence on the translation 
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efficiency of the SSY5 mRNA.  The construct used in this analysis was reporter #1 from 
figures 8 and 9 so the expected sizes are the same (at ~104.4 kD and ~62.2 kD) and are 
indicated with red asterisks.  40µg of total protein was added per lane.  Non-specific 
bands serve as an informal loading control; membranes were also stained with Ponceau S 
(not shown).  Western blots were done with three independent trials and results were 
reproducible. 
 
Fig. 2-11.  SSY5 mRNA is not protected from NMD by trans-acting factor Pub1.  A) 
Northern blot analysis of the steady-state accumulation of SSY5 mRNA in wild-type 
(AAY277), upf1Δ (AAY363), pub1Δ (AAY538), and pub1Δupf1Δ (AAY590) strains in 
the BY4741 background.  Strains were grown in rich media (YAPD).  CYH2 pre-mRNA 
is an NMD control (CYH2 pre-mRNA is an NMD substrate, CYH2 mRNA is not an 
NMD substrate) and SCR1 is shown for loading.  Fold change values are normalized and 
determined as a fold change ratio from wild-type; values are an average of three 
independent trials.  B) Northern blot analysis of the steady-state accumulation of SSY5 
mRNA in wild-type (AAY277), upf1Δ (AAY363), and pub1Δ (AAY538) strains in the 
BY4741 background.  Strains were grown in minimal media (SD + his, leu, met, ura, 
lys).  C) Northern blot analysis of SSY5 mRNA half-lives in wild-type (AAY277) and 
pub1Δ (AAY538) strains in the BY4741 background.  Strains were grown in minimal 
media (SD + his, leu, met, ura, lys).  10µg/ml Thiolutin was added to mid-log cultures at 
time=0 min.  Half-life calculations were determined using a graph of percent mRNA 
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remaining at each time point during the exponential decay and are the average of three 
independent trials. 
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Figure 2-5 
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Figure 2-6 
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Figure 2-6 (continued) 
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Figure 2-10 
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Table 2-1.  Strains used in this study 
Strain 
Parent 
Strain 
Genotype Source 
W303  
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 
Ralser et al., 
2012 
BY4741  MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
Winston et al., 
1998 
AAY320 W303 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 upf1::URA3 
Atkin lab 
AAY363 BY4741 MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 Atkin lab 
BY4743  
MATa/MATα  his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 
met15Δ0/MET15 ura3Δ0/ura3Δ0 lys2Δ0/LYS2 
[suc2Δ/suc2Δ] 
Winston et al., 
1998 
AAY538 BY4741 MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pub1Δ 
Open 
Biosystems 
AAY561* BY4743 
MATa/MATα  his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 
met15Δ0/MET15 ura3Δ0/ura3Δ0 lys2Δ0/LYS2 
[suc2Δ/suc2Δ] pGAL-GFP-HISMX6-SSY5/SSY5 
Atkin lab 
AAY568* AAY561* 
MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pGAL-GFP-
HISMX6-SSY5 
Atkin lab 
AAY572* BY4741 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 GFP-HISMX6-
SSY5 before ORF stop codon 
Atkin lab 
AAY576* BY4741 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 SSY5 
3'UTR::ADH1 3'UTR(HIS3) 
Atkin lab 
AAY581* BY4741 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 GFP-HISMX6-
SSY5 before reinitiation stop codon 
Atkin lab 
AAY585* BY4741 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 GFP-HISMX6-
SSY5 before readthrough stop codon 
Atkin lab 
AAY590* AAY538 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pub1Δ 
upf1::URA3 
Atkin lab 
AAY601* AAY576* 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 SSY5 
3'UTR::ADH1 3'UTR(HIS3) 
Atkin lab 
AAY623* AAY572* 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 GFP-
HISMX6-SSY5 before ORF stop codon 
Atkin lab 
AAY625* AAY568* 
MATα  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 
pGAL-GFP-HISMX6-SSY5 
Atkin lab 
AAY630* BY4743 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pGAL-HISMX6-
SSY5 
Atkin lab 
AAY632* AAY630* 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 
pGAL-HISMX6-SSY5 
Atkin lab 
* = new strain created for this study 
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CHAPTER 3 
SSY5 mRNA is decay predominantly 5’ to 3’   
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Abstract 
 The degradation of mRNAs contributes significantly to the regulation of gene 
expression as all mRNAs are subject to turnover.  In Saccharomyces cerevisiae, most 
cytoplasmic wild-type mRNAs are decapped in a deadenylation-dependent manner and 
subsequently degraded by the 5’3’ exonuclease Xrn1.  Alternatively, mRNAs can be 
degraded 3’5’ by the exosome complex, albeit at a much slower rate.  mRNAs that are 
targeted for degradation by nonsense-mediated mRNA decay (NMD) are distinguished 
from wild-type mRNAs at the early stages of mRNA decay.  NMD substrates are rapidly 
decapped in a deadenylation-independent manner and degraded 5’3’ by Xrn1 as well 
as being rapidly deadenylated.  The SSY5 mRNA is a wild-type mRNA in S. cerevisiae 
with multiple NMD-targeting signals but is not degraded by NMD.  We hypothesized that 
investigating the genetic requirements for SSY5 mRNA decay would provide insight into 
how this mRNA is degraded and when protection from NMD is incurred.  Here we show 
that the SSY5 mRNA is predominantly degraded 5’3’ because blocking Dcp1-mediated 
decapping and Xrn1-mediated 5’3’ degradation results in increased accumulation and 
stability of the SSY5 mRNA.  In contrast, blocking deadenylation does not cause a 
significant change in SSY5 mRNA accumulation.  We also show that the 3’ end of the 
SSY5 mRNA is longer in wild-type and upf1Δ strains but is shortened in strains where 
decapping or 5’3’ exonucloelytic degradation is blocked suggesting that SSY5 mRNA 
is deadenylated prior to 5’3’ degradation.    
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Introduction 
 In all organisms the fidelity of gene expression is a crucial aspect of cell health 
and survival.  Aberrant gene expression often result in deleterious consequences for the 
organism.  There are several mechanisms that act coordinately to ensure proper gene 
expression.  Two of these mechanisms are the opposing processes of mRNA transcription 
and mRNA degradation.  
In yeast, wild-type mRNAs are typically degraded in the cytoplasm by a 
deadenylation-dependent mechanism that begins with shortening of the 3’ poly(A) tail to 
an oligo(A) length of 10-12 nt by the Ccr4/Pop2/Not and Pan2/Pan3 deadenylase 
complexes (Brown and Sachs, 1998; Decker and Parker, 1993; Tucker et al., 2002; 
Tucker et al., 2001; Wahle and Winkler, 2013).  Deadenylation is the rate-limiting step in 
wild-type mRNA decay (Decker and Parker, 1993).  Deadenylation of the mRNA 
disrupts the circularization of the mRNP and exposes the 7-methylguanosine 5’ cap of the 
mRNA.  The coupling of translation termination to deadenylation is suggested by the 
observation that translation termination factor eRF3 directly interacts poly(A) binding 
protein, Pab1 (Cosson et al., 2002).  Additionally, disruption of the eRF3-Pab1 
interaction leads to defective deadenylation (Funakoshi et al., 2007; Kobayashi et al., 
2004).  However, it has also been shown that mRNAs that never initiate translation are 
also deadenylated, so translation termination does not appear to be a prerequisite for 
deadenylation (Beelman and Parker, 1994; Muhlrad et al., 1995). 
For wild-type mRNAs, deadenylation subsequently leads to rapid decapping of 
the mRNA by the Dcp1/Dcp2 holoenzyme complex (Coller and Parker, 2004).  
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Additionally, wild-type mRNAs with poly(A) tails are resistant to decapping, and this 
resistance depends on the presence of  Pab1 (Beilharz and Preiss, 2007; Gallie, 1991; 
Wilusz et al., 2001).  Removal of the 5’ cap generates a 5’ monophosphate on the mRNA 
end allowing the rapid 5’3’ mRNA degradation by the exonuclease Xrn1, which is the 
predominant pathway for mRNA degradation in yeast (Decker and Parker, 1993; Hsu and 
Stevens, 1993; Muhlrad et al., 1995; Muhlrad and Parker, 1994).  Alternatively, mRNAs 
can also be degraded 3’5’ by the exosome complex (Fig.1; Anderson and Parker, 1998; 
Mangus and van Hoof, 2003; Mitchell and Tollervey, 2003).  
 In addition to wild-type mRNA turnover, eukaryotes have a conserved 
surveillance mechanism known as the nonsense-mediated mRNA decay pathway (NMD) 
that also plays a large role in the fidelity of gene expression (Bedwell et al., 1997; Conti 
and Izaurralde, 2005; Hall and Thein, 1994; Hentze and Kulozik, 1999; Maquat and 
Carmichael, 2001; Maquat and Serin, 2001; Pulak and Anderson, 1993).  This mRNA 
decay pathway is responsible for removing mRNAs that contain premature termination 
codons (PTCs) from the translation pool before they lead to the buildup of truncated 
proteins which could have deleterious effects (Gonzalez et al., 2001; Isken and Maquat, 
2008; Muhlemann et al., 2008).  Importantly, in addition to degrading transcripts with 
PTCs the NMD pathway is also responsible for the regulation of a large portion of wild-
type mRNAs as well.  Previous work shows that ~5-20% of the yeast, Drosophila, and 
human transcriptomes are affected upon inactivation of NMD (Guan et al., 2006; He et 
al., 2003; Johansson et al., 2007; Lelivelt and Culbertson, 1999; Mendell et al., 2004).  
Several mechanisms have been identified that target a wild-type mRNA for degradation 
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by NMD.  These include: 1) a long 3’ UTR (Amrani et al., 2004; Kebaara and Atkin, 
2009; Muhlrad and Parker, 1999), 2) translation of an upstream open reading frame 
(uORF; Amrani et al., 2006; Barbosa et al., 2013; Guan et al., 2006; Nyiko et al., 2009), 
3) a start codon in a suboptimal context which can lead to leaky scanning and out of 
frame initiation of translation (Welch and Jacobson, 1999), and 4) the presence of 
programmed ribosome frameshift (PRF) sites (Plant et al., 2004).  The execution of NMD 
for both PTC-containing substrates and wild-type substrates requires the three trans-
acting factors Upf1, Upf2 and Upf3.  Mutations or deletions in any one of the genes 
encoding these factors causes significant accumulation (≥2.0 fold) of NMD substrates 
(Cui et al., 1995; He et al., 1997; He and Jacobson, 1995; Lee and Culbertson, 1995; 
Lelivelt and Culbertson, 1999; Maderazo et al., 2000).   
Degradation of NMD substrates is different from that of wild-type mRNAs in that 
NMD-substrates are rapidly decapped by Dcp1/Dcp2 without prior removal of the 
poly(A) tail (Beelman et al., 1996; Cao and Parker, 2003; Hagan et al., 1995).  This 
deadenylation-independent decapping is likely due to improper termination of translation 
in which the ribosome terminates too far from the poly(A) tail to interact with Pab1.  This 
is supported by the observation that tethering Pab1 close to a prematurely terminating 
ribosome is able to block decapping (Coller et al., 1998).  Additionally, wild-type 
mRNAs with long 3’ UTRs are substrates for degradation by NMD (Amrani et al., 2004; 
Kebaara and Atkin, 2009; Muhlrad and Parker, 1999), and the presence a long 3’ UTR 
would mimic the context of a prematurely terminating ribosome placing the ribosome too 
far from the poly(A) tail to interact with Pab1 (Amrani et al., 2004).  After decapping the 
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mRNA is subjected to rapid 5’3’ degradation by Xrn1 and accelerated deadenylation 
by the deadenylase complexes (Cao and Parker, 2003).  However, if decapping or 5’3’ 
decay is blocked NMD substrates can also undergo 3’5’ decay via the exosome, but 
this occurs at a much slower rate (Fig. 1; Cao and Parker, 2003; Mitchell and Tollervey, 
2003; Muhlrad and Parker, 1994).   
 Previously, we showed that an mRNA in Saccharomyces cerevisiae, the SSY5 
mRNA, has multiple NMD-targeting signals but is not degraded by the NMD pathway 
(Kebaara and Atkin, 2009; Obenoskey et al., 2014; Chapter 2).  We have shown that the 
protection of the SSY5 mRNA from NMD is not explained by any of the known 
mechanisms of protection.  Thus, this mRNA is likely protected by a novel mechanism.  
Determining the mechanism of protection of the SSY5 mRNA from NMD will add 
valuable insight into the underlying gene regulatory mechanisms by NMD. 
 Since we have previously ruled out the known mechanisms of protection from 
NMD for the SSY5 mRNA we have sought to determine how the SSY5 mRNA is 
degraded.  The comparison of SSY5 mRNA decay with decay patterns of known NMD 
substrates (ENT4 mRNA and CYH2 pre-mRNA) and non-NMD substrates (PGK1 mRNA 
and CYH2 mRNA) will provide clues as to how protection from NMD occurs.  Here we 
show that the SSY5 mRNA decay is predominately 5’3’ because mutations in the genes 
encoding the enzymes required for decapping (Dcp1) and 5’3’ mRNA decay (Xrn1) 
result in the accumulation and stabilization of the SSY5 mRNA.  In contrast, mutations in 
genes encoding components of the deadenylation complexes have no effect on SSY5 
mRNA accumulation.  We also show that the SSY5 mRNA is likely deadenylated prior to 
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decapping because the predominant 3’ ends of the SSY5 mRNA in dcp1Δ and xrn1Δ 
strains are significantly shorter than in the wild-type and upf1Δ strains.  This is the same 
pattern observed for the predominant 3’ ends of the PGK1 mRNA, which is not degraded 
by NMD.  Alternatively, the predominant 3’ ends of the ENT4 mRNA, which is degraded 
by NMD, are longer in the dcp1Δ and xrn1Δ strains than in the wild-type and upf1Δ 
strains.  Finally, we compare the susceptibility of the SSY5 mRNA to NMD in different 
genetic backgrounds and show that protection of the SSY5 mRNA from NMD may be 
background-dependent.  In the commonly used BY4741 and W303 genetic backgrounds 
SSY5 mRNA shows no difference in accumulation between wild-type and upf1Δ strains.  
However, in a different genetic background, similar to W303, the SSY5 mRNA actually 
has a FCR of 1.9±0.2 between wild-type and upf1Δ strains.  This suggests that slight 
changes in genetic background may influence the protection of the SSY5 mRNA from 
NMD. 
 
Materials and Methods 
Yeast strains 
The yeast strains used in this study are listed in Table 3-1.  All yeast 
transformations were done using Lithium Acetate-Mediated transformation as previously 
described (Gietz and Woods, 2002).  AAY589 was constructed by transforming AAY360 
with the upf1Δ2 fragment from pAA70 using primers oAA48 and oAA79.  AAY594, 
AAY595, AAY596, AAY609, AAY610, AAY611 and AAY621 were constructed by 
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transforming the corresponding parent strain (listed in Table 3-1) with the upf1Δ6 
fragment from pAA167 using primers oAA48 and oAA79.   
 
Growth conditions 
Unless otherwise noted yeast cells were grown using standard techniques with 
mild agitation equivalent to 225rpm at 30˚C.  All strains were grown in YAPD media, 
which consists of: 1% yeast extract, 2% Bacto-Peptone, 2% dextrose, and 100mg/L 
Adenine hemisulfate salt.  Strains were maintained on YAPD from initial plating from 
frozen stocks and all through subsequent liquid cultures. 
 
RNA Extractions 
Yeast strains were grown in 10mL cultures to an OD600 of 0.4-0.6.  Cells were 
harvested by centrifugation, washing in DEPC-ddH20, and flash-freezing in dry 
ice/ethanol or liquid nitrogen.  Cell pellets were stored at -70˚C until used for RNA 
extractions.  RNA extractions were performed as previously described (Kebaara et al., 
2012).  RNA samples were diluted to 1µg/µl in DEPC-ddH20 and stored at -70˚C.  RNA 
quality check gels are performed for every RNA sample (1µl of 1µg/µl Total RNA is run 
through a 0.8% agarose gel to check for degradation). 
 
Quantitative Northern Analysis 
10µg of Total RNA mixed with 3µl Formaldehyde loading dye (Ambion, cat. no. 
8552) was separated through a 1.0% agarose gel containing 5.6% Formaldehyde and 1% 
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MOPS (10X MOPS: 0.2 M sodium morpholinopropanesulfonic acid (MOPS), pH 7.0, 
0.05 M sodium acetate, 0.01 M EDTA; adjust pH to 7.0 with 10 M NaOH, do not 
autoclave, store at room temperature in the dark.)  RNA was transferred onto a 
GeneScreen Plus membrane (PerkinElmer) using NorthernMax transfer buffer (Ambion, 
cat. no. 8672) following the manufacturer’s protocol for downward transfer.  The lane 
with the RNA ladder was cut off of the gel before transfer and stained overnight in 
0.5µg/ml ethidium bromide.  Membranes were rinsed in 2X SSC and dried for 15 
minutes at 80˚C.   
 Membranes were hybridized with NorthernMax prehybridization/hybridization 
buffer (Ambion # 8677).  32P-labelled probes were synthesized using ~25ng of PCR 
product corresponding to the gene of interest, the RadPrime DNA Labeling System® 
(Invitrogen #18428-011), and ∼50 μCi [α-32P]dCTP (3000 Ci/mmol, 10 mCi/ml) (Perkin 
Elmer) following the manufacturer’s protocol.  Probes are purified through a Sephadex 
G-50 column equilibrated with TE pH 8.0.  Membranes were hybridized overnight (12-24 
hours) and then washed once at room temperature with 2X SSPE and once at 65˚C with 
2X SSPE/2% SDS.  Membranes were PhosphorImagedTM (GE Healthcare, Typhoon FLA 
9500) and quantified using the ImageQuantTM software.  All membranes were also 
autoradiographed using a phosphorescent ruler to determine the size of the bands by 
comparison to the RNA ladder.  Membranes are stripped and stored at -20˚C for re-
probing.  Detailed protocol for Northern analysis can be found in Kebaara et al. (2012). 
 
 
127 
 
Poly(A) tail length analysis 
This experiment was performed as described in the protocol provided with the 
Poly(A) Tail-Length Analysis Kit® (Affymetrix 76455).  Prior DNase treatment of RNA 
samples was done using the TURBO DNA-free kit® (AM1907).  Primers were designed 
using the information provided in the Saccharomyces Genome Database for predicted 
polyadenylation sites.  Since all of the mRNAs we were interested in contained multiple 
predicted poly(A) sites, the primers pairs were designed to anneal upstream of the 
polyadenylation site that is predicted to be most 3’ of the other predicted sites.  PCR 
products were resolved on a 2.5% TAE agarose gel. 
 
Results 
SSY5 mRNA accumulation and half-life are significantly increased in xrn1Δ cells 
 The predominant decay route for both wild-type mRNAs and NMD substrates is 
through Xrn1-mediated 5’3’ exonucloelytic degradation following removal of the 5’ 
mRNA cap, although this process tends to occur more rapidly for NMD substrates (Cao 
and Parker, 2003).  Given this, we hypothesized that the SSY5 mRNA is likely degraded 
5’3’ by Xrn1, so SSY5 mRNA levels should significantly increase in an xrn1Δ strain, 
but we are unsure as to what extent since we do not know the contribution of 3’5’ 
decay for the SSY5 mRNA.  If the SSY5 mRNA accumulates to significantly high levels 
(comparable to a known NMD substrate such as the ENT4 mRNA) then it is likely that 
3’5’ decay rate is significantly slower. 
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When 5’3’ decay in blocked by deletion of the Xrn1 exonuclease (xrn1Δ) 
quantitative Northern analysis of steady-state mRNA levels reveals a significant increase 
in SSY5 mRNA accumulation compared to wild-type with a fold-change ratio (FCR) of 
xrn1Δ/wild-type=7.8±0.6, n=3 (Fig. 2A).  The half-life (T1/2) of the SSY5 mRNA in 
xrn1Δ cells is also significantly longer at 33.9 minutes compared to 12.2 minutes in wild-
type cells, n=1 (Fig. 2B).  The ENT4 mRNA is shown for comparison as this mRNA is a 
wild-type mRNA that is a substrate for NMD likely due to the presence of its long 3’ 
UTR (Kebaara and Atkin, 2009; Chapter 2).  The CYH2 pre-mRNA is also shown for 
comparison as a wild-type NMD substrate, whereas the CYH2 mRNA and PGK1 mRNA 
are not NMD substrates (Figure 2A).  We show that xrn1Δ results in a significant 
increase in ENT4 mRNA accumulation indicating the 5’3’ decay mechanism is the 
predominant route of decay and that exosome-mediated 3’5’ decay is not sufficient to 
compensate for loss of Xrn1 (likely due to the slower rate of 3’5’ for NMD substrates; 
Muhlrad and Parker, 1994).   The PGK1 mRNA and CYH2 mRNA have been used 
extensively in mRNA decay studies and these wild-type mRNAs are degraded by the 
canonical deadenylation-dependent mRNA decay pathway (Cao and Parker, 2003; 
Mitchell and Tollervey, 2003; Muhlrad and Parker, 1994; Tucker et al., 2002; Tucker et 
al., 2001).  Our results show that xrn1Δ has no significant impact on the accumulation of 
the PGK1 mRNA indicating a much more significant role of 3’5’ decay (Fig. 2A-B; 
Muhlrad and Parker, 1994).  In comparison, the SSY5 mRNA yields FCRs that are much 
closer to the pattern exhibited by the ENT4 and CYH2 mRNAs than the PGK1 mRNA.  
These results indicate that the predominant route of degradation for SSY5 mRNA is 
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through Xrn1-mediated 5’3’ decay.  This resembles the pattern for known NMD 
substrates (ENT4 mRNA and CYH2 pre-mRNA) and is different than the effect of xrn1Δ 
on non-NMD substrates (PGK1 and CYH2 mRNAs). 
Additionally, the accumulation of SSY5 mRNA in the double mutant xrn1Δupf1Δ 
is also significantly higher compared to wild-type cells with a FCR of xrn1Δupf1Δ/wild-
type=9.7±0.6, n=3 (Fig. 2A).  Likewise, SSY5 mRNA T1/2 in xrn1Δupf1Δ cells is 
significantly longer at 40.3 minutes compared to 12.2 minutes in wild-type cells, n=1 
(Fig. 2B).  We do recognize that both the steady-state accumulation and T1/2 of the SSY5 
mRNA in the double mutant are slightly increased from the xrn1Δ cells (FCR of 
xrn1Δupf1Δ/ xrn1Δ=1.2±0.6, n=3, and difference in T1/2 of +6.4 minutes, n=1; Fig. 2A-
B).  However, this can be accounted for by considering the slight increase in 
accumulation and T1/2 of SSY5 mRNA between wild-type and upf1Δ strains alone (Fig. 
2A-B).  This difference is addressed in greater detail below (Fig. 6).  This same pattern is 
also observed for the ENT4 mRNA and CYH2 pre-mRNA. 
 
SSY5 mRNA accumulation is modestly increased in dcp1Δ cells 
 During mRNA decay, Dcp1/2-mediated decapping immediately precedes 5’3’ 
degradation by Xrn1 (Hsu and Stevens, 1993; Muhlrad and Parker, 1994).  If the mRNA 
is not decapped, 5’3’ decay cannot occur because the 5’ end of the mRNA is not 
exposed for exonucloelytic degradation (Stevens, 2001).  Because these two events occur 
in sequence, we hypothesized that blocking decapping of the mRNA by deletion of DCP1 
(dcp1Δ) might yield similar results to blocking 5’3’ degradation by Xrn1 (xrn1Δ).  
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Alternatively, we might see different results because in the dcp1Δ strains the mRNAs are 
capped whereas in the xrn1Δ strains the population of mRNAs includes both newly 
synthesized capped mRNAs and decapped mRNAs unable to undergo 5’3’ decay (He 
and Jacobson, 2001).  Decapped mRNAs accumulate in p-bodies and p-bodies lack 
3’5’ decay enzymes (Balagopal and Parker, 2009; Sheth and Parker, 2003).  This may 
lead to higher accumulation levels observed in xrn1Δ strains.  
Our results show that dcp1Δ had a modest effect on the steady-state accumulation 
of SSY5 mRNA with a FCR of dcp1Δ/wild-type=2.3±0.4, n=3 (Fig. 3A).  This is 
significantly less than the SSY5 mRNA accumulation that resulted from xrn1Δ (FCR of 
dcp1Δ/wild-type=7.8±0.6, n=3; Fig. 2A).  However, the T1/2 of SSY5 mRNA in dcp1Δ 
cells increased to 35.9 minutes compared to 12.2 minutes in wild-type cells (n=1), which 
is a similar difference to that observed with the xrn1Δ vs wild-type cells (Fig. 3B).  
Similar to SSY5 mRNA, the ENT4 mRNA and CYH2 pre-mRNA also show a modest 
increase in accumulation upon dcp1Δ (FCR of dcp1Δ/wild-type=1.8±0.4 and 6.4±0.5, 
respectively, n=3; Fig. 3A).  Interestingly, the ENT4 mRNA shows a reduction in mRNA 
stability in the dcp1Δ cells compared to upf1Δ cells, although the fold change in mRNA 
accumulation between the two is not quite 2-fold (Fig. 3A).  The double mutant 
dcp1Δupf1Δ strains also showed a different trend in accumulation between the SSY5 
mRNA and the ENT4 mRNA.  In contrast, accumulation of the non-NMD substrates 
PGK1 and CYH2 mRNAs, as well as the half-life of the PGK1 mRNA, was the same in 
wild-type, upf1Δ, dcp1Δ, and dcp1Δupf1Δ cells (Fig. 3A-B).   
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Moreover, the trend observed for the accumulation of the PGK1 mRNA is quite 
similar to the trend seen in accumulation of the CYH2 mRNA in the dcp1Δ cells and 
dcp1Δupf1Δ cells, which is consistent with both mRNAs being non-NMD substrates (Fig. 
3A).  The trend observed for the ENT4 mRNA is quite similar to the trend seen in 
accumulation of the CYH2 pre-mRNA in the dcp1Δ cells and dcp1Δupf1Δ, which is 
consistent with both being NMD substrates (Fig. 3A).  Accumulation of the SSY5 mRNA 
in the dcp1Δ cells and dcp1Δupf1Δ cells, however, does not fit the pattern of either the 
CYH2 mRNA or pre-mRNA.  Together these results lead us to the conclusion that SSY5 
mRNA degradation is different from wild-type mRNA degradation and NMD-substrate 
degradation at the step of decapping.   
 
SSY5 mRNA accumulation is not significantly impacted by deletion of different 
deadenylation components 
 In S. cerevisiae newly synthesized mRNAs contain poly(A) tails approximately 
60-80nt in length (Beilharz and Preiss, 2007).  The length of the mRNA poly(A) tail 
functions, in combination with the 5’ mRNA cap, to regulate both translational efficiency 
and mRNA decay (Anderson and Parker, 1998; Gallie, 1991; Muhlrad et al., 1995; 
Munroe and Jacobson, 1990).  The degradation of an mRNA involves a deadenylation 
step regardless of the mRNA being an NMD substrate or a wild-type mRNA degraded 
through the canonical pathway (Norbury, 2013).  The difference is the prerequisite of 
deadenylation to precede decapping for wild-type mRNA degradation where it is the rate-
limiting step of mRNA decay (Cao and Parker, 2003; Decker and Parker, 1993; Muhlrad 
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and Parker, 1994).  While deadenylation is not a prerequisite for decapping of NMD 
substrates, the mRNAs do undergo rapid deadenylation (Cao and Parker, 2003; Muhlrad 
and Parker, 1994). 
 Deadenylation of an mRNA occurs through the combined efforts of the 
Pan2/Pan3 and the Ccr4/Pop2/Not deadenylase complexes (Wahle and Winkler, 2013; 
Wiederhold and Passmore, 2010).  The Pan2/Pan3 deadenylation complex was the first to 
be discovered in yeast (Boeck et al., 1996; Lowell et al., 1992; Sachs and Deardorff, 
1992).  The Pan2 subunit is responsible for the catalytic activity of the complex (Wahle 
and Winkler, 2013).  The Ccr4/Pop2/Not complex is a multisubunit complex containing 
at least one definitive catalytic subunit, Ccr4 (Chen et al., 2002; Tucker et al., 2002; 
Tucker et al., 2001).  There are conflicting reports on whether or not Caf1 is a catalytic 
subunit as well in S. cerevisiae, although the catalytic activity of this subunit has been 
verified in other organisms (Andersen et al., 2009; Daugeron et al., 2001; Jonstrup et al., 
2007; Liang et al., 2009; Thore et al., 2003; Tucker et al., 2002; Viswanathan et al., 
2004).  It was originally shown that the Pan2/Pan3 complex acted first in the initial 
trimming of the poly(A) tail in a Pab1-dependent manner (Brown and Sachs, 1998).  
However, later it was observed that pan2Δ and pan3Δ strains have few defects in mRNA 
deadenylation (Boeck et al., 1996; Brown et al., 1996).  Together these observations 
suggest that in the absence of the Pan2/Pan3 complex, the Ccr4/Pop2/Not complex is 
capable of handling the full range of mRNA deadenylation (Tucker et al., 2001).  
Considering these observations in the context of our previous results (Figs. 2 and 3) we 
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hypothesized that deadenylation would likely play a pertinent role in the degradation of 
the SSY5 mRNA. 
To test this hypothesis we analyzed the SSY5 mRNA steady-state accumulation in 
several deadenylation mutant strains.  Fold-change ratios between the wild-type strain 
and those lacking Ccr4 (ccr4Δ strains) or Caf1 (caf1Δ strains) subunits, or both 
(ccr4Δcaf1Δ strains) showed very little effect on SSY5 mRNA levels, n=3 (Fig. 4).  
Likewise, deletion of the Pan2 (pan2Δ strains) catalytic subunit of the Pan2/Pan3 
complex showed very little effect on SSY5 mRNA levels as well, n=3 (Fig 4).  These 
results are not surprising as deletion of the catalytic activity of one complex can be 
compensated for by the catalytic activity of the other complex (Tucker et al., 2001).  
However, the SSY5 mRNA levels showed little change in strains in which both 
complexes were rendered inactive (pan2Δccr4Δ) compared to wild-type strains, n=3 (Fig. 
4).  A previous study showed that the MFA2 mRNA contains the longest poly(A) tail in 
the pan2Δccr4Δ strain indicating a lack of deadenylation in this strain as expected.  
However, decay intermediates of the MFA2 mRNA were observed in the pan2Δccr4Δ 
strain indicating that at least some mRNAs in this strain can still be degraded due to a 
slow rate of deadenylation-independent decapping and 5’3’ decay (Tucker et al., 
2001).  Alternatively, this observation can also be explained by the possibility that the 
Caf1 subunit is able to compensate for the loss of both Ccr4 and Pan2, which would 
support the studies claiming Caf1 does indeed have deadenylase activity.  There is also 
no previous data that would support the exosome being able to compensate for loss of 
deadenylase activity.  Additionally, we observed the effect of NMD on the accumulation 
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of the SSY5 mRNA in the deadenylation mutant strains by deletion of Upf1 (upf1Δ 
strains).  We observed no significant fold changes upon Upf1 deletion in these strains 
compared to strains with a wild-type Upf1 allowing us to conclude that the effect 
observed for SSY5 mRNA accumulation is independent of NMD (Fig. 4).  We do note 
that band intensity of the upf1Δ strains does appear to be darker, however, fold change 
values do not reflect a difference in SSY5 mRNA accumulation for these strains.  
Originally, this was surprising, but upon closer analysis we determined this is most likely 
due to the bands in the upf1Δ strains actually being thicker in width, which reflects a 
slightly wider variation in mRNA lengths, but not necessarily more intense in pixel 
density. 
We also analyzed steady-state accumulation of NMD substrates (ENT4 mRNA 
and CYH2 pre-mRNA) as well as non-NMD substrates (PGK1 and CYH2 mRNAs) for 
comparison.  Similar to the SSY5 mRNA, none of these mRNAs appear to be largely 
effected by perturbation of deadenylation (Fig. 4).  The only difference can be seen in the 
upf1Δ strains for the ENT4 mRNA and CYH2 pre-mRNA, which is expected since these 
are NMD substrates.  
 Based on these results we can conclude that blocking deadenylation as little effect 
on SSY5 mRNA steady-state accumulation.  However, this result is consistent with that of 
both an NMD-substrate (ENT4 mRNA) and a wild-type mRNA (PGK1 mRNA). 
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SSY5 mRNA has a shortened 3’ end in xrn1Δ and dcp1Δ strains 
 Following the results in Figures 2-4 we wanted to determine if the SSY5 mRNA 
was deadenylated and, if so, if we could determine at which step the mRNA is 
deadenylated.  We hypothesized that the mRNA would be deadenylated as both wild-type 
mRNAs and NMD-substrates are deadenylated, but we were unsure if deadenylation was 
occurring as a prerequisite to decapping.  To do this we used the Poly(A) Tail-Length 
Assay Kit from Affymetrix (Materials and Methods).  Briefly, a poly(A) polymerase first 
adds a short series of guanosine and inosine residues (G/I) to the 3’ ends of 
polyadenylated mRNAs.  The G/I tails become the priming site for reverse transcription 
of the mRNAs to cDNA molecules.  Two pairs of primers are then used to amplify the 3’ 
ends of target mRNAs.  The first primer pair, the gene-specific (G.S.) primer pair, 
consists of a forward and reverse primer that anneal to the 3’ end of the mRNA both of 
which are upstream of the polyadenylation site(s).  The second primer pair, the poly(A) 
tail (“Tail”) primer pair, consists of the same upstream primer from the G.S. primer pair 
and a universal reverse primer that anneals to the G/I tail (Fig. 5A).  PCR products 
obtained from the use of these two primer pairs are then compared in order to determine 
the length of the 3’ poly(A) tail.  It should be noted that because the poly(A) sites for the 
mRNAs we used are not definitive (as there are multiple predicted sites) we designed the 
G.S. primer pair to anneal upstream (3’) of all predicted poly(A) sites (SGD). 
 The Poly(A) Tail-Length Assay Kit was used to determine the length of the 3’ 
end, which includes the poly(A) tail, of steady-state SSY5, ENT4, and PGK1 mRNAs in 
wild-type, upf1Δ, xrn1Δ, and dcp1Δ strains, n=2.  However, an RNase H control was not 
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done so we are unable to positively confirm that the results observed are strictly due to 
differences in poly(A) tail length.  We can, however, use the results to analyze 
differences in the 3’ end length of the mRNAs which allows us to make a preliminary 
assumption about the poly(A) tail length of the mRNAs.  As shown in Figure 5B, the 3’ 
end of the SSY5 mRNA is the same in both wild-type and upf1Δ strains (lane with the 
“Tail” primers product).  In contrast, the 3’ end of the SSY5 mRNA is much shorter in 
both xrn1Δ and dcp1Δ strains.  This indicates that in the absence of decapping or 5’3’ 
nucleolytic degradation the SSY5 mRNA can be shortened from the 3’ end.  This same 
pattern is observed for the 3’ end of the PGK1 mRNA among all four strains (Fig.5 B).  
In contrast, the ENT4 mRNA shows the same 3’ end length in both wild-type and upf1Δ 
strains, but in these strains the 3’ end is much shorter than in the xrn1Δ and dcp1Δ strains 
(Fig.5 B).  This leads to the preliminary conclusion that when the ENT4 mRNA, which is 
an NMD substrate, cannot be degraded by the 5’ end then shortening of the 3’ end of the 
mRNA is perturbed as well. 
 From these results we can conclude that the 3’ end of the SSY5 mRNA is 
behaving just like wild-type mRNA (PGK1 mRNA) in contrast to an NMD substrate 
(ENT4 mRNA) when comparing wild-type, upf1Δ, xrn1Δ, and dcp1Δ strains. 
 
SSY5 mRNA has different stability in different strain backgrounds 
 In order to examine the behavior of the SSY5 mRNA in the decapping and 5’3’ 
decay mutants discussed above (Figs. 2 and 3) we utilized previously constructed strains 
which are of a different genetic background (He et al., 1997; He and Jacobson, 1995).  It 
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was previously shown that relative mRNA accumulation in wild-type and upf1Δ strains 
can differ depending on strain background (Kebaara et al., 2003).  With this knowledge 
we originally analyzed SSY5 mRNA levels in both commonly used BY4741 and W303 
genetic backgrounds and found no difference in susceptibility of SSY5 mRNA to NMD 
(Chapter 2).  However, we unexpectedly found a slight difference in the susceptibility of 
the SSY5 mRNA to NMD in the decay mutants utilized in Figures 2 and 3.  Figure 6 
shows a direct comparison of the SSY5 mRNA steady-state accumulation in the BY4741 
and W303 backgrounds along with the wild-type and upf1Δ strains from the same 
background used for construction of the dcp1Δ and xrn1Δ strains (He et al., 1997; He and 
Jacobson, 1995, 2001).  Here we show there is no difference in SSY5 mRNA 
accumulation between wild-type and upf1Δ strains in either the BY4741 or the W303 
backgrounds.  However, in the background used for the dcp1Δ and xrn1Δ strains, SSY5 
mRNA accumulation shows a FCR of upf1Δ/wild-type =1.9±0.2, (n=3; Fig 6).  Likewise, 
ENT4 mRNA accumulation shows a similar FCR between wild-type and upf1Δ strains in 
both the BY4741 background and the W303 background, but in the strain background 
used to create the dcp1Δ and xrn1Δ strains this FCR is higher, (n=3; Fig. 6; He et al., 
1997; He and Jacobson, 1995, 2001).  We created the isogenic upf1Δ strain used with this 
set of strains, but the strain was constructed by transformation of the wild-type strain 
(AAY360) of this genetic background with the upf1Δ2 cassette.  The strain background 
of this set wild-type, upf1Δ, xrn1Δ and dcp1Δ strains is published as having the same 
auxotrophic markers as the W303 background that we originally tested (He et al., 1997; 
He and Jacobson, 1995).  However, there is clearly a difference in the accumulation of 
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the SSY5 mRNA between these strains and our original W303 strains.  From these 
observations we conclude that the protection of the SSY5 mRNA from NMD is not 
entirely robust in all strain backgrounds.  However, this can be used to our advantage in 
determining what protects the SSY5 mRNA from NMD, discussed below. 
 
Discussion 
 In this study we began to dissect the mechanism of SSY5 mRNA decay.  The SSY5 
mRNA is a wild-type mRNA with multiple NMD-targeting signals but is not degraded by 
the NMD pathway (Kebaara and Atkin, 2009; Obenoskey et al., 2014; Chapter 2).  We 
have previously presented the case that the SSY5 mRNA is likely protected from NMD by 
a novel mechanism (Chapter 2).  The goal in studying the mechanism of SSY5 mRNA 
decay was to determine if the mRNA was being degraded via the wild-type 
deadenylation-dependent decapping pathway or by the deadenylation-independent 
decapping NMD pathway.  As a consequence we were hoping to be able to identify if 
protection of the SSY5 mRNA from NMD is incurred before recognition as an NMD 
substrate, in which we would see evidence of degradation by the deadenylation-
dependent decapping pathway, or if protection is incurred at a point after recognition as 
an NMD substrate, in which we would potentially see evidence of deadenylation-
independent decapping and decay.  However, our data presented here does not provide a 
clear-cut answer.  Instead, we learn something quite intriguing about SSY5 mRNA decay. 
When Xrn1-mediated 5’3’ decay is blocked in xrn1Δ strains, SSY5 mRNA accumulates 
to significantly higher levels compared to wild-type cells (Fig. 2).  However, when Dcp1-
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mediated decapping is blocked in dcp1Δ strains, SSY5 mRNA accumulates at much lower 
levels than in the xrn1Δ cells.  Previous work has shown that a significant fraction of the 
mRNAs in xrn1Δ cells are in fact decapped (He and Jacobson, 2001).  This indicates that 
the presence of the 5’ mRNA cap (in dcp1Δ cells) is able to increase the rate of exosome-
mediated 3’5’ degradation, while this process is much slower when the cap is removed 
(in xrn1Δ cells) allowing for the greater accumulation of SSY5 mRNA (Figs. 2A and 3A).  
This exact same trend is not consistent for either an NMD substrate (ENT4 mRNA) or a 
wild-type mRNA (PGK1; Figs. 2A and 3A).  Further, blocking deadenylation through 
deletion of the catalytic subunits of either the Pan2/Pan3 deadenylase complex (pan2Δ 
strains) or the Ccr4/Pop2/Not complex (ccr4Δ, caf1Δ, ccr4Δcaf1Δ strains) or both 
complexes (ccr4Δpan2Δ strains) had very little effect on the steady-state accumulation of 
SSY5 mRNA (Fig. 4).  Together these results suggest an incredibly tight window in the 
regulation of SSY5 mRNA levels as there is a significant difference in mRNA 
accumulation between the dcp1Δ strains and the xrn1Δ strains, two steps that occur in 
immediate sequence during 5’3’ mRNA decay (Figs. 2A and 3A).  
Moreover, a previous study was done to identify direct targets of the NMD 
pathway in S. cerevisiae by virtue of association with core NMD factor Upf1 (Johansson 
et al., 2007).  Interestingly, in this study Upf1 was found to specifically associate with the 
SSY5 mRNA.  An mRNA was considered to be enriched for association with Upf1 if the 
signal intensity from the mRNAs co-purifying with TAP-Upf1 differed from the negative 
control by at least two-fold.  The SSY5 mRNA showed an enrichment of 4.76 fold over 
the negative control.  If enriched association of an mRNA with Upf1 is indicative of the 
140 
 
mRNA being a direct NMD substrate, as was hypothesized in this study, the SSY5 mRNA 
is being recognized by the NMD machinery as an NMD substrate.  According to this 
interpretation, protection of the SSY5 mRNA from NMD should be incurred at a point 
after substrate recognition.  It is also possible that protection is incurred even earlier but I 
a way that does not interfere with stable Upf1 binding. 
 Additionally, we found that in working with a new strain background SSY5 
mRNA susceptibility to NMD was slightly different than in the BY4741 and W303 
backgrounds used previously (Fig 6).  Upon further contemplation, this initially 
surprising and somewhat frustrating observation can actually be used to our advantage.  
Previously, we determined that trans-acting factor Pub1 is not responsible for the 
protection of SSY5 mRNA from NMD.  We had thought this may be the case based on an 
earlier study showing Pub1 is responsible for the protection of GCN4 and YAP1 mRNAs 
from NMD (Ruiz-Echevarria and Peltz, 2000).  This leaves us in search of potential 
trans-acting factors that may be involved in the protection of SSY5 mRNA from NMD.  
We have developed the strains to be able to test RNA binding protein (RBP) mutants for 
the effect on SSY5 mRNA levels (Chapter 2), but taking on the entire yeast RBP 
collection at once is a cumbersome task.  By comparing differences between the BY4741 
and W303 backgrounds with those of the dcp1Δ and xrn1Δ strain background we are 
presented with a much more realistic starting point for determining which factors may be 
involved in SSY5 protection from NMD. 
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Figure legends 
Fig. 3-1.  Wild-type mRNAs and NMD substrates are degraded by different mechanisms.  
Most wild-type mRNAs are first deadenylated by the Pan2/Pan2 and Ccr4/Pop2/Not 
deadenylase complexes.  Shortening of the poly(A) tail leads to deadenylation-dependent 
decapping by the Dcp1/Dcp2 decapping complex.  Once decapped the mRNA is 
subjected to 5’3’ degradation by the Xrn1 exonuclease or 3’5’ degradation by the 
exosome complex.  NMD substrates are rapidly decapped in a deadenylation-independent 
manner, followed by rapid deadenylation and 5’3’ degradation by Xrn1.  In the 
absence of decapping or 5’3’ degradation NMD substrates can also undergo 3’5’ 
degradation, but at a much slower rate. 
 
Fig. 3-2.  SSY5 mRNA steady-state accumulation is significantly increased and it has a 
significantly longer half-life in an xrn1Δ strain.  A)  Northern blot analysis of the steady-
state accumulation of the SSY5, ENT4 (a wild-type NMD substrate), and PGK1 (a wild-
type mRNA degraded by the canonical pathway) mRNAs in wild-type (AAY360), upf1Δ 
(AAY589), xrn1Δ (AAY389), and xrn1Δupf1Δ (AAY611) strains grown in YAPD to 
mid-log phase.  CYH2 pre-mRNA is an NMD control (CYH2 pre-mRNA is an NMD 
substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown for loading.  Fold 
change values are normalized and determined as a fold change ratio from wild-type; 
values are an average of three independent trials.  B) mRNA half-life analysis of the SSY5 
and PGK1 mRNAs in the same strains used in part A.  Strains were grown in YAPD and 
10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-life calculations 
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were determined using a graph of percent mRNA remaining at each time point during the 
exponential decay.   
 
Fig. 3-3.  SSY5 mRNA steady-state accumulation is moderately increased in a dcp1Δ 
strain while half-lives are significantly stabilized in a dcp1Δ strain.  A)  Northern blot 
analysis of the steady-state accumulation of the SSY5, ENT4, and PGK1 mRNAs in wild-
type (AAY360), upf1Δ (AAY589), dcp1Δ (AAY390), and dcp1Δupf1Δ (AAY621) strains 
grown in YAPD to mid-log phase.  CYH2 pre-mRNA is an NMD control (CYH2 pre-
mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown 
for loading.  Fold change values are normalized and determined as a fold change ratio 
from wild-type; values are an average of three independent trials.  B) mRNA half-life 
analysis of the SSY5 and PGK1 mRNAs in the same strains used in part A.  Strains were 
grown in YAPD.  10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-
life calculations were determined using a graph of percent mRNA remaining at each time 
point during the exponential decay.   
 
Fig. 3-4.  Mutations altering the deadenylase complexes do not have a significant 
influence on SSY5 mRNA stability.  Northern blot analysis of the steady-state 
accumulation of the SSY5, ENT4, and PGK1 mRNAs in wild-type (AAY391), upf1Δ 
(AAY594), ccr4Δ (AAY393), and ccr4Δupf1Δ (AAY596), ccr4Δcaf1Δ (AAY394), 
ccr4Δcaf1Δupf1Δ (AAY609), pan2Δ (AAY395), pan2Δupf1Δ (AAY595), pan2Δccr4Δ 
(AAY396), and pan2Δccr4Δupf1Δ (AAY610) strains grown in YAPD.  CYH2 pre-
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mRNA is an NMD control (CYH2 pre-mRNA is an NMD substrate, CYH2 mRNA is not 
an NMD substrate) and SCR1 is shown for loading.  Fold change values are normalized 
and determined as a fold change ratio from wild-type; values are an average of three 
independent trials. 
 
Fig. 3-5.  SSY5 mRNA has a shortened 3’ end in xrn1Δ and dcp1Δ strains.  A) Schematic 
of how the Poly(A) Tail Length Analysis works.  This analysis was done using the 
“Poly(A) Tail-Length Assay Kit” from Affymetrix (#76455).  In this assay, a G/I tail is 
added to the end of mRNAs containing a Poly(A) tail.  These G/I-tailed mRNAs are then 
reverse transcribed to cDNA, which provides a template for subsequent PCR.  PCR is 
performed using two sets of primers independently. The Gene Specific (G.S.; teal) primer 
pair is comprised of a forward primer that binds anywhere within the open reading frame 
(ORF) or 3’ UTR and a reverse primer that binds immediately upstream (5’) of the 
Poly(A) start site. *It is important to note that the exact Poly(A) start site of the mRNAs 
in this figure were unknown so the reverse primer was designed just upstream of the first 
predicted Poly(A) start site according to the Saccharomyces Genome Database (SGD).  
The Poly(A) Tail (Tail; pink) primer pair uses the same forward primer from the G.S. 
pair and a reverse primer that anneals to the G/I tail (provided with the kit).  B) Products 
from the PCR reactions using the above primer pairs for the SSY5, ENT4, and PGK1 
mRNAs in the wild-type (AAY360), upf1Δ (AAY589), xrn1Δ (AAY389), and dcp1Δ 
(AAY390) strains were resolved on a 2.5% agarose TAE gel.  Strains were grown in 
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YAPD and the total RNA samples used for the reactions were the same RNA samples 
that were used for Northern analysis in figures 2A and 3A. 
 
Fig. 3-6. SSY5 mRNA has different stability in different strain backgrounds.  Northern 
blot analysis of the steady-state accumulation of the SSY5 and ENT4 mRNAs in wild-type 
(AAY277) and upf1Δ (AAY363) in the BY4741 background, wild-type (AAY187) and 
upf1Δ (AAY320) in the W303 background, and in wild-type (AAY360) and upf1Δ 
(AAY589) in the “W303” background that originated from the wild-type strain in He and 
Jacobson, 1995.  Strains were grown in YAPD.  CYH2 pre-mRNA is an NMD control 
(CYH2 pre-mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and 
SCR1 is shown for loading.  Fold change values are normalized and determined as a fold 
change ratio from wild-type; values are an average of three independent trials. 
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Figure 3-5  
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Table 3-1.  Strains used in this study 
Strain 
Parent 
Strain 
Genotype Source 
W303  
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 
Ralser et al., 
2012 
BY4741  MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
Winston et al., 
1998 
AAY320 W303 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 upf1::URA3 
Atkin lab 
AAY360   
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 
He and 
Jacobson, 1995 
AAY363 BY4741 MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 Atkin lab 
AAY389 AAY360 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 xrn1::ADE2 
He and 
Jacobson, 2001 
AAY390 AAY360 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 dcp1::URA3 
He and 
Jacobson, 2001 
AAY391   
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM 
Tucker et al., 
2001 
AAY393 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO 
Tucker et al., 
2001 
AAY394 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO caf1::URA3 
Tucker et al., 
2001 
AAY395 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM pan2::URA3 
Tucker et al., 
2001 
AAY396 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO pan2::URA3 
Tucker et al., 
2001 
AAY589* AAY360 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 upf1::URA3 
Atkin lab 
AAY594* AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM upf1::TRP1 
Atkin lab 
AAY595* AAY395 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM pan2::URA3 upf1::TRP1 
Atkin lab 
AAY596* AAY393 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO upf1::TRP1 
Atkin lab 
AAY609* AAY394 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO caf1::URA3 upf1::TRP1  
Atkin lab 
AAY610* AAY396 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO pan2::URA3 upf1::TRP1 
Atkin lab 
AAY611* AAY389 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 xrn1::ADE2 upf1::TRP1 
Atkin lab 
AAY621* AAY390 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 dcp1::URA3 upf1::TRP1 
Atkin lab 
* = new strain created for this study 
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CHAPTER 4 
The protection of the Saccharomyces cerevisiae wild-type GCN4 and YAP1 mRNAs 
from degradation by NMD  
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Abstract 
 Nonsense-mediated mRNA decay was first discovered because of its role in the 
rapid degradation of mRNAs that harbor premature termination codons (PTCs).  It is now 
recognized that a significant fraction of wild-type mRNAs are regulated by NMD as well.  
Importantly, not all of the underlying mechanisms of the NMD pathway are understood.  
Because as many as 1/3 of all genetic diseases and cancers link to NMD the development 
of safe and effective therapies to treat these diseases is a pressing area of research.  Given 
this it is absolutely critical that we continue to elucidate the underlying molecular 
mechanisms of NMD.  Here we investigate two wild-type mRNAs, YAP1 and GCN4, 
which both contain at least one NMD-targeting signal but neither mRNA is degraded by 
NMD.  Previously, it was reported that both mRNAs are protected by trans-acting factor 
Pub1; however, we were unable to confirm these results.  We show that both mRNAs 
cofractionate with polyribosomes so are likely to be translated.  We also show that 
blocking 5’3’ exonucloelytic degradation results in moderate accumulation of both 
mRNAs while blocking decapping has little effect on the accumulation of either mRNA.  
Additionally, blocking deadenylation has little effect on the accumulation of either 
mRNA.  Together these results show that both YAP1 mRNA and GCN4 mRNA likely 
have a unique method of degradation that is tightly regulated.  
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Introduction 
 The regulation of gene expression in all cells is critical for the proper functioning 
of the organism.  Many things contribute to the fidelity of gene expression but among the 
most influential are the biogenesis of mRNA molecules through transcription and the 
decay of mRNA molecules through mRNA degradation.  In yeast, wild-type mRNAs are 
typically degraded in the cytoplasm by a process that is initiated by removal of the 3’ 
poly(A) tail by the Pan2/Pan3 and Ccr4/Pop2/Not deadenylase complexes.  Once the 
poly(A) tail reaches a length of 10-12 adenine residues the circularization of the mRNP is 
disrupted due to the lack of poly(A) binding protein (Pab1), which was originally bound 
to the poly(A) tail (Brown and Sachs, 1998; Decker and Parker, 1993; Tucker et al., 
2002; Tucker et al., 2001; Wahle and Winkler, 2013).  Disruption of the mRNP 
circularization results in the exposure of the 5’ 7-methylguanosine to the decapping 
complex Dcp1/2, which rapidly decaps the mRNA leaving a 5’ monophosphate exposed 
(Coller and Parker, 2004).  This 5’ monophosphate becomes the substrate for the 
exoribonuclease Xrn1, which then degrades the mRNA in a 5’3’ direction.  This 
appears to be the primary pathway for the degradation of most yeast mRNAs (Decker and 
Parker, 1993; Hsu and Stevens, 1993; Muhlrad et al., 1995; Muhlrad and Parker, 1994).  
Alternatively, mRNAs can also be degraded 3’5’ by the exosome complex following 
deadenylation (Anderson and Parker, 1998; Mangus et al., 2003; Mangus and van Hoof, 
2003; Mitchell and Tollervey, 2003). 
 Another part of the fidelity of gene expression is the presence of several quality 
control pathways, which are responsible for the rapid degradation of aberrant mRNA 
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transcripts (Behm-Ansmant et al., 2007; Hilleren et al., 2001; Isken and Maquat, 2007, 
2008; Lykke-Andersen et al., 2001).  One of these quality control pathways is the 
nonsense-mediated mRNA decay pathway (NMD), which is responsible for the rapid 
degradation of mRNAs that harbor premature termination codons (PTCs).  If mRNAs 
with PTCs were not rapidly removed from the translational pool of the cell they would 
lead to the build-up of truncated proteins which could have dominant negative effects 
(Gonzalez et al., 2001; Isken and Maquat, 2007; Muhlemann et al., 2008).  NMD is a 
conserved mRNA decay pathway which is present in all eukaryotes that have been 
examined (Bedwell et al., 1997; Conti and Izaurralde, 2005; Hall and Thein, 1994; 
Hentze and Kulozik, 1999; Maquat and Carmichael, 2001; Maquat and Serin, 2001; 
Pulak and Anderson, 1993).  Importantly, it is now recognized the NMD plays a vital role 
in wild-type gene regulation as well.  It has been observed that ~5-20% of the yeast, 
Drosophila, and human transcriptomes are affected upon inactivation of NMD (Guan et 
al., 2006; He et al., 2003; Johansson et al., 2007; Lelivelt and Culbertson, 1999; Mendell 
et al., 2004).  NMD requires three trans-acting factors: Upf1, Upf2 and Upf3.  Mutations 
or deletions in one or more of the genes encoding these factors stabilizes NMD substrates 
(Cui et al., 1995; He et al., 1997; He and Jacobson, 1995; Lee and Culbertson, 1995; 
Lelivelt and Culbertson, 1999; Maderazo et al., 2000).   
 Several mechanisms have been identified which can be responsible for targeting 
wild-type mRNAs for degradation by NMD including: 1) a long 3’ UTR (Amrani et al., 
2004; Kebaara and Atkin, 2009; Muhlrad and Parker, 1999), 2) translation of an upstream 
open reading frame (uORF; Amrani et al., 2006; Barbosa et al., 2013; Nyiko et al., 2009), 
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3) a start codon in a suboptimal context which can lead to leaky scanning and out of 
frame initiation of translation (Welch and Jacobson, 1999), 4) the presence of 
programmed ribosome frameshift (PRF) sites (Plant et al., 2004), and 5) the presence of 
pre-mRNA introns and regulated alternative splicing resulting in PTCs (He et al., 1993; 
Lewis et al., 2003; McGlincy and Smith, 2008; Ni et al., 2007). 
 The degradation of NMD substrates is different from that of most wild-type 
mRNAs in that NMD substrates are rapidly decapped in a deadenylation-independent 
process (Beelman et al., 1996; Cao and Parker, 2003; Hagan et al., 1995).  NMD 
substrates are also rapidly deadenylated but the deadenylation does not need to occur as a 
prerequisite for mRNA decapping (Cao and Parker, 2003).  After decapping NMD 
substrates are rapidly degraded 5’3’ by Xrn1 (He and Jacobson, 2001; He et al., 2003).  
NMD substrates can also be degraded 3’5’ by the exosome complex following 
deadenylation, but this degradation takes place at a much slower rate (Cao and Parker, 
2003; Mitchell and Tollervey, 2003; Muhlrad and Parker, 1994). 
It was previously shown that two wild-type mRNAs in Saccharomyces cerevisiae, YAP1 
and GCN4, which have translated uORFs, are protected from degradation by NMD 
(Ruiz-Echevarria et al., 1998; Ruiz-Echevarria and Peltz, 2000; Vilela et al., 1998).  In 
this study we further characterize the mechanism of protection of these two wild-type 
mRNAs from NMD by determining that they both co-fractionate as expected with 
polyribosomes, and also by determining their stability and accumulation in various decay 
and deadenylation mutants.  We also show that trans-acting factor, Pub1, is not likely 
responsible for the protection of these two mRNAs from NMD in contrast to what was 
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previously reported (Ruiz-Echevarria and Peltz, 2000). 
 
Materials and Methods 
Yeast strains 
The yeast strains used in this study are listed in Table 4-1.  All yeast 
transformations were done using Lithium Acetate-Mediated transformation as previously 
described (Gietz and Woods, 2002).  AAY590 was constructed by transforming AAY538 
with the upf1Δ2 fragment from pAA70 using primers oAA48 and oAA79.  AAY589 was 
constructed by transforming AAY360 with the upf1Δ2 fragment from pAA70 using 
primers oAA48 and oAA79.  AAY594, AAY595, AAY596, AAY609, AAY610, 
AAY611 and AAY621 were constructed by transforming the corresponding parent strain 
(listed in Table 4-1) with the upf1Δ6 fragment from pAA167 using primers oAA48 and 
oAA79. 
 
Growth conditions 
Unless otherwise noted yeast cells were grown using standard techniques with 
mild agitation equivalent to 225rpm at 30˚C.  When cells are stated as being grown in a 
certain type of media, the same media was used to grow plate cultures from frozen stock 
and all subsequent liquid cultures.  In this study, YAPD media consists of: 1% yeast 
extract, 2% Bacto-Peptone, 2% dextrose, and 100mg/L Adenine hemisulfate salt; and 
minimal media (SD+amino acids) consists of: 0.67% yeast nitrogen base without amino 
acids, 2% dextrose, 20 mg/L L-Histidine, 30 mg/L L-Leucine, 20 mg/L L-Methionine, 20 
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mg/L Uracil, and 30 mg/L L-Lysine. 
 
RNA Extractions 
Yeast strains were grown in 10mL cultures to an OD600 of 0.4-0.6.  Cells were 
harvested by centrifugation, washing in DEPC-ddH20, and flash-freezing in dry 
ice/ethanol or liquid nitrogen.  Cell pellets were stored at -70˚C until used for RNA 
extractions.  RNA extractions were performed as previously described (Kebaara et al., 
2012).  RNA samples were diluted to 1µg/µl in DEPC-ddH20 and stored at -70˚C.  RNA 
quality check gels are performed for every RNA sample (1µl of 1µg/µl Total RNA is run 
through a 0.8% agarose gel to check for degradation). 
 
Quantitative Northern Analysis 
10µg of Total RNA mixed with 3µl Formaldehyde loading dye (Ambion, cat. no. 
8552) was separated through a 1.0% agarose gel containing 5.6% Formaldehyde and 1% 
MOPS (10X MOPS: 0.2 M sodium morpholinopropanesulfonic acid (MOPS), pH 7.0, 
0.05 M sodium acetate, 0.01 M EDTA; adjust pH to 7.0 with 10 M NaOH, do not 
autoclave, store at room temperature in the dark.)  RNA was transferred onto a 
GeneScreen Plus membrane (PerkinElmer) using NorthernMax transfer buffer (Ambion, 
cat. no. 8672) following the manufacturer’s protocol for downward transfer.  The lane 
with the RNA ladder was cut off of the gel before transfer and stained overnight in 
0.5µg/ml ethidium bromide.  Membranes were rinsed in 2X SSC and dried for 15 
minutes at 80˚C.   
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 Membranes were hybridized with NorthernMax prehybridization/hybridization 
buffer (Ambion # 8677).  32P-labelled probes were synthesized using ~25ng of PCR 
product corresponding to the gene of interest, the RadPrime DNA Labeling system 
(Invitrogen #18428-011), and ∼50 μCi [α-32P]dCTP (3000 Ci/mmol, 10 mCi/ml) (Perkin 
Elmer) following the manufacturer’s protocol.  Probes are purified through a Sephadex 
G-50 column equilibrated with TE pH 8.0.  Membranes were hybridized overnight (12-24 
hours) and then washed once at room temperature with 2X SSPE and once at 65˚C with 
2X SSPE/2% SDS.  Membranes were PhosphorImagedTM (GE Healthcare, Typhoon FLA 
9500) and quantified using the ImageQuantTM software.  All membranes were also 
autoradiographed using a phosphorescent ruler to determine the size of the bands by 
comparison to the RNA ladder.  Membranes are stripped and stored at -20˚C for re-
probing.  Detailed protocol for Northern analysis can be found in Kebaara et al. (2012). 
  
Polyribosome Analysis 
Yeast polyribosome analysis was performed as previously described (Atkin et al., 
1995).  Lysis buffer was composed of 20mM Tris-HCl pH 8.0, 140mM KCl, 1.5 mM 
MgCl2, 1% Triton X, 0.1 mg/ml Cycloheximide, and 1.0 mg/ml Heparin; Cycloheximide 
and Heparin were made fresh and added just before use.  Gradient buffer (50% and 15% 
sucrose) was composed of 20mM Tris-HCl pH 8.0, 140mM KCl, 5.0 mM MgCl2, 0.1 
mg/ml Cycloheximide, 0.5 mg/ml Heparin, and 0.5mM DTT; Cycloheximide, Heparin, 
and DTT were made fresh and added just before use.  15%-50% sucrose gradients were 
made by hand, frozen at -70˚C and thawed at 4˚C overnight just before use.  After 
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fractionation RNA was extracted from each fraction using acid phenol/chloroform 
extraction.  Total RNA from each fraction collected was loaded onto an RNA Northern 
gel and transferred to a GeneScreen Plus membrane as described above.  Membranes 
were hybridized with a 32P-labelled probe as described above. 
 
Poly(A) tail length analysis 
This experiment was performed as described in the protocol provided with the 
Poly(A) Tail-Length Analysis Kit® (Affymetrix 76455).  Prior DNase treatment of RNA 
samples was done using the TURBO DNA-free kit® (AM1907).  Primers were designed 
using the information provided in the Saccharomyces Genome Database for predicted 
polyadenylation sites.  Since all of the mRNAs we were interested in contained multiple 
predicted poly(A) sites, the primers pairs were designed to anneal upstream of the 
polyadenylation site that is predicted to be most 3’ of the other predicted sites.  PCR 
products were resolved on a 2.5% TAE agarose gel. 
 
Results 
YAP1 mRNA is protected from degradation by NMD while GCN4 mRNA is 
partially protected from degradation by NMD 
 A previous study showed that the uORF-containing GCN4 and YAP1 mRNAs are 
not degraded by the NMD pathway despite presence of an NMD-targeting signal (Ruiz-
Echevarria et al., 1998).  Because we recently identified the SSY5 mRNA as a wild-type 
mRNA that is also protected from NMD we were hoping to include the GCN4 and YAP1 
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mRNAs in our studies as well (Kebaara and Atkin, 2009; Chapter 2). 
In order to validate these results we grew S.cerevisiae cells in rich growth medium 
(YAPD) and confirmed by quantitative Northern analysis that steady-state accumulation 
of YAP1 and GCN4 mRNAs show no significant fold change (FC) between wild-type and 
upf1Δ strains.  Additionally, because it has been shown that different genetic 
backgrounds of yeast strains can result in varying sensitivity of mRNAs to NMD we 
tested the steady-state accumulation of these mRNAs in two of the most commonly used 
genetic backgrounds, BY4741 and W303 (Kebaara et al., 2003).  We found that the YAP1 
mRNA is protected from significant degradation by NMD in both the BY4741 and W303 
genetic backgrounds with a FCR of upf1Δ/wild-type=1.4±0.1 and 1.3±0.2, respectively 
(Fig. 1A).  Interestingly, in the upf1Δ strains we consistently notice a slower migrating 
band for the YAP1 mRNA, which appears at a much lower intensity (Fig. 1A).  For the 
GCN4 mRNA we do not see ≥2.0 fold change in accumulation between wild-type and 
upf1Δ strains that would be indicative of an NMD substrate.  However, the stead-state 
accumulation of the GCN4 mRNA is consistently elevated in the upf1Δ strains in both the 
BY4741 and W303 genetic backgrounds with a FCR of upf1Δ/wild-type =1.9±0.1 and 
1.6±0.1, respectively (Fig. 1A).  The ENT4 mRNA is shown because it is a wild-type 
mRNA in S. cerevisiae that has a long 3’ UTR and is an NMD substrate (Chapter 2).  
Additionally, the CYH2 pre-mRNA is an NMD substrate while the mature CYH2 mRNA 
is not.  SCR1 is shown for the loading control. 
Further, in rich media the half-life (T1/2) of the YAP1 mRNA exceeds 60 minutes 
in both the wild-type and upf1Δ strains (Fig. 1B).  The T1/2 of the GCN4 mRNA is also 
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not significantly different between wild-type (T1/2=47.0min) and upf1Δ strains 
(T1/2=47.5min; Fig. 1B).  Based on the T1/2 analysis of the YAP1 and GCN4 mRNAs, 
neither mRNA appears to be a substrate for NMD. 
The YAP1 and GCN4 mRNAs do not appear to be substrates for the NMD 
pathway when cells are grown in rich media (Fig. 1A-B).  However, the GCN4 mRNA 
codes for a transcriptional activator of amino acid biosynthetic genes, thus we 
hypothesized that the GCN4 mRNA might have varying stability in different growth 
media that had decreased availability of extracellular amino acids.  To test this hypothesis 
we grew the cells in minimal media which contained only the amino acids necessary to 
support the auxotrophies of the strains (Materials and Methods).  Consistent with results 
in rich media, the steady-state accumulation of the GCN4 mRNA was only moderately 
increased and not significantly different between wild-type and upf1Δ strains 
(FCR=1.5±0.3; Fig. 1C).  Additionally, the T1/2 of the GCN4 mRNA was not 
significantly different between wild-type (T1/2=21.2±3.7 min) and upf1Δ strains 
(T1/2=20.7±1.0 min) when cells were grown in minimal media (Fig. 1D).  However, the 
T1/2 in both the wild-type and upf1Δ strains is much longer when the cells are grown in 
rich media compared to when the cells are grown in minimal media (Figs. 1B and 1D).  
So, the difference in growth media does influence GCN4 mRNA stability but not as a 
result of NMD.  This same pattern was observed for the SSY5 mRNA in Chapter 2. 
In yeast, the YAP1 mRNA codes for a transcription factor required for oxidative stress 
tolerance.  However, since we already had the membranes prepared we also analyzed the 
YAP1 mRNA when cells were grown in minimal media.  Consistent with the results from 
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cells grown in rich media, the YAP1 mRNA steady-state accumulation was not 
significantly different between wild-type and upf1Δ strains when cells were grown in 
minimal media (FCR of upf1Δ/wild-type=1.1±0.2; Fig. 1C).  Likewise, the T1/2 of the 
YAP1 mRNA was not significantly different between wild-type (T1/2=15.3±1.5 min) and 
upf1Δ strains (T1/2=14.0±0.9 min) when cells were grown in minimal media (Fig. 1D).  
But again, just like the GCN4 and SSY5 mRNAs, the T1/2 for the YAP1 mRNA in both the 
wild-type and upf1Δ strains is much longer when the cells are grown in rich media 
compared to when the cells are grown in minimal media (Figs. 1B and 1D).  
Together, these results allow us to confirm that both the GCN4 and YAP1 mRNAs 
are wild-type mRNAs that are not likely substrates for the NMD pathway.  However, the 
regulation of the GCN4 mRNA is not quite as clear as previously shown (Ruiz-
Echevarria et al., 1998; Ruiz-Echevarria and Peltz, 2000; Vilela et al., 1998).  
 
YAP1 and GCN4 mRNAs are not protected from NMD by trans-acting factor Pub1 
 A follow up study to the one that originally showed YAP1 and GCN4 mRNAs 
were protected from NMD identified poly(U) binding protein, Pub1, as being the trans-
acting factor responsible for this protection from NMD (Ruiz-Echevarria and Peltz, 
2000).  In light of our previous work which identified the SSY5 mRNA as a wild-type 
mRNA that is protected from NMD these results piqued our interest (Kebaara and Atkin, 
2009; Chapter 2).  We hypothesized that if Pub1p was involved in protection of the YAP1 
and GCN4 mRNAs from NMD then it could also be involved in SSY5 mRNA protection 
from NMD.  We did analyze SSY5 mRNA steady-state accumulation in wild-type, upf1Δ, 
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pub1Δ, and upf1Δpub1Δ strains and did not find any influence of Pub1 on SSY5 mRNA 
susceptibility to NMD (Chapter 2).  However, during this analysis the YAP1 and GCN4 
mRNAs were included as positive controls since it was previously shown that Pub1 does 
protect these mRNAs from NMD (Ruiz-Echevarria and Peltz, 2000).  In contrast to the 
previous study we do not show a Pub1-dependent protection of the YAP1 and GCN4 
mRNAs from NMD (Fig. 2). 
 When cells are grown in either rich or minimal media we do not see a significant 
increase in YAP1 mRNA stability upon deletion of Pub1 with a FCR of pub1Δ/wild-
type=0.9±0.2 in rich media and a FCR of pub1Δ/wild-type=0.9±0.0 in minimal media 
(Fig. 1A-B).  Likewise, we do not see a significant increase in GCN4 mRNA stability 
upon deletion of Pub1 with a FCR of pub1Δ/wild-type=0.8±0.0 in rich media and a FCR 
of pub1Δ/wild-type=0.8±0.1 in minimal media (Fig. 1A-B).  Further, T1/2 analysis in 
pub1Δ strains showed no significant difference in T1/2 of the YAP1 mRNA in wild-type 
(T1/2=13.2±0.4 min) versus pub1Δ strains (T1/2=16.3±2.5 min; Fig. 2C).  The GCN4 
mRNA also showed no difference in T1/2 between wild-type (T1/2=20.5±5.1 min) and 
pub1Δ strains (T1/2=24.1±4.2 min; Fig. 2C). 
It should be noted that we were unable to obtain the exact strains used in the 
original publication as the lab is no longer in operation (Ruiz-Echevarria and Peltz, 
2000).  However, we analyzed steady-state mRNA accumulation in multiple strain 
backgrounds including the parent strains for those used in the publication and were still 
unable to see any effect of pub1Δ on mRNA stability (data not shown). 
From this we conclude that trans-acting factor Pub1 is not responsible for YAP1 or GCN4 
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mRNA protection from NMD in the strain backgrounds and conditions that we used.  
Thus, there is likely another mechanism of protection that is stabilizing these two 
mRNAs. 
 
YAP1 and GCN4 mRNAs co-fractionate with polyribosomes 
 Since we have confirmed that the YAP1 and GCN4 mRNAs are wild-type mRNAs 
that are not degraded by NMD (Fig. 1), and we are unable to confirm that trans-acting 
factor Pub1 is responsible for this protection (Fig. 2), we wanted to try to identify the 
mechanism of protection of these two mRNAs.  One way in which mRNAs can be 
protected from NMD is by inhibition of translation (Oliveira and McCarthy, 1995; 
Shoemaker and Green, 2012).  We hypothesize that both YAP1 and GCN4 mRNAs are 
translated because of the vital functions of their protein products within the cell.  
 To confirm whether or not the YAP1 and GCN4 mRNAs are likely translated we 
performed a polyribosome analysis for each of these mRNAs.  As expected, the YAP1 
mRNA is present in the polyribosome fractions (Fig. 3A).  There is no significant 
difference in the YAP1 mRNA co-fractionation with polyribosomes between wild-type 
and upf1Δ strains other than the presence of the larger migrating band in the upf1Δ strain, 
which is also consistently present in the upf1Δ strain in the steady-state and T1/2 analysis 
(Fig. 3A; Fig. 1A-B).  Interestingly, this slower migrating band of the YAP1 mRNA 
behaves just like the pre-mRNA of CYH2, which is an NMD substrate, in the 
polyribosome analysis with the larger migrating band accumulating to higher levels in the 
lighter fractions in the upf1Δ strain (Chapter 2, Fig. 6).  The pre-mRNA of CYH2 
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contains an intron, but the sequence analysis for YAP1 mRNA does not indicate the 
presence of an intron, which would generate a pre-mRNA (SGD).  This larger migrating 
band could be a longer form of the mRNA generated by translation initiation at an 
alternate upstream AUG, the one of the uORF for instance. In this case the ribosome 
would translate a significant portion of the 5’ leader of the YAP1 mRNA and proceed to 
translate in an alternate reading frame which ultimately results in the introduction of a 
PTC.  This would explain why the longer mRNA is a substrate for NMD and is not 
detected in wild-type strains.  Alternatively, the ribosome may readthrough the ORF stop 
codon and terminate downstream leading to the generation of a longer mRNA, however, 
this does not readily explain the sensitivity of the larger migrating band to NMD. 
 The GCN4 mRNA also associates with polyribosomes as expected.  The GCN4 
mRNA contains four short uORFs preceding the ORF.  Translation of these uORFs and 
the scanning of the small ribosomal subunit along the 5’ leader is what controls 
translation of the GCN4 ORF where translation of the uORFs generally represses GCN4 
ORF translation (Grant and Hinnebusch, 1994; Gunisova et al., 2016; Hinnebusch, 2005).  
Because these short uORFs are continually translated more actively than the GCN4 ORF 
it is expected that the GCN4 mRNA will co-fractionate in the lighter fractions as the 
mRNA is associated with fewer ribosomes which occupy the short (2-3 codons) uORFs 
(Hinnebusch, 2005).  Consistent with this, we do see the GCN4 mRNA heavily present in 
the lighter fractions and more faintly present in the heavier fractions (Fig. 3B).  Thus, 
although the GCN4 ORF may not be actively translated at all times, the mRNA is still co-
fractionating in a manner indicating that the mRNA is associating with ribosomes.  
173 
 
Importantly, the polyribosome profile of the GCN4 mRNA is not significantly different 
between wild-type and upf1Δ strains (Fig. 3B). 
 From this we can conclude that both YAP1 and GCN4 mRNAs are likely to 
associate with polyribosomes as they co-fractionate in a pattern that is indicative of 
polyribosome association.  However, further studies are needed to confirm the production 
of Yap1 and Gcn4 protein products. 
 
YAP1 and GCN4 mRNAs accumulate significantly in xrn1Δ strains 
 The predominant decay route for both wild-type mRNAs and NMD substrates is 
through Xrn1-mediated 5’3’ exonucloelytic degradation, although this process tends to 
occur more rapidly for NMD substrates (Cao and Parker, 2003).  Given this, we 
hypothesized that the YAP1 and GCN4 mRNAs are likely degraded 5’3’ by Xrn1.  
However, the levels to which these mRNAs accumulate in an xrn1Δ strain will give us an 
indication of the contribution of 3’5’ mRNA decay by the exosome. 
Upon deletion of the cytoplasmic 5’3’ exonuclease, Xrn1, both YAP1 and GCN4 
mRNAs accumulate to significantly higher levels compared to wild-type strains.  The 
YAP1 mRNA had a FCR of xrn1Δ/wild-type=6.7±0.9 and GCN4 mRNA had a FCR of 
xrn1Δ/wild-type=3.8±0.3 (Fig. 4A).  It is interesting to note that though the fold changes 
are significantly increased in xrn1Δ strain for the YAP1 and GCN4 mRNAs accumulation 
is not nearly as high as what is seen for the ENT4 mRNA (a wild-type NMD substrate), 
but also differ from the PGK1 mRNA (a wild-type mRNA degraded by the 
deadenylation-dependent decapping pathway) which shows no significant difference in 
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fold change (Fig. 4A).  Additionally, the fold changes for the YAP1 and GCN4 mRNAs in 
the xrn1Δ strain are less than what was seen for the SSY5 mRNA (Chapter 2). 
 Consistently, the T1/2 analysis of the YAP1 and GCN4 mRNAs both indicate 
significant stabilization of the mRNAs in the xrn1Δ strain (Fig. 4B).  The YAP1 mRNA 
has a T1/2 of 19.2 minutes in wild-type strains compared to a T1/2 of 31.3 minutes in the 
xrn1Δ strain.  Likewise, the GCN4 mRNA has a T1/2 of 28.1 minutes in wild-type strains 
compared to a T1/2 of 44.9 minutes in the xrn1Δ strain. 
 From this we can conclude that 5’3’ exonucloelytic degradation by Xrn1 is a 
significant contributor to the degradation of both the YAP1 and GCN4 mRNAs.  
However, because the steady-state mRNA accumulation fold changes in the xrn1Δ strain 
are not quite as significant as for other mRNAs we have looked at (e.g. SSY5 and ENT4) 
the 3’5’ decay is likely more efficient for the YAP1 and GCN4 mRNAs. 
 
YAP1 and GCN4 mRNAs do not accumulate in dcp1Δ strains, but half-life analysis 
shows that dcp1Δ stabilizes the mRNAs albeit to different extents 
 When degradation of an mRNA is initiated the Dcp1/2 decapping complex 
removes the 5’ 7-methylguanosine cap to expose a 5’ monophosphate which becomes the 
immediate substrate of the Xrn1 5’3’ exonuclease (Coller and Parker, 2004).  If the 
mRNA is not decapped, 5’3’ decay cannot occur because the 5’ end of the mRNA is 
not exposed for exonucloelytic degradation by Xrn1 (Decker and Parker, 1993; Hsu and 
Stevens, 1993; Muhlrad et al., 1995; Muhlrad and Parker, 1994).  Given this, we 
hypothesized that blocking decapping of the mRNA by deletion of Dcp1 (dcp1Δ) would 
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yield similar results to blocking 5’3’ degradation by Xrn1 (xrn1Δ) as these two events 
occur in immediate sequence.   
Surprisingly, when the mRNA decapping complex Dcp1/2 is rendered inactive by 
deletion of the Dcp1 catalytic subunit the steady-state accumulations of the YAP1 and 
GCN4 mRNAs are not significantly affected compared to the wild-type strain.  The YAP1 
mRNA only shows a FCR of dcp1Δ/wild-type=1.7±0.1, which is equivalent to the 
accumulation seen in the upf1Δ strain (FCR of dcp1Δ/wild-type=1.8±0.0) and is not 
considered to be significant (Fig. 5A).  Similarly, the GCN4 mRNA shows a FCR of 
dcp1Δ/wild-type=1.2±0.0, which is even less than the accumulation seen in the upf1Δ 
strain (FCR of dcp1Δ/wild-type=2.0±0.2; Fig. 5A).  Both the YAP1 and GCN4 mRNAs 
exhibit a pattern that is similar to the wild-type NMD substrate ENT4 mRNA. 
 However, the T1/2 analysis in these strains reveals a bit of a different story, 
especially for the YAP1 mRNA.  Compared to the wild-type strain, in which the YAP1 
mRNA has a T1/2=19.2 minutes, the T1/2 of the YAP1 mRNA in the dcp1Δ strain is more 
than double that in the wild-type strain at 51.2 minutes (Fig 5B).  For the GCN4 mRNA 
the difference is not quite as significant but is still increased compared to the steady-state 
mRNA accumulations.  In the wild-type strain the GCN4 mRNA has a T1/2=28.1 minutes 
compared to 39.2 minutes in the dcp1Δ strain (Fig 5B). 
 Although mRNA stability measurements are typically more indicative of what is 
actually happening to the mRNA, the trend seen in the mRNA steady-state accumulations 
for the YAP1 and GCN4 mRNAs cannot simply be ignored.  From these results we can 
conclude that at steady-state levels in the cell the YAP1 and GCN4 mRNAs are able to be 
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efficiently degraded 3’5’ by the exosome when decapping is blocked.  When 
considering the T1/2 analysis of the YAP1 mRNA, blocking of decapping actually 
stabilizes the mRNA even more than in the xrn1Δ strain (Fig. 4B and Fig. 5B).  The same 
is not true for the GCN4 mRNA, however, where blocking decapping has a relatively 
similar effect to deletion of Xrn1 (Fig. 4B and Fig. 5B).  Up until now our analysis has 
shown similar behavior of the YAP1 and GCN4 mRNAs.  However, the decay of these 
two mRNAs seems to be slightly different in the influence of decapping of the mRNAs. 
 
Some strains show greater YAP1 and GCN4 mRNA susceptibility to NMD 
 As was noticed with the SSY5 mRNA, the YAP1 and GCN4 mRNAs appear to 
have differential susceptibility to NMD in the different strain backgrounds used in these 
studies.  We originally only tested the susceptibility of the YAP1 and GCN4 mRNAs to 
NMD in the commonly used BY4741 and W303 backgrounds.  Using these strains we 
saw no difference in YAP1 or GCN4 mRNA susceptibility to NMD (Fig. 1).  However, 
when we began using the dcp1Δ and xrn1Δ strains we noticed a difference in both YAP1 
and GCN4 mRNA accumulation in the wild-type versus upf1Δ strains from the same 
background (Figs. 4A and 5A).  The YAP1 and GCN4 mRNAs show a steady-state FCR 
of upf1Δ/wild-type=1.8±0.0 and 2.0±0.2, respectively (Figs. 4A and 5A).  Likewise, 
ENT4 mRNA accumulation shows a similar FCR between wild-type and upf1Δ strains in 
both the BY4741 background and the W303 background, but in the strain background 
used to create the dcp1Δ and xrn1Δ strains this FCR is increased (compare ENT4 mRNA 
in Fig. 1A with ENT4 mRNA in Figs. 4A and 5A).  The wild-type and upf1Δ strains from 
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the same background as the xrn1Δ and dcp1Δ strains were genetically constructed in the 
W303 background and the auxotrophic markers are published as being the same as the 
W303 strains that we originally tested (He et al., 1997; He and Jacobson, 1995, 2001).  
However, there is clearly a difference in the accumulation of the YAP1 and GCN4 
mRNAs between these strains and our original W303 strains.  Identifying the 
difference(s) between the strains from our earlier studies and the strains showing 
increased NMD susceptibility will be very beneficial in determining how the YAP1 and 
GCN4 mRNAs are protected from NMD. 
 
Deadenylation mutants show little effect on YAP1 and GCN4 mRNA stability 
The length of the mRNA poly(A) tail (~60-80 nt at steady state in S. cerevisiae) 
functions, in combination with the 5’ mRNA cap, to regulate both the translational 
efficiency of the mRNA and the regulation of mRNA decay (Anderson and Parker, 1998; 
Beilharz and Preiss, 2007; Gallie, 1991; Muhlrad et al., 1995; Munroe and Jacobson, 
1990).  All mRNAs undergo a deadenylation step regardless of whether or not the mRNA 
is an NMD substrate (Norbury, 2013).  The difference is that wild-type mRNA 
degradation is initiated by deadenylation of the mRNA poly(A) tail, which is a 
prerequisite for 5’ decapping of the mRNA (Decker and Parker, 1993; Muhlrad and 
Parker, 1994).  NMD substrates on the other hand undergo rapid 5’ decapping and rapid 
deadenylation, but deadenylation is not required prior to decapping (Cao and Parker, 
2003; Muhlrad et al., 1994; Muhlrad and Parker, 1994).   
Deadenylation of an mRNA occurs through the combined efforts of the 
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Pan2/Pan3 and the Ccr4/Pop2/Not deadenylase complexes (Wahle and Winkler, 2013; 
Wiederhold and Passmore, 2010).  The Pan2 subunit of the Pan2/Pan3 complex exhibits 
specific deadenylase activity and the Ccr4 subunit of the Ccr4/Pop2/Not is the catalytic 
subunit (Chen et al., 2002; Daugeron et al., 2001; Tucker et al., 2002; Tucker et al., 
2001).  There are conflicting reports on whether or not Caf1 is a catalytic subunit as well 
in S. cerevisiae, although the catalytic activity of this subunit has been verified in other 
organisms (Andersen et al., 2009; Daugeron et al., 2001; Jonstrup et al., 2007; Liang et 
al., 2009; Thore et al., 2003; Tucker et al., 2002; Viswanathan et al., 2004).  Previous 
observations indicate that in the absence of the Pan2/Pan3 complex the Ccr4/Pop2/Not 
complex is capable of full mRNA deadenylation (Tucker et al., 2001).  Because 
deadenylation is an important step in mRNA decay we hypothesized that deadenylation 
would likely play a prominent role in the degradation of the YAP1 and GCN4 mRNAs.   
To test this hypothesis we analyzed the YAP1 and GCN4 mRNA steady-state 
accumulation in several deadenylation mutant strains.  To our surprise, the various 
deadenylation mutants did not cause a significant increase or decrease in the steady-state 
accumulation of either the YAP1 or GCN4 mRNAs (Fig. 6).  Because the Pan2/Pan3 and 
Ccr4/Pop2/Not complexes can compensate for loss of the other it was not totally 
surprising that single deletions which only effected one of the complexes did not result in 
drastic changes in mRNA accumulation.  However, deletions that render both complexes 
inactive (ccr4Δpan2Δ) did not result in significant accumulation either (YAP1 mRNA 
FCR ccr4Δpan2Δ/wild-type=1.1±0.1 and GCN4 mRNA FCR ccr4Δpan2Δ/wild-
type=1.3±0.2; Fig. 6).  The only strain in which there were slight notable differences, 
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although not considered significant according to the ≥ 2.0 FCR threshold, was the 
ccr4Δcaf1Δ strain for the YAP1 mRNA (FCR ccr4Δcaf1Δ/wild-type=1.6±0.2) and in the 
same strain for the GCN4 mRNA where the double deletion seemed to have the opposite 
effect (FCR ccr4Δcaf1Δ/wild-type=0.6±0.0; Fig. 6).  It is possible based on this 
observation that the Pan2/Pan3 deadenylase complex is more efficient in compensating 
for loss of Ccr4/Pop2/Not activity on the GCN4 mRNA than on the YAP1 mRNA. 
We also analyzed steady-state accumulation of both the ENT4 mRNA and the PGK1 
mRNA for comparison.  Similar to the YAP1 and GCN4 mRNAs, neither the ENT4 
mRNA nor the PGK1 mRNA seem to be largely effected by loss of deadenylation (Fig. 
4).  The only difference can be seen in the upf1Δ strains for the ENT4 mRNA, which is 
expected since this mRNA is an NMD substrate. 
From this we can conclude that blocking deadenylation through the Pan2/Pan3 
complex or the Ccr4/Pop2/Not complex or both has little effect on YAP1 and GCN4 
mRNA steady-state accumulation in cells.  This can be explained by: 1) efficient 
decapping and 5’3’ mRNA decay without prior deadenylation, and/or 2) another 
mechanism of deadenylation aside from the Pan2/Pan3 and Ccr4/Pop2/Not deadenylase 
complexes. 
 
The YAP1 mRNA 3’ end is significantly shorter in xrn1Δ and dcp1Δ strains 
compared to wild-type and upf1Δ strains 
Finally, we wanted to determine at which step the YAP1 and GCN4 mRNAs are 
deadenylated.  We hypothesized that the mRNA would be likely deadenylated as both 
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wild-type mRNAs and NMD-substrates are deadenylated, but we were unsure if 
deadenylation was occurring as a prerequisite to decapping.  To do this we used the 
Poly(A) Tail-Length Assay Kit from Affymetrix (Materials and Methods).  Using this kit 
a poly(A) polymerase first adds a short series of guanosine and inosine residues (G/I) to 
the 3’ ends of polyadenylated mRNAs.  The G/I tails become the priming site for reverse 
transcription of the mRNAs to cDNA molecules.  Two pairs of primers are then used to 
amplify the 3’ ends of the desired mRNAs.  The first primer pair is the gene-specific 
(G.S.) primer pair, which consists of a forward and reverse primer that anneal to the 3’ 
end of the mRNA both of which are upstream of the polyadenylation site(s).  It is 
important to note that because the poly(A) sites for the mRNAs we used are not definitive 
as there are multiple predicted poly(A) sites we designed the G.S. primer pair to anneal 
upstream (3’) of all predicted poly(A) sites (SGD).  The second primer pair is the poly(A) 
tail (“Tail”) primer pair, which consists of the same upstream primer from the G.S. 
primer pair and a universal reverse primer that anneals to the G/I tail (Fig. 7A).  PCR 
products obtained from the use of these two primer pairs are then compared in order to 
determine the length of the 3’ poly(A) tail.   
 The Poly(A) Tail-Length Assay Kit was used to determine the poly(A) tail length 
of steady-state YAP1, ENT4, and PGK1 mRNAs in wild-type, upf1Δ, xrn1Δ, and dcp1Δ 
strains.  Due to the cost of the kit and the number of reactions provided in each kit we did 
not analyze the 3’ end of the GCN4 mRNA.  An RNase H control was not done so we are 
unable to positively confirm that the results observed are strictly due to differences in 
poly(A) tail length.  We can, however, use the results to analyze differences in the 3’ end 
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length of the mRNAs. 
 The results of this assay are shown in Figure 7B.  In wild-type and upf1Δ strains 
the YAP1 mRNA has a longer 3’ end compared to the xrn1Δ and dcp1Δ strains.  This 
pattern is consistent to what is seen for the PGK1 mRNA (not an NMD substrate) and 
also the SSY5 mRNA (Chapter 3, Figure 5), which is a wild-type mRNA that is protected 
from NMD (Fig. 7B; Kebaara and Atkin, 2009; Obenoskey et al., 2014; Chapter 2).  
Additionally, the pattern of 3’ end length for the YAP1 mRNA is opposite of the pattern 
for the ENT4 mRNA, which is a wild-type NMD substrate, in the tested strains.  
However, it is important to note that the product resulting from use of the “Tail” primers 
is smaller than the product for the G.S. primers, which should not be the case if the 
primers were designed accurately.  This indicates that the primers for the YAP1 mRNA 
need redesigned for a more accurate analysis. 
 From this we can conclude that the YAP1 mRNA is able to be shortened at the 3’ 
end when either decapping or 5’3 decay are blocked.  This also shows that the 3’ end 
shortening is occurring much more slowly or not at all when both decapping and 5’3’ 
decay are functioning normally as in the wild-type and upf1Δ strains. 
 
Discussion 
 Previously we presented the case of the SSY5 mRNA, which is a wild-type mRNA 
in S. cerevisiae that contains multiple NMD-targeting signals but is not degraded by 
NMD (Chapter 2).  Here we investigate two additional wild-type mRNAs in S. 
cerevisiae, the YAP1 and GCN4 mRNAs that also have at least one NMD-targeting 
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signal—a translated uORF—and are protected from degradation by NMD (Fig. 1).  The 
discovery of the YAP1 and GCN4 mRNAs as wild-type mRNAs protected from NMD 
was not novel as this was previously shown (Ruiz-Echevarria et al., 1998; Vilela et al., 
1998).  However, a follow-up study identified a simple mechanism of protection of these 
two mRNAs from NMD by which trans-acting factor Pub1 binds to a stabilizer element 
in the 5’ leader region of the mRNAs.  In this study the binding of Pub1 to the STE was 
convincingly shown to be solely responsible for the protection of both YAP1 and GCN4 
mRNAs from NMD (Ruiz-Echevarria and Peltz, 2000).  These results were of great 
interest to us as we searched for the mechanism by which the SSY5 mRNA is protected 
from degradation by NMD.  The SSY5 mRNA also has a translated uORF just like the 
YAP1 and GCN4 mRNAs, and it seemed like an appropriate hypothesis that Pub1 could 
also be responsible for the protection of the SSY5 mRNA from NMD.  However, when 
we began the experiments to see if Pub1 was responsible for the protection of SSY5 
mRNA from NMD (Chapter 2) we were unable to reproduce the results showing Pub1 
was responsible for the protection of YAP1 and GCN4 mRNAs from NMD, which had 
been included in the experiment as positive controls (Fig. 2).  Cells were grown in both 
rich and minimal media (Fig. 2) and we tested as many different strain backgrounds as 
we could obtain in order to rule out all known variables (data not shown). 
 We were able to confirm that both the YAP1 and GCN4 mRNAs are likely 
protected from degradation by NMD, but this stability is not quite as clear as previously 
reported and is likely strain dependent (Figs. 1, 4-5).  The T1/2 analysis of both mRNAs in 
wild-type and upf1Δ strains is more indicative of protection from NMD than is the 
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analysis of the steady-state accumulation of the mRNAs in wild-type and upf1Δ strains 
(Fig. 1).  Further, we were able to show that YAP1 mRNA does cofractionate with heavy 
fractions of the polyribosomes, which is an indication of association with polyribosomes 
(Fig 3A).  Likewise, the GCN4 mRNA is also found cofractionating where we would 
expect although this pattern looks rather different from a normally translated mRNA (Fig. 
3B).  Translation of the GCN4 mRNA is regulated by the translation of its four short 
uORFs, which are continually translated in order to repress the translation of the main 
ORF until the gene product, Gcn4, is needed (Grant and Hinnebusch, 1994; Gunisova et 
al., 2016; Hinnebusch, 2005).  Thus, the GCN4 mRNA is expected to be present in the 
lighter fractions since the continual translation of its four short uORFs means the mRNA 
is associated with fewer ribosomes as these uORFs are only 2-3 codons in length.  
Importantly, neither the YAP1 mRNA nor the GCN4 mRNA show differences in 
fractionation between the wild-type and upf1Δ strains (Fig. 3A-B).  Association with 
polyribosomes (in the case of the YAP1 mRNA) or the few uORF occupying ribosomes 
(in the case of the GCN4 mRNA) leads to the likely hypothesis that the mRNA is being 
actively translated, although Westerns would need to be done in order to positively 
confirm this.  If the mRNA is being actively translated then it rules out the possibility that 
the mRNA is protected from degradation by NMD by inhibition of translation.  
 We also looked at the stability of the YAP1 and GCN4 mRNAs in decapping, 
5’3’ decay, and various deadenylation mutants.  When 5’3’ decay is blocked in the 
xrn1Δ strains, both the YAP1 and GCN4 mRNAs behave similarly and accumulate to 
significantly higher levels compared to the wild-type strain.  However, this accumulation 
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is not as great as what we saw for the SSY5 mRNA (Chapter 2) or for the ENT4 mRNA (a 
wild-type NMD substrate; Fig. 4).  The two most obvious explanations for this are 1) the 
exosome-mediated 3’5’ decay of the YAP1 and GCN4 mRNAs is more efficient (i.e. 
faster) than for the SSY5 or ENT4 mRNAs, or 2) Rat1 (also known as Kem1) digestion, 
which was identified as the only other enzyme in yeast with 5’3’ exonuclease activity, 
is able to work more efficiently on the YAP1 and GCN4 mRNAs than on the SSY5 or 
ENT4 mRNAs (He and Jacobson, 2001). 
A previous study also showed that Upf1 can actually stimulate the degradation of 
decapped transcripts in an xrn1Δ strain (He and Jacobson, 2001).  This could be one of 
the reasons that we see higher steady-state accumulations and slightly longer T1/2 in the 
xrn1Δupf1Δ strains.  Another reason could also be that in this background the YAP1 and 
GCN4 mRNAs are slightly more susceptible to NMD as can be seen comparing the wild-
type and upf1Δ strains (Fig. 4). 
 Interestingly, blocking decapping in the dcp1Δ strain, which we expected to yield 
a similar result as seen in the xrn1Δ strain, had very little influence on the steady-state 
accumulation of either the YAP1 mRNA or the GCN4 mRNA (Fig. 5A).  This indicates 
that the exosome-mediated 3’5’ degradation of both mRNAs is much more efficient 
when the 5’ mRNA cap is present since mRNAs in the xrn1Δ strain are decapped (He and 
Jacobson, 2001).  However, the T1/2 analysis for the YAP1 and GCN4 mRNAs in the 
dcp1Δ strain tells a bit of a different story.  Both mRNAs are more stable in the dcp1Δ 
strain compared to the wild-type strain, and this increase in stability is significant for the 
YAP1 mRNA (Fig. 5B).  Taking into consideration the T1/2 analysis of both mRNAs in 
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the wild-type, xrn1Δ, and upf1Δ strains it does appear that blocking both decapping and 
5’3’ degradation causes significant mRNA stabilization indicating that the 3’5’ 
degradation is not as efficient as the steady-state analysis in the dcp1Δ strain leads us to 
believe.  This also leads us to point out that steady-state accumulations do not always tell 
the whole story and a T1/2 analysis is an important piece of the puzzle, which we also saw 
in Figure 1. 
 When blocking deadenylation through deletion of the catalytic subunits of either 
the Pan2/Pan3 complex or the Ccr4/Pop2/Not complex, or both we saw little influence on 
steady-state mRNA accumulation of either the YAP1 mRNA or the GCN4 mRNA (Fig. 
6).  However, as pointed out previously, a T1/2 analysis of both mRNAs in these strains 
would need to be done in order to make any definitive conclusions.  If we make the 
assumption that the T1/2 analysis would agree with the steady-state accumulations, then 
we can say that blocking deadenylation has little effect on the degradation of the YAP1 or 
GCN4 mRNAs.  This tells us that deadenylation-independent decapping and subsequent 
5’3’ decay is able to proceed in the absence of deadenylation.  Although the Pan2/Pan3 
complex and the Ccr4/Pop2/Not complex are able to compensate for loss of one another, 
the fold changes in the double mutant ccr4Δpan2Δ are the most revealing about how lack 
of deadenylation influences the stability of these two mRNAs (Fig. 6).  To make this 
analysis more complete it would also be helpful to look at the steady-state mRNA 
accumulation and half-lives in 3’5’ decay (exosome) mutants. 
 When we used the Poly(A) Tail-Length Analysis kit to determine what was 
happening on the 3’ end of the mRNA we found that the YAP1 mRNA behaved more 
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similarly to the PGK1 mRNA, which is not an NMD substrate and is typically degraded 
5’3’ by the deadenylation-dependent decapping mechanism.  However, the PGK1 
mRNA can also undergo 3’5’ degradation when 5’3’ degradation is blocked, but this 
process occurs more slowly (Muhlrad and Parker, 1994).  This appears to be what is 
happening for both the PGK1 mRNA and the YAP1 mRNA according to our results in 
Figure 7.  Both the PGK1 and YAP1 mRNAs show longer 3’ ends in the wild-type and 
upf1Δ strains and shorter 3’ ends in the xrn1Δ and dcp1Δ strains.  In contrast, the known 
wild-type NMD substrate ENT4 mRNA shows the opposite pattern with longer 3’ ends in 
the xrn1Δ and dcp1Δ strains than in the wild-type and upf1Δ strains (Fig. 7). 
 Going forward, it will be important to identify if the NMD mRNP, which 
ultimately triggers the degradation of an mRNA through the NMD pathway, is 
assembling on the YAP1 mRNA or the GCN4 mRNA.  If the NMD mRNP is forming on 
these mRNAs then protection from NMD is most likely incurred at a point downstream 
of substrate recognition.  Conversely, if the NMD mRNP complex never forms on the 
mRNA, then protection is likely incurred before substrate recognition. 
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Figure Legends 
Fig. 4-1. YAP1 mRNA is protected from degradation by NMD while GCN4 mRNA is 
partially protected from degradation by NMD.  A) Northern blot analysis of the steady-
state accumulation of the YAP1, GCN4 and ENT4 (a wild-type NMD substrate) mRNAs 
in wild-type (AAY277) and upf1Δ (AAY363) strains in the BY4741 background and in 
wild-type (AAY187) and upf1Δ (AAY320) strains in the W303 background.  Strains 
were grown in rich media (YAPD).  CYH2 pre-mRNA is an NMD control (CYH2 pre-
mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown 
for loading.  Fold change values are normalized and determined as a fold change ratio 
from wild-type; values are an average of three independent trials.  B) Northern blot 
analysis of the YAP1 and GCN4 mRNA half-lives in wild-type (AAY277) and upf1Δ 
(AAY363) strains from the BY4741 background.  Strains were grown in rich media 
(YAPD).  10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-life 
calculations were determined using a graph of percent mRNA remaining at each time 
point during the exponential decay.  C) Northern blot analysis of the steady-state 
accumulation of the YAP1, GCN4 and ENT4 mRNAs in wild-type (AAY277) and upf1Δ 
(AAY363) strains in the BY4741 background.  Strains were grown in minimal media (SD 
+ his, leu, met, ura, lys).  D) Northern blot analysis of the YAP1 and GCN4 mRNA half-
lives in wild-type (AAY277) and upf1Δ (AAY363) strains from the BY4741 background.  
Strains were grown in minimal media (SD + his, leu, met, ura, lys).  10µg/ml Thiolutin 
was added to mid-log cultures at time=0 min.  Half-life calculations were determined 
using a graph of percent mRNA remaining at each time point during the exponential 
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decay and are the average of three independent trials. 
 
Fig. 4-2. YAP1 and GCN4 mRNAs are not protected from NMD by trans-acting factor 
Pub1.  A) Northern blot analysis of the steady-state accumulation of YAP1 and GCN4 
mRNAs in wild-type (AAY277), upf1Δ (AAY363), pub1Δ (AAY538), and pub1Δupf1Δ 
(AAY590) strains in the BY4741 background.  Strains were grown in rich media 
(YAPD).  CYH2 pre-mRNA is an NMD control (CYH2 pre-mRNA is an NMD substrate, 
CYH2 mRNA is not an NMD substrate) and SCR1 is shown for loading.  Fold change 
values are normalized and determined as a fold change ratio from wild-type; values are 
an average of three independent trials.  B) Northern blot analysis of the steady-state 
accumulation of YAP1 and GCN4 mRNAs in wild-type (AAY277), upf1Δ (AAY363), 
and pub1Δ (AAY538) strains in the BY4741 background.  Strains were grown in minimal 
media (SD + his, leu, met, ura, lys).  C) Northern blot analysis of YAP1 and GCN4 
mRNA half-lives in wild-type (AAY277) and pub1Δ (AAY538) strains in the BY4741 
background.  Strains were grown in minimal media (SD + his, leu, met, ura, lys).  
10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-life calculations 
were determined using a graph of percent mRNA remaining at each time point during the 
exponential decay and are the average of three independent trials. 
 
Fig. 4-3. YAP1 and GCN4 mRNAs co-fractionate with polyribosomes.  Polyribosome 
analysis of YAP1 (A) and GCN4 (B) mRNAs in wild-type (AAY187) and upf1Δ 
(AAY320) strains.  Strains were grown in YAPD.  Whole cell lysate was centrifuged 
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through a 15-50% sucrose gradient.  Total RNA was extracted from each fraction 
collected and total RNA from fractions 2-19 was transferred to a membrane for Northern 
analysis.  Fractions corresponding to the 40S ribosomal peak are in lanes 4-5, fractions 
corresponding to the 60S ribosomal peak are in lanes 6-7, the fraction corresponding to 
the 80S ribosomal peak is in lane 8 and polyribosome fractions are in lanes 9-15.  The 
graph represents the distribution of the mRNA in each fraction based on the relative 
corrected volume of the mRNA present in each lane.  In lanes where two bands were 
present only the band corresponding to the size of the expected band for the mRNA was 
quantified (~2.0 kb for the YAP1 mRNA).  Polysome analysis was repeated twice with 
similar results. 
 
Fig. 4-4. YAP1 and GCN4 mRNAs accumulate significantly in xrn1Δ strains.  Northern 
blot analysis of the steady-state accumulation of the YAP1, GCN4, ENT4, and PGK1 
mRNAs in wild-type (AAY360), upf1Δ (AAY589), xrn1Δ (AAY389), and xrn1Δupf1Δ 
(AAY611) strains grown in YAPD.  CYH2 pre-mRNA is an NMD control (CYH2 pre-
mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown 
for loading.  Fold change values are normalized and determined as a fold change ratio 
from wild-type; values are an average of three independent trials.  B) mRNA half-life 
analysis of the YAP1 and GCN4 mRNAs in the same strains used in part A.  Strains were 
grown in YAPD.  10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-
life calculations were determined using a graph of percent mRNA remaining at each time 
point during the exponential decay. 
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Fig. 4-5. YAP1 and GCN4 mRNAs do not accumulate in dcp1Δ strains, but half-life 
analysis shows that dcp1Δ stabilizes the mRNAs albeit to different extents.  A)  Northern 
blot analysis of the steady-state accumulation of the YAP1, GCN4, ENT4 and PGK1 
mRNAs in wild-type (AAY360), upf1Δ (AAY589), dcp1Δ (AAY390), and dcp1Δupf1Δ 
(AAY621) strains grown in YAPD.  CYH2 pre-mRNA is an NMD control (CYH2 pre-
mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown 
for loading.  Fold change values are normalized and determined as a fold change ratio 
from wild-type; values are an average of three independent trials.  B) mRNA half-life 
analysis of the YAP1 and GCN4 mRNAs in the same strains used in part A.  Strains were 
grown in YAPD.  10µg/ml Thiolutin was added to mid-log cultures at time=0 min.  Half-
life calculations were determined using a graph of percent mRNA remaining at each time 
point during the exponential decay.   
 
Fig. 4-6. Deadenylation mutants show little effect on YAP1 and GCN4 mRNA stability.  
Northern blot analysis of the steady-state accumulation of the YAP1, GCN4, ENT4, and 
PGK1 mRNAs in wild-type (AAY391), upf1Δ (AAY594), ccr4Δ (AAY393), and 
ccr4Δupf1Δ (AAY596), ccr4Δcaf1Δ (AAY394), ccr4Δcaf1Δupf1Δ (AAY609), pan2Δ 
(AAY395), pan2Δupf1Δ (AAY595), pan2Δccr4Δ (AAY396), and pan2Δccr4Δupf1Δ 
(AAY610) strains grown in YAPD.  CYH2 pre-mRNA is an NMD control (CYH2 pre-
mRNA is an NMD substrate, CYH2 mRNA is not an NMD substrate) and SCR1 is shown 
for loading.  Fold change values are normalized and determined as a fold change ratio 
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from wild-type; values are an average of three independent trials. 
 
Fig. 4-7. The YAP1 mRNA 3’ end is significantly shorter in xrn1Δ and dcp1Δ strains 
compared to wild-type and upf1Δ strains.  A) Schematic of how the Poly(A) Tail Length 
Analysis works.  This analysis was done using the “Poly(A) Tail-Length Assay Kit” from 
Affymetrix (#76455).  In this assay, a G/I tail is added to the end of mRNAs containing a 
Poly(A) tail.  These G/I-tailed mRNAs are then reverse transcribed to cDNA, which 
provides a template for subsequent PCR.  PCR is performed using two sets of primers 
independently. The Gene Specific (G.S.; teal) primer pair is comprised of a forward 
primer that binds anywhere within the open reading frame (ORF) or 3’ UTR and a 
reverse primer that binds immediately upstream (5’) of the Poly(A) start site. *It is 
important to note that the exact Poly(A) start site of the mRNAs in this figure were 
unknown so the reverse primer was designed just upstream of the first predicted Poly(A) 
start site according to the Saccharomyces Genome Database (SGD).  The Poly(A) Tail 
(Tail; pink) primer pair uses the same forward primer from the G.S. pair and a reverse 
primer that anneals to the G/I tail (provided with the kit).  B) Products from the PCR 
reactions using the above primer pairs for the YAP1, ENT4, and PGK1 mRNAs in the 
wild-type (AAY360), upf1Δ (AAY589), xrn1Δ (AAY389), and dcp1Δ (AAY390) strains 
were resolved on a 2.5% agarose TAE gel.  Strains were grown in YAPD and the total 
RNA samples used for the reactions were the same RNA samples that were used for 
Northern analysis in figures 2A and 3A.  
  
192 
 
Figure 4-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
A. Rich Media C. Minimal Media 
B. Rich Media 
D. Minimal Media 
193 
 
 
Figure 4-2 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
Rich Media A. B. Minimal Media 
C. Minimal Media 
194 
 
Figure 4-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
A. 
B. 
195 
 
Figure 4-4 
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Figure 4-5 
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Figure 4-6 
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Figure 4-7 
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Table 4-1.  Strains used in this study 
Strain 
Parent 
Strain 
Genotype Source 
W303  
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 
Ralser et al., 
2012 
BY4741  MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
Winston et al., 
1998 
AAY320 W303 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 upf1::URA3 
Atkin lab 
AAY360   
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 
He and 
Jacobson, 1995 
AAY363 BY4741 MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 upf1::URA3 Atkin lab 
AAY389 AAY360 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 xrn1::ADE2 
He and 
Jacobson, 2001 
AAY390 AAY360 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 dcp1::URA3 
He and 
Jacobson, 2001 
AAY391   
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM 
Tucker et al., 
2001 
AAY393 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO 
Tucker et al., 
2001 
AAY394 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO caf1::URA3 
Tucker et al., 
2001 
AAY395 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM pan2::URA3 
Tucker et al., 
2001 
AAY396 AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO pan2::URA3 
Tucker et al., 
2001 
AAY538 BY4741 MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pub1Δ 
Open 
Biosystems 
AAY589* AAY360 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 upf1::URA3 
Atkin lab 
AAY590* AAY538 
MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pub1Δ 
upf1::URA3 
Atkin lab 
AAY594* AAY391 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM upf1::TRP1 
Atkin lab 
AAY595* AAY395 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM pan2::URA3 upf1::TRP1 
Atkin lab 
AAY596* AAY393 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO upf1::TRP1 
Atkin lab 
AAY609* AAY394 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO caf1::URA3 upf1::TRP1  
Atkin lab 
AAY610* AAY396 
MATa  his4-539 trp1 ura3-52 leu2-3,112 
cup1Δ::LEU2PM ccr4::NEO pan2::URA3 upf1::TRP1 
Atkin lab 
AAY611* AAY389 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 xrn1::ADE2 upf1::TRP1 
Atkin lab 
AAY621* AAY390 
MATa  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-
100 dcp1::URA3 upf1::TRP1 
Atkin lab 
* = new strain created for this study 
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Abstract 
 
A scalable four-step synthesis of the ornithine transcarbamylase inhibitor N5-
phosphonoacetyl-L-ornithine (PALO) is reported based upon selective protection of the 
amino acid of ornithine as a boroxazolidinone.  Investigations in the model organism 
Saccharomyces cerevisiae found PALO did not influence growth rate or expression of 
genes involved in arginine metabolism. 
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Introduction 
N5-Phosphonoacetyl-L-ornithine (PALO) is a bisubstrate transition-state analog 
which competitively inhibits ornithine transcarbamylase (OTC), shutting down the 
biosynthesis of citrulline in both the urea and the arginine biosynthetic pathways (Mori et 
al., 1977; Penninckx and Gigot, 1978).  Competitive inhibitors of amino acid metabolism 
have been key components in studies ranging from arginine starvation in fungi and bacteria 
to studies on OTC deficiency (Alewood et al., 1984; Kinney and Lusty, 1989).   
Earlier work by Kinney and Lusty suggested that PALO would be an effective tool 
for the study of arginine metabolism in the yeast Saccharomyces cerevisiae (Kinney and 
Lusty, 1989).  Arginine is used by all organisms for protein synthesis, and is also used by 
yeast as a nitrogen source (Hoogenraad, 1978; Penninckx and Gigot, 1978, 1979).  The 
biosynthesis and metabolism of arginine are carefully regulated (Wu and Morris, 1998).  
Arginine metabolism is required for the escape of the human pathogenic yeast Candida 
albicans from macrophages (Lorenz et al., 2004).  We were specifically interested in 
applying PALO as a tool to determine whether both arginine biosynthesis and metabolism 
are required for this evasion of the immune system, which is presumed critical to the 
success of C. albicans as an invasive opportunistic pathogen. We now report a short and 
scalable synthesis of PALO, as well as results of investigations into the influence of PALO 
on growth and arginine metabolism in the model organism S. cerevisiae.  
 
Materials and Methods 
Yeast strains and growth conditions 
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Saccharomyces cerevisiae strains BY4741 (MATa his3-1 leu2-0 met15-0 ura3-0) 
(Ref 1, 2, 7), YSC1178-7500224 (MATa his3-1 leu2-0 met15-0 ura3-0 ARG5,6-
TAP), YSC1178-7502950 (MATa his3-1 leu2-0 met15-0 ura3-0, CPA1-TAP) and 
YSC1178-7500415 (MATa his3-1 leu2-0 met15-0 ura3-0, TRP5-TAP) were used.  
BY4741 was purchased from the American Type Culture Collection (ATCC, Manassas, 
VA).  The YSC1178 strains were purchased from Open Biosystems Products (Huntsville, 
AL).  S. cerevisiae strains were inoculated from a saturated culture incubated at 30°C in 
YPD in a tube roller in minimal medium supplemented with leucine, methionine, uracil 
and histidine.  Cultures were treated with 15 µM PALO in a 50 mM potassium phosphate 
pH 6.8 buffer, potassium phosphate buffer pH 6.8 alone (untreated), 1 mg/mL arginine, 
or both 15 µM PALO and 1 mg/mL arginine at the time of inoculation.  Cells were 
incubated at 30°C and then harvested at mid-log growth phase (OD600 0.4-0.6).  Cells 
were observed for effects on growth via incubation at 30°C in nitrogen-limiting medium 
containing 2% dextrose, 1 mM ammonium sulfate, 100 µM potassium phosphate buffer 
pH 6.8, and 10 µg/mL leucine, methionine, uracil and histidine. 
 
Quantitative northern analysis of mRNA levels   
Steady-state mRNA levels were measured as previously described.  Oligolabeled DNA 
probes were used to probe the northern blots.  DNA probes were generated using primer 
sets for amplifying yeast open reading frames based on the sequences available from the 
Saccharomyces Genome Database (http://www.yeastgenome.org/). 
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Western blot analysis 
Western blots were prepared as previously described (Atkin et al., 1995).  TAP-tagged 
Arg5,6p, Cpa1p and Trp5p were detected with Supersignal West Pico chemiluminescent 
substrate, using the manufacturers protocol (Pierce, Rockford, IL).  Rabbit anti-TAP 
polyclonal antibodies were purchased from Thermo Fisher Scientific Inc. (Rockford, IL) 
and goat anti-rabbit IgG polyclonal antibodies conjugated with horseradish peroxidase 
were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). 
 
Results 
A study by Kinney and Lusty reported that PALO increased expression of CPA1, 
CPA2, HIS3, and TRP5 reporter constructs in the yeast S. cerevisiae (Kinney and Lusty, 
1989).  The data were consistent with limitation of arginine leading to specific up 
regulation of arginine biosynthetic genes (CPA1 and CPA2), and a general amino acid 
starvation response typified by up regulation of HIS3 and TRP5. 
We tested whether treatment with PALO resulted in changes in mRNA 
accumulation and/or translation of genes involved in amino acid biosynthesis.  We 
examined expression of two genes required for arginine biosynthesis; ARG5,6, which 
encodes protein involved in the second and third steps of arginine biosynthesis from 
glutamate, and CPA1, which encodes a subunit of arginine-specific carbamyl-phosphate 
synthetase.  Both of these genes are up regulated specifically in response to arginine 
limitation.  Expression of TRP5, which encodes an enzyme that catalyzes the final step in 
tryptophan biosynthesis, was also examined as an indicator of the general amino acid 
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starvation response.  Quantitative northern analysis was performed to measure mRNA 
abundance, a measure of the combined rates of transcription and mRNA decay. Western 
analysis was performed to measure mRNA abundance, a measure of the combined rates 
of transcription and MRNA decay.  Western Analysis was used to look at the level of 
protein synthesis for these genes.  This combined approach enabled direct evaluation of 
effects on transcription, mRNA stability, and translation. 
Although the yeast strains from the earlier studies were not available, (Kinney and 
Lusty, 1989) they were derived from the W303 genetic background, which usually carry 
the can1-100 mutation (Thomas and Rothstein, 1989).  As CAN1 encodes an arginine 
permease required for efficient uptake of arginine, the can1-100 mutation is not well 
suited for the current experiments. As a compromise, and to assess if PALO will be 
generally useful as a metabolic tool in S. cerevisiae, the current data was obtained using 
the BY4741 strain of S. cerevisiae (Brachmann et al., 1998).  This strain is derived from 
S288C, the strain used in the systematic sequencing project, and it is the most commonly 
used genetic background for genome-wide functional analyses. 
If PALO affects transcription or mRNA stability, we expected to observe an 
increase in expression of ARG5,6 CPA1, and TRP5 mRNA transcripts in the presence of 
PALO.  We also expected that addition of arginine would relieve the arginine limitation 
induced by PALO.  Cells were grown and treated with either 15 μM of the synthesized 
PALO, 1 mg/mL L-arginine, or 15 μM of the synthesized PALO and 1 mg/mL L-arginine 
as described by Kinney and Lusty (Kinney and Lusty, 1989).  An untreated culture was 
grown in the same media as a control.  The abundance of ARG5,6, CPA1, and TRP5 
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mRNAs was measured by quantitative northern analysis (Fig. 1A).  The abundance of 
ARG5,6, CPA1, and TRP5 mRNAs in the PALO treated cells was not significantly 
different from the untreated cells.  The abundance of ARG5,6 and CPA1, but not TRP5 
mRNAs was lower in cells treated with arginine regardless of whether the cells were 
treated with PALO or not.  Additionally, the abundance of the TRP5 transcript did not 
show any variation in response to addition of PALO, arginine, or both.  In summary, 
treatment with PALO had no effect on the abundance of ARG5,6, CPA1 or TRP5 
mRNAs.  
The possible effect of PALO on translation was investigated by western analysis 
(Fig. 1B).  If PALO affects translation, we expected to see an increase in the production 
of Arg5,6p, Cpa1p, and Trp5p in the presence of PALO.  We also expected that addition 
of L-arginine would reduce protein levels of Arg5,6p and Cpa1p, but not Trp5p.  We 
used cell extracts from strains (YSC1178-7500224, YSC1178-7502950 and YSC1178-
7500415, respectively) carrying TAP-tagged alleles of ARG5,6, CPA1, and TRP5 for the 
Western analysis.  These strains produce a TAP-fusion protein for each gene, which can 
be detected on western blots with anti-TAP antibodies.  BY4741 was used as an untagged 
control because it is the parent strain for the TAP-tagged strains.  Cells were grown and 
treated in the same manner as for the northern analysis.  Measurement of the signal 
intensity of the bands was detected by western blotting revealed no difference in the 
production of Arg5,6, Cpa1, or Trp5 between strains treated with 15 μM PALO and the 
control.  As expected, addition of L-arginine reduced production of Arg5,6 and Cpa1p, 
but not Trp5p regardless of whether PALO was added or not.  In summary, PALO had no 
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effect on Arg5,6, Cpa1, and Trp5 protein levels. 
PALO did not affect the growth rate of BY4741 in minimal media or nitrogen-
limiting medium (data not shown), used in an attempt to increase sensitivity to PALO by 
lowering intracellular arginine concentrations.  Growth in nitrogen-limiting medium 
induces cells to use amino acids, including arginine, as a source of nitrogen.  These 
findings were consistent with the observations reported by Kinney and Lusty (Kinney and 
Lusty, 1989). 
 
Conclusions 
We have developed an efficient synthesis of very pure PALO by a route suitable 
for both analytical and preparative applications. In contrast to a previous report 
describing PALO-induced arginine starvation, (Kinney and Lusty, 1989) we observed no 
response in S. cerevisiae strain BY4741 to treatment with PALO (Fig. 1).  The 
discrepancy suggests either that not all yeast strains are sensitive to PALO or that the 
earlier indications of arginine starvation resulted from impurities in the samples of PALO 
employed.  The current results are consistent with observations that PALO had no effect 
in isolated rat mitochondria, intact rat hepatocytes, or E. coli (Hoogenraad, 1978; 
Penninckx and Gigot, 1979). 
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Figure Legend 
Fig. 5-1. PALO has no effect on expression of the ARG5,6, CPA1, and TRP5 genes in 
Saccharomyces cerevisiae.  S. cerevisiae strains (Brachmann et al., 1998) were 
inoculated from a saturated culture into minimal medium supplemented with leucine, 
methionine, uracil, and histidine. Cultures were treated with 15 μM PALO in a potassium 
phosphate pH 6.8 buffer, potassium phosphate buffer pH 6.8 alone (untreated), 1 mg/mL 
L-Arginine, or both 15 μM PALO and 1 mg/mL L-Arginine at the time of inoculation.  
Cells were incubated at 30°C and then harvested at mid-log growth phase (OD600 0.4-
0.6).  A) Northern blots were prepared with total RNA extracted from BY4741 
(Brachmann et al., 1998) and probed with oligolabeled DNA probes (Kebaara et al., 
2003).  DNA probes were generated using primer sets for amplifying yeast open reading 
frames based on the sequences available from the Saccharomyces Genome Database.  
Shown are representative phosphor-images of a northern blot probed with radioactive 
ARG5,6, CPA1, TRP5, and SCR1 DNAs.  SCR1 was used as a loading control.  
Quantitative results depicted are the average of three replicate trials and are normalized to 
the SCR1 loading control.  B) Western blots were prepared using protein extracts from S. 
cerevisiae YSC1178-7500224, YSC1178-7502950 and YSC1178-7500415 strains 
expressing TAP-fusion proteins Arg5,6-TAP, Cpa1-TAP, and Trp5-TAP, respectively, as 
well as BY4741 (untagged control; Atkin et al., 1995).  The TAP-tagged proteins were 
detected using an anti-TAP antibody.  No proteins bound the anti-TAP antibody in the 
untagged control.  Duplicate polyacrylamide gels were stained with Coomassie blue for 
use as loading controls.  The corresponding loading controls are shown beneath the 
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western blots. 
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Summary and Future Directions 
The regulation of gene expression in eukaryotes is a very delicate process 
regulated at multiple levels.  A mishap at any point in the regulatory process can be 
detrimental to organisms.  On the same token, as long as all of the cellular processes that 
contribute to the regulation of gene expression are in-check, then organisms are able to 
maintain cellular homeostasis and overall health.  The phrase “gene expression” is often 
most closely associated with the regulation of translation.  While this is not incorrect, we 
must be aware that the regulation of gene expression begins on a much deeper level.  
Even before the translation machinery begins translating an mRNA the mRNA itself is 
subject to extensive regulation through the regulation of mRNA transcription and mRNA 
degradation.  Further, there are cellular quality control processes that ensure improperly 
transcribed mRNAs are not further translated into deleterious or toxic proteins.  These 
quality control processes include: 1) no-go decay (NGD), which is responsible for 
releasing ribosomes that have stalled on the mRNA and degrading the mRNA (Harigaya 
and Parker, 2010), 2) nonstop decay (NSD), which degrades transcripts that lack a stop 
codon allowing the ribosome to translate through the poly(A) tail adding a string of poly-
lysines to the end of the protein (Frischmeyer et al., 2002), and 3) nonsense-mediated 
mRNA decay (NMD), which is responsible for the rapid degradation of mRNAs that 
harbor premature termination codons (PTCs; Akimitsu, 2008; Baker and Parker, 2004; 
Behm-Ansmant et al., 2007; Chang et al., 2007; Frischmeyer and Dietz, 1999; Hentze 
and Kulozik, 1999; Hilleren and Parker, 1999; Muhlemann et al., 2008; Schweingruber et 
al., 2013; Shyu et al., 2008).  While NMD was first discovered as an mRNA surveillance 
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mechanism it is now recognized that NMD plays a much broader role in the regulation of 
wild-type mRNAs as well (Guan et al., 2006; He et al., 2003; Johansson et al., 2007; 
Kalyna et al., 2012; Lelivelt and Culbertson, 1999; Mendell et al., 2004; Mitrovich and 
Anderson, 2005; Peccarelli and Kebaara, 2014; Rayson et al., 2012; Rehwinkel et al., 
2005). 
The known features that have been shown to target a wild-type mRNA for 
degradation by NMD include: 1) a long 3’ UTR (Amrani et al., 2004; Kebaara and Atkin, 
2009; Muhlrad and Parker, 1999), 2) translation of an upstream open reading frame 
(uORF; Amrani et al., 2006; Barbosa et al., 2013; Gaba et al., 2005; Nyiko et al., 2009), 
3) a start codon in a suboptimal context which can lead to leaky scanning and out of 
frame initiation of translation (Welch and Jacobson, 1999), 4) the presence of 
programmed ribosome frameshift (PRF) sites (Plant et al., 2004) and 5) the presence of 
pre-mRNA introns and regulated alternative splicing resulting in PTCs (He et al., 1993; 
Lewis et al., 2003; McGlincy and Smith, 2008; Ni et al., 2007). 
Further, not all mRNAs with NMD-targeting signals are degraded by NMD.  The 
mechanisms of protection of mRNAs from degradation by NMD that have been 
identified include: 1) inhibition of translation (Bertram et al., 2001; Czaplinski et al., 
1998; Gozalbo and Hohmann, 1990; He et al., 1993; Herrick et al., 1990; Keeling et al., 
2004; Kisselev et al., 2003; Peltz et al., 1992; Rospert et al., 2005; Tholstrup et al., 2012; 
Zhang et al., 1997; Zuk and Jacobson, 1998), 2) stop codon readthrough (Bonetti et al., 
1995; Keeling et al., 2004; Namy et al., 2001), 3) translation reinitiation after a ribosome 
encounters a stop codon (Hall and Thein, 1994; Neu-Yilik et al., 2011; Thein et al., 
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1990), and, 4) trans-acting factor Pub1 (Ruiz-Echevarria and Peltz, 2000). 
Although the NMD pathway has been studied extensively over the past decade, 
and in multiple eukaryotes including Saccharomyces cerevisiae, Drosophila, C. elegans, 
Arabidopsis, and mammalian cells, the exact molecular mechanism of the NMD pathway 
remains obscure (Bedwell et al., 1997; Grimson et al., 2004; Hall and Thein, 1994; He et 
al., 2003; Hentze and Kulozik, 1999; Kalyna et al., 2012; Kurihara et al., 2009; Maquat 
and Carmichael, 2001; Maquat and Serin, 2001; Mendell et al., 2004; Pulak and 
Anderson, 1993; Rayson et al., 2012; Rehwinkel et al., 2005).  Because as many as one 
third of all genetic diseases and cancers are linked to NMD, manipulation of the NMD 
pathway has been a targeted area of study for the development of disease therapies 
(Culbertson, 1999; Frischmeyer and Dietz, 1999; Kuzmiak and Maquat, 2006; Peltz et 
al., 2013).  However, the development of safe and effective therapies is hindered by the 
obscurity of the exact molecular mechanisms of the NMD pathway.  Thus, a thorough 
understanding of how the cellular machinery distinguishes and wild-type mRNA from an 
NMD substrate is a vital piece of being able to effectively treat NMD-related diseases. 
Here we have provided a detailed investigation of a unique mRNA in 
Saccharomyces cerevisiae, the SSY5 mRNA, which contains multiple NMD-targeting 
signals but is not degraded by the NMD pathway.  We show that many of the known 
mechanisms that are responsible for the protection of mRNAs from NMD do not apply to 
the SSY5 mRNA, thus, this mRNA is protected from NMD through a novel mechanism 
(Chapter 2).  We also show that the SSY5 mRNA is very tightly regulated during the 
mRNA decay process (Chapter 3).  Additionally, we also begin to characterize the 
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stability of two additional wild-type mRNAs in S. cerevisiae, the YAP1 and GCN4 
mRNAs, which are protected from degradation by NMD despite containing translated 
uORFs—an NMD-targeting signal (Chapter 4).  Characterization of the stability of the 
SSY5, YAP1 and GCN4 mRNAs provides valuable clues to understanding the molecular 
mechanisms that control wild-type gene regulation by NMD. 
 
Chapter 1:  The S. cerevisiae SSY5 mRNA is not degraded by NMD despite multiple 
NMD-targeting signals 
 The SSY5 mRNA was originally identified as a wild-type mRNA that should be 
degraded by NMD in a screen for mRNAs in S. cerevisiae which contained long 3’ UTRs 
(Kebaara and Atkin, 2009).  Initial data from this study indicated that the SSY5 mRNA 
was the only mRNA identified in the screen that contained a long 3’ UTR but showed no 
difference in mRNA accumulation or half-life between wild-type and upf1Δ strains.  
Upon closer analysis of the SSY5 mRNA we discovered that there were actually multiple 
NMD-targeting signals present including: 1) a translated uORF, 2) a start codon in a poor 
context that could lead to leaky scanning and out-of-frame initiation of translation, and 3) 
the presence of five predicted ribosome frameshift sites.  The long 3’ UTR of the SSY5 
mRNA was previously characterized as a positive NMD-targeting signal (Obenoskey et 
al., 2014).  The translation of the uORF is shown with ribosome footprint data from 
genome-wide studies that has been compiled in the GWIPS-viz genome browser (Michel 
et al., 2014).  However, further studies are needed to determine if leaky scanning or 
programmed ribosome frameshifting is occurring.   
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Our studies confirm that the SSY5 mRNA shows similar accumulation and half-
life in both wild-type and upf1Δ strains in two different S. cerevisiae genetic 
backgrounds, BY4741 and W303.  Additionally, differences in amino acid composition 
of growth media does not affect SSY5 mRNA stability.  The amino acid composition of 
the growth media was taken into consideration because the SSY5 mRNA codes for an 
essential proteolytic component of the SPS amino-acid-sensing complex in S. cerevisiae 
(Conrad et al., 2014; Ljungdahl, 2009).  
 A previous study showed that when the long 3’ UTR of the SSY5 mRNA is placed 
on an NMD-insensitive mRNA and the construct becomes a substrate for NMD 
(Obenoskey et al., 2014).  This data provides evidence that the long 3’ UTR of the SSY5 
mRNA is sufficient to target an mRNA for degradation by NMD.  Thus, there is a 
mechanism that is protecting the SSY5 mRNA from being degraded by NMD.  We further 
showed that replacing the long 3’ UTR of the SSY5 mRNA with the short 3’ UTR of the 
ADH1 mRNA does not affect the stability of the construct.  So, the mechanism of 
protection from NMD is not contained within the SSY5 mRNA 3’ UTR.  We also 
removed the SSY5 mRNA uORF by replacing the 5’ leader of the SSY5 mRNA with the 
galactose promoter sequence.  This construct did not have altered mRNA accumulation 
or half-life in wild-type vs upf1Δ strains showing that the SSY5 mRNA uORF is not 
required for protection from NMD. 
 The SSY5 mRNA is also not protected from NMD by known mechanism of 
protection.  We showed that the SSY5 mRNA co-fractionates with polyribosomes and is 
actively translated.  Additionally, although the SSY5 mRNA 3’ UTR is favorable for both 
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stop codon readthrough and reinitiation of translation, we do not find evidence of either. 
 Together, these studies show that the SSY5 mRNA is a very likely candidate for 
degradation by the NMD pathway, and the protection of this mRNA from NMD occurs 
through a novel mechanism.  Future studies should investigate whether the NMD mRNP 
is forming, either partially or completely, on the SSY5 mRNA.  This would provide 
information as to whether or not the SSY5 mRNA is recognized by the NMD machinery 
as a substrate for NMD.  Preliminary studies of this have begun but the experimental 
procedures and controls need further optimization. 
 Additionally, we characterized the ENT4 mRNA in S. cerevisiae as a wild-type 
mRNA that has a long 3’ UTR and is a substrate for NMD.  This provides a positive 
control for a wild-type substrate of NMD.  Moreover, the current function of the gene 
product of the ENT4 mRNA is unknown.  Determining the function of the product of the 
ENT4 mRNA will provide further insight into the physiological significance of wild-type 
gene regulation by NMD in S. cerevisiae. 
 Further, the SPS-sensing pathway, which Ssy5 is an essential component of, is 
critical for amino-acid sensing of the human fungal commensal and pathogen Candida 
albicans.  Importantly, the SPS pathway also controls the expression of virulence factors 
in C. albicans (Davis et al., 2011).  Further investigation of the stability of the SSY5 
mRNA in C. albicans could provide important clues for understanding both the 
pathogenicity of C. albicans in humans as well as SSY5 mRNA regulation by NMD. 
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Chapter 3:  The SSY5 mRNA is very tightly regulated during mRNA degradation 
 Further characterization of the degradation of the SSY5 mRNA shows several 
unique characteristics.  First, the SSY5 mRNA does not follow a pattern representative of 
wild-type mRNA decay through a deadenylation-dependent mechanism nor does the 
mRNA follow a pattern of deadenylation-independent degradation representative of an 
NMD substrate.  Second, SSY5 mRNA accumulation is significantly increased when the 
primary 5’3’ exonuclease Xrn1 is deleted.  However, when decapping is blocked by 
deletion of decapping component Dcp1, SSY5 mRNA accumulation is very modestly 
increased.  So, when the SSY5 mRNA is capped (in the dcp1Δ cells) the mRNA can still 
be rapidly degraded 3’5’ by the exosome, but when the mRNA is decapped and 5’3’ 
degradation is blocked (in the xrn1Δ cells), 3’5’ degradation is not able to adequately 
compensate.  Further, deletion of any of the deadenylation components does not impact 
SSY5 mRNA stability.  Together these results show that SSY5 mRNA stability is very 
tightly regulated at a step between mRNA decapping and 5’3’ exonucloelytic 
degradation.  This is fascinating because these processes occur subsequently and very 
rapidly during mRNA decay.  For completeness, future experiments should include an 
analysis of the SSY5 mRNA in mutants of the components of the cytoplasmic exosome, 
such as the catalytic component Dis3. 
 Additionally, analysis of the 3’ end of the SSY5 mRNA shows a pattern of 3’ end 
shortening that is similar to what is seen for a wild-type mRNA that is deadenylated 
before being decapped (PGK1 mRNA).  Both the PGK1 and SSY5 mRNAs have longer 
3’ ends in wild-type and upf1Δ strains and shorter 3’ ends in xrn1Δ and dcp1Δ strains.  
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This is in contrast to the ENT4 mRNA—a wild-type substrate degraded NMD in S. 
cerevisiae—which shows the opposite pattern with a shorter 3’ end in wild-type and 
upf1Δ strains and a longer 3’ end in xrn1Δ and dcp1Δ strains.  This observation is likely 
the result of the rate at which the 3’ end is degraded in wild-type versus NMD substrates 
where 3’ end degradation occurs very rapidly following decapping for an NMD substrate 
(Cao and Parker, 2003).  However, to be able to conclude a change in length of the 3’ end 
is the result of deadenylation we need to repeat the experiment with an RNase H control, 
which removes the poly(A) tail. 
 An unexpected result of the studies in this section was that in a certain strain 
background (not BY4741 or W303) the SSY5 mRNA does appear to be slightly stabilized 
in the upf1Δ mutant.  Initially, this was a troubling observation.  However, upon further 
consideration we have realized this can be used to our advantage.  By determining the 
difference(s) between this strain background and the BY4741 and W303 strains we can 
drastically narrow down potential NMD-protecting mechanisms.  Further characterization 
of this strain background will be required.  Once differences in the strain background are 
identified we can begin studies to determine what might be, at least partially, responsible 
for the protection of the SSY5 mRNA from NMD.  This mechanism of protection may 
then be further studied for other wild-type mRNAs that have NMD-targeting signals but 
are not degraded by NMD, such as the YAP1 and GCN4 mRNAs. 
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Chapter 4:  The S. cerevisiae wild-type mRNAs YAP1 and GCN4 also contain NMD-
targeting signals but are not degraded by NMD 
 The YAP1 and GCN4 mRNAs were previously identified as wild-type mRNAs in 
S. cerevisiae that have translated uORFS—an NMD-targeting signal—but are not 
degraded by NMD (Ruiz-Echevarria et al., 1998; Vilela et al., 1998).  A subsequent study 
showed that both the YAP1 and GCN4 mRNAs are protected from degradation by NMD 
due to the trans-acting factor Pub1 binding to a stabilizer element (STE) in the 5’ leader 
of the mRNA downstream of the uORF stop codon (Ruiz-Echevarria and Peltz, 2000). 
 During our initial investigation into the protection of the SSY5 mRNA from NMD 
we made the hypothesis that, based on the previous results, Pub1 could also be involved 
in the protection of the SSY5 mRNA from NMD.  Because Pub1 had already been clearly 
implicated in the protection of both YAP1 and GCN4 mRNAs from NMD these were 
included as controls.  However, in our hands we were unable to reproduce the previously 
published results despite extensive efforts.  This means that we now have two additional 
mRNAs in S. cerevisiae that have at least one NMD-targeting signal (we have not looked 
for others) but are protected from degradation by NMD through an unknown mechanism. 
 We confirmed that both YAP1 and GCN4 mRNAs are protected from degradation 
by NMD.  However, half-life analysis in wild-type and upf1Δ strains provided stronger 
confirmation of protection from NMD than steady-state mRNA accumulations.  Because 
the product of the GCN4 mRNA, Gcn4, is also involved in amino acid regulation we 
again looked to see if the amino acid composition of the media had any influence on 
mRNA stability of either of these mRNAs.  We found that neither strain background nor 
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amino acid composition of the media influenced the stability of either mRNA.  However, 
as was the case when looking at SSY5 mRNA stability, the same holds true here where 
we could not use a true amino-acid starvation media due to the auxotrophies of the strains 
used.  We could only provide fewer amino acids than are present in rich YAPD media.  
True amino acid starvation or complete nitrogen starvation may influence mRNA 
stability, but we were unable to test this. 
 We were unable to show that trans-acting factor Pub1 is solely responsible for the 
protection of GCN4 and YAP1 mRNAs from NMD.  However, we have preliminary data 
that suggests, at least for the YAP1 mRNA, that Pub1 may be involved in the stability of 
the mRNA but its role is more complex than previously indicated.  Additionally, in 
looking at the decay of the YAP1 and GCN4 mRNAs we find a unique pattern that does 
not mimic that of a known NMD substrate (ENT4 mRNA), a wild-type mRNA degraded 
by the deadenylation-dependent decapping pathway (PGK1 mRNA), or the SSY5 mRNA.  
Unlike the SSY5 and ENT4 mRNAs, the YAP1 and GCN4 mRNAs show only a slight 
increase in accumulation in an xrn1Δ strain, but still more accumulation than what is 
observed for the PGK1 mRNA.  Further, the YAP1 and GCN4 mRNAs show no 
significant difference in accumulation in a dcp1Δ strain.  This is again in contrast to the 
SSY5 mRNA, which shows a slight increase in accumulation in a dcp1Δ strain.  However, 
it is similar to what is observed for the PGK1 mRNA, which shows no significant 
difference in accumulation in a dcp1Δ strain.  This does point to a tight window of 
regulation between decapping and 5’3’ mRNA decay for both YAP1 and GCN4 
mRNAs, but the fold changes are less than what are observed for the SSY5 mRNA, which 
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could suggest a larger role of 3’5’ mRNA decay for YAP1 and GCN4 mRNAs.  The 
deadenylation mutants also did not influence the accumulation of the YAP1 or GCN4 
mRNAs consistent with what we observed for the SSY5, ENT4 and PGK1 mRNAs. 
 We also looked at the behavior of the 3’ end of the YAP1 mRNA in the wild-type, 
upf1Δ, xrn1Δ and dcp1Δ strains.  The data from this experiment shows that the 3’ end of 
the YAP1 mRNA behaves similarly to the 3’ end of the PGK1 mRNA in all of the 
mutants.  The 3’ end of both YAP1 and PGK1 mRNAs is longer in wild-type and upf1Δ 
strains and shorter in xrn1Δ and dcp1Δ strains.  Again, to be able to conclude this change 
in length is the result of deadenylation we need to repeat the experiment with an RNase H 
control.  This assay also needs to be performed for the GCN4 mRNA, which was not 
originally included due to the cost of the kit and the minimal number of reactions 
provided. 
 
Final Thoughts 
Although manipulation of the NMD pathway as a means of disease treatment 
seems logical, and is currently being pursued all the way into clinical trials, this is 
troubling given how much we still do not know about the underlying mechanisms of the 
NMD pathway and wild-type gene regulation by NMD.  Clinical trials of drugs, such as 
Ataluren, are optimistically reporting no significant side effects of such therapies.  
However, no long-term study data is available as these are newly developed therapies.  It 
is quite possible that side-effects may become apparent several years down the line.  
Thus, it is absolutely critical that we continue attempts to elucidate the underlying 
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mechanisms of the NMD pathway in order to make treatments safer and more effective.  
As with the development of any disease therapy, NMD-disease therapies will continue to 
be modified as we learn more about the mechanisms of NMD.  However, clinical trials of 
NMD-related therapies at this point seems troublingly premature.  
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